doczyai-pipelines/fieldExtraction/crosswalk/mapping_csvs/proc_cd/cpt.csv at 664397d7137d700da68b17274b1c5968ed3ea97a

Files

T

Katon Minhas 664397d713 Merged in feature/proc-desc (pull request #400 )

feature/proc desc

* Update crosswalks - individual code level

* add embeddings

* Update embeddings

* Proc mappings

* code description mapping for PROC codes

* Code map bug fixes

* docstrings

* Initialize Rev and Diag descriptions

* Add 0 to front for rev codes

* Comments

* Merged main into feature/proc-desc

* Comments

* Separate grouper and diag codes

* add grouper version

* Bugfix"

* Add admit type code

* add proc mod description

* Add bill type pos mapping

* Merged main into feature/proc-desc

* Uncomment test code

* Bugfix

* Remove test.py

* list bugfix

* Merged main into feature/proc-desc

* concurrency


Approved-by: Alex Galarce

2025-02-20 04:10:33 +00:00

2.6 MiB

Raw Blame History

1	Code	Description	Short_Description
2	G0525	Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model	Est pt-cg dyad dem mod cmplx
3	G0519	Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model	New pt-cg dyad dem low cmplx
4	J3247	Injection, secukinumab, intravenous, 1 mg	Inj secukinumab intrav 1mg
5	C1605	Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation	Pmkr, dual, leadless
6	J3393	Injection, betibeglogene autotemcel, per treatment	Inj, betibeglogene autotemce
7	J7171	Injection, adamts13, recombinant-krhn, 10 iu	Inj, adzynma, 10 iu
8	J2468	Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to j2469, 25 micrograms	Inj, palonosetron (avyxa)
9	Q4318	E-graft, per square centimeter	E-graft, per sq cm
10	G0522	Management of a new patient with dementia, low complexity, for use in cmmi model	Mgt nw pt dementia low cmplx
11	J2246	Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg	Inj, micafungin (baxter)
12	J9361	Injection, efbemalenograstim alfa-vuxw, 0.5 mg	Inj, efbemalenograstim alfa-
13	Q4324	Amniotx, per square centimeter	Amniotx, per sq cm
14	Q4331	Axolotl graft, per square centimeter	Axolotl graft, per sq cm
15	G0528	Management of established patient with dementia, moderate to high complexity, for use in cmmi model	Mgt est pt dem mod-hi cmplx
16	J0687	Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg	Inj cefazolin (wg crit care)
17	Q4316	Amchoplast, per square centimeter	Amchoplast, per sq cm
18	G0520	Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model	New pt-cg dyad dem mod cmplx
19	Q4322	Caregraft, per square centimeter	Caregraft, per sq cm
20	G9037	Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes	Intrpro req fr rec phys/qhcp
21	G0531	Facility-based respite, 24-hour unit, for use in cmmi model	Fclty-based respite, 24 hr u
22	Q4319	Sanograft, per square centimeter	Sanograft, per sq cm
23	J7355	Injection, travoprost, intracameral implant, 1 microgram	Inj travoprost intra impl
24	Q4325	Acapatch, per square centimeter	Acapatch, per sq cm
25	J2267	Injection, mirikizumab-mrkz, 1 mg	Inj, mirikizumab-mrkz, 1 mg
26	J3263	Injection, toripalimab-tpzi, 1 mg	Inj, toripalimab-tpzi, 1 mg
27	Q4329	Singlay, per square centimeter	Singlay, per sq cm
28	Q5138	Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg	Inj, wezlana, iv, 1 mg
29	Q4330	Total, per square centimeter	Total, per sq cm
30	G0521	Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model	New pt-cg dyad dem hig cmplx
31	Q4323	Alloply, per square centimeter	Alloply, per sq cm
32	J2183	Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg	Inj meropenem (wg crit care)
33	J0211	Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)	Inj, nithiodote, 3mg / 125mg
34	Q4333	Ardeograft, per square centimeter	Ardeograft, per sq cm
35	J2470	Injection, pantoprazole sodium, 40 mg	Inj pantoprazole sodium 40mg
36	Q4315	Regenelink amniotic membrane allograft, per square centimeter	Regenelink amniotic mem allo
37	J8611	Methotrexate (jylamvo), oral, 2.5 mg	Oral methotrexate (jylamvo)
38	Q2055	Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose	Idecabtagene vicleucel car
39	J9046	Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg	Inj, bortezomib, dr. reddy's
40	J0893	Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg	Inj, decitabine (sun pharma)
41	J1806	Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg	Inj esmolol hcl wg crit care
42	J0401	Injection, aripiprazole (abilify maintena), 1 mg	Inj, abilify maintena, 1 mg
43	J2806	Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms	Inj sincalide, maia, 5 mcg
44	J9258	Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg	Paclitaxel (teva)
45	J0873	Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg	Inj daptomycin (xellia)
46	J2021	Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg	Inj, linezolid (hospira)
47	J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	Inj, acetaminophen (hikma)
48	J9294	Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg	Inj pemetrexed, hospira 10mg
49	J9322	Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg	Inj pemetrexed (bluepoint)
50	J9172	Injection, docetaxel (ingenus), not therapeutically equivalent to j9171, 1 mg	Docetaxel (ingenus), 1 mg
51	J0652	Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg	Inj, levothyroxine, hikma
52	C9113	Injection, pantoprazole sodium, per vial	Inj pantoprazole sodium, via
53	C9166	Injection, secukinumab, intravenous, 1 mg	Injection, secukinumab
54	J9371	Injection, vincristine sulfate liposome, 1 mg	Inj, vincristine sul lip 1mg
55	Q4277	Woundplus membrane or e-graft, per square centimeter	Woundplus e-grat, per sq cm
56	S0164	Injection, pantoprazole sodium, 40 mg	Injection pantroprazole
57	C9167	Injection, adamts13, recombinant-krhn, 10 iu	Inj, adzynma, 10 iu
58	G0238	THERAPEUTIC PROCEDURES TO IMPROVE RESPIRATORY FUNCTION, OTHER THAN DESCRIBED BY G0237, ONE ON ONE, FACE TO FACE, PER 15 MINUTES (INCLUDES MONITORING)	Oth resp proc, indiv
59	G0252	PET IMAGING, FULL AND PARTIAL-RING PET SCANNERS ONLY, FOR INITIAL DIAGNOSIS OF BREAST CANCER AND/OR SURGICAL PLANNING FOR BREAST CANCER (E.G. INITIAL STAGING OF AXILLARY LYMPH NODES)	PET imaging initial dx
60	61596	Transcochlear approach to posterior cranial fossa, jugular foramen or midline skull base, including labyrinthectomy, decompression, with or without mobilization of facial nerve and/or petrous carotid artery	TRANSCOCHLEAR APPROACH/SKUL
61	61641	Balloon dilatation of intracranial vasospasm, percutaneous; each additional vessel in same vascular territory (List separately in addition to code for primary procedure)	DILAT IC VSPSM EA VSL SM TE
62	61750	Stereotactic biopsy, aspiration, or excision, including burr hole(s), for intracranial lesion;	INCISE SKULL/BRAIN BIOPSY
63	61790	Creation of lesion by stereotactic method, percutaneous, by neurolytic agent (eg, alcohol, thermal, electrical, radiofrequency); gasserian ganglion	TREAT TRIGEMINAL NERVE
64	61797	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, simple (List separately in addition to code for primary procedure)	SRS CRAN LES SIMPLE ADDL
65	61850	Twist drill or burr hole(s) for implantation of neurostimulator electrodes, cortical	IMPLANT NEUROELECTRODES
66	62220	Creation of shunt; ventriculo-atrial, -jugular, -auricular	ESTABLISH BRAIN CAVITY SHUN
67	62281	Injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; epidural, cervical or thoracic	TREAT SPINAL CORD LESION
68	62291	Injection procedure for discography, each level; cervical or thoracic	NJX PX DISCOGRAPHY CRV/THRC
69	62321	Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)	NJX INTERLAMINAR CRV/THRC
70	J9070	Cyclophosphamide, 100 mg	Cyclophosphamide 100 mg inj
71	C9162	Injection, avacincaptad pegol, 0.1 mg	Inj, avacincaptad peg 0.1 mg
72	J1850	Injection, kanamycin sulfate, up to 75 mg	Kanamycin sulfate 75 mg inj
73	J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	Methylprednisolone injection
74	FR	The supervising practitioner was present through two-way, audio/video communication technology	Two-way a/v dir supervision
75	J7294	Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each	Seg acet and eth estr yearly
76	J1445	Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron	Inj triferic avnu 0.1mg iron
77	Q0240	Injection, casirivimab and imdevimab, 600 mg	Casirivi and imdevi 600 mg
78	J2406	Injection, oritavancin (kimyrsa), 10 mg	Injection, oritavancin 10 mg
79	Q0244	Injection, casirivimab and imdevimab, 1200 mg	Casirivi and imdevi 1200 mg
80	J1448	Injection, trilaciclib, 1mg	Injection, trilaciclib, 1mg
81	S9432	Medical foods for non-inborn errors of metabolism	Med food non inborn err meta
82	C9780	Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance	Insert cv cath inf & sup app
83	J1426	Injection, casimersen, 10 mg	Injection, casimersen, 10 mg
84	K1027	Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment	Oral dev without fix mech
85	J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	Inj, cabote rilpivir 2mg 3mg
86	J1305	Injection, evinacumab-dgnb, 5mg	Inj, evinacumab-dgnb, 5mg
87	Q2054	Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose	Lisocabtagene mara car pos t
88	M0248	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	Sotrovimab inf, home admin
89	M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	Sotrovimab infusion
90	J9349	Injection, tafasitamab-cxix, 2 mg	Inj., tafasitamab-cxix
91	Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	Bamlanivimab and etesevima
92	C9776	Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)	Fluo bile duct imaging w/icg
93	S1091	Stent, non-coronary, temporary, with delivery system (propel)	Stent non-coronary propel
94	Q2053	Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose	Brexucabtagene car pos t
95	J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	Hyalgan supartz visco-3 dose
96	G9868	Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes	Cmmi asyntelehealth <10min
97	Q0247	Injection, sotrovimab, 500 mg	Sotrovimab
98	J9353	Injection, margetuximab-cmkb, 5 mg	Inj. margetuximab-cmkb, 5 mg
99	Q0239	Injection, bamlanivimab-xxxx, 700 mg	Bamlanivimab-xxxx
100	J7295	Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each	Eth estr and eton monthly
101	A4453	Rectal catheter for use with the manual pump-operated enema system, replacement only	Rec cath man pump enema repl
102	M0241	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses	Casiri and imdev repeat hm
103	M0249	Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose	Adm tocilizu covid-19 1st
104	C9779	Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed	Esd endoscopy or colonoscopy
105	J9318	Injection, romidepsin, non-lyophilized, 0.1 mg	Inj romidepsin non-lyo 0.1mg
106	M0240	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses	Casiri and imdev repeat
107	J2407	Injection, oritavancin (orbactiv), 10 mg	Injection, oritavancin
108	C9078	Injection, trilaciclib, 1 mg	Inj, trilaciclib, 1 mg
109	C9075	Injection, casimersen, 10 mg	Injection, casimersen, 10 mg
110	J9315	Injection, romidepsin, 1 mg	Romidepsin injection
111	G2150	Multimodal pain management was not used	No mpm
112	G9582	Door to puncture time of greater than 90 minutes, no reason given	Door to punc time >2hr, nrg
113	G9368	At least two orders for high-risk medications from the same drug class not ordered	>= 2 same hi-rsk med not ord
114	G9823	Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation	Endo smpl/hyst bx res doc
115	G9419	Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)	Med reas not incl histo type
116	G9367	At least two orders for high-risk medications from the same drug class	>= 2 same hi-rsk med ord
117	G9627	Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery	Pt no bl srg 30 day pst srg
118	G2148	Multimodal pain management was used	Mpm used
119	G9580	Door to puncture time of 90 minutes or less	Door to punc time <2hrs
120	G2142	Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater	Fs odi 9-15mo postop<= 22
121	G2173	Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)	Uri w comorb 12m oth dx
122	G8433	Screening for depression not completed, documented patient or medical reason	Scr for dep not cpt doc rsn
123	G9928	Fda-approved anticoagulant not prescribed, reason not given	No warf or fda drug presc
124	G9554	Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended	Ct/cta/mri/a chst foll rec
125	G1013	Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program	Cdsm evidencecare
126	G2175	Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)	Pt comorb dx 12m of epi
127	G2122	Depression, anxiety, apathy, and psychosis not assessed	Psy/dep/anx/apandicd noasse
128	G8950	Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented	Pre-htn or htn doc, f/u indc
129	G9428	Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors	Patho rpt incl pt ctg
130	G2097	Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)	Dx uri 3d after other dx
131	G9716	Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason	Bmi doc onl fup not cmpltd
132	J5	Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service	Dmepos comp bid fur by pt/ot
133	J9305	Injection, pemetrexed, not otherwise specified, 10 mg	Inj. pemetrexed nos 10mg
134	G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	Alcohol/subs interv 15-30mn
135	L8702	Elbow, wrist, hand, finger device, powered, with single or double upright(s), any type joint(s), includes microprocessor, sensors, all components and accessories	Ewhf s/d uprt micro sensor
136	M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	Casirivi and imdevi inj hm
137	62328	Spinal puncture, lumbar, diagnostic; with fluoroscopic or CT guidance	DX LMBR SPI PNXR W/FLUOR/CT
138	63077	Discectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; thoracic, single interspace	SPINE DISK SURGERY THORAX
139	63270	Laminectomy for excision of intraspinal lesion other than neoplasm, intradural; cervical	EXCISE INTRSPINL LESION CRV
140	63662	Removal of spinal neurostimulator electrode plate/paddle(s) placed via laminotomy or laminectomy, including fluoroscopy, when performed	REMOVE SPINE ELTRD PLATE
141	64480	Injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or CT); cervical or thoracic, each additional level (List separately in addition to code for primary procedure)	INJ FORAMEN EPIDURAL ADD-ON
142	64530	Injection, anesthetic agent; celiac plexus, with or without radiologic monitoring	N BLOCK INJ CELIAC PELUS
143	64605	Destruction by neurolytic agent, trigeminal nerve; second and third division branches at foramen ovale	INJECTION TREATMENT OF NERV
144	64624	Destruction by neurolytic agent, genicular nerve branches including imaging guidance, when performed	DSTRJ NULYT AGT GNCLR NRV
145	64635	Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint	DESTROY LUMB/SAC FACET JNT
146	64726	Decompression; plantar digital nerve	RELEASE FOOT/TOE NERVE
147	64771	Transection or avulsion of other cranial nerve, extradural	SEVER CRANIAL NERVE
148	64821	Sympathectomy; radial artery	REMOVE SYMPATHETIC NERVES
149	64865	Suture of facial nerve; infratemporal, with or without grafting	REPAIR OF FACIAL NERVE
150	65765	Keratophakia	REVISION OF CORNEA
151	65778	Placement of amniotic membrane on the ocular surface; without sutures	COVER EYE W/MEMBRANE
152	66172	Fistulization of sclera for glaucoma; trabeculectomy ab externo with scarring from previous ocular surgery or trauma (includes injection of antifibrotic agents)	INCISION OF EYE
153	66920	Removal of lens material; intracapsular	EXTRACTION OF LENS
154	66930	Removal of lens material; intracapsular, for dislocated lens	EXTRACTION OF LENS
155	66999	Unlisted procedure, anterior segment of eye	EYE SURGERY PROCEDURE
156	67210	Destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; photocoagulation	TREATMENT OF RETINAL LESION
157	67255	Scleral reinforcement (separate procedure); with graft	REINFORCE/GRAFT EYE WALL
158	67312	Strabismus surgery, recession or resection procedure; 2 horizontal muscles	REVISE TWO EYE MUSCLES
159	67825	Correction of trichiasis; epilation by other than forceps (eg, by electrosurgery, cryotherapy, laser surgery)	REVISE EYELASHES
160	67961	Excision and repair of eyelid, involving lid margin, tarsus, conjunctiva, canthus, or full thickness, may include preparation for skin graft or pedicle flap with adjacent tissue transfer or rearrangement; up to one-fourth of lid margin	REVISION OF EYELID
161	67974	Reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; total eyelid, upper, 1 stage or first stage	RECONSTRUCTION OF EYELID
162	68020	Incision of conjunctiva, drainage of cyst	INCISE/DRAIN EYELID LINING
163	68371	Harvesting conjunctival allograft, living donor	HARVEST EYE TISSUE ALOGRAFT
164	69150	Radical excision external auditory canal lesion; without neck dissection	EXTENSIVE EAR CANAL SURGERY
165	67908	Repair of blepharoptosis; conjunctivo-tarso-Muller's muscle-levator resection (eg, Fasanella-Servat type)	REPAIR EYELID DEFECT
166	67973	Reconstruction of eyelid, full thickness by transfer of tarsoconjunctival flap from opposing eyelid; total eyelid, lower, 1 stage or first stage	RECONSTRUCTION OF EYELID
167	68801	Dilation of lacrimal punctum, with or without irrigation	DILATE TEAR DUCT OPENING
168	69020	Drainage external auditory canal, abscess	DRAIN OUTER EAR CANAL LESIO
169	69210	Removal impacted cerumen requiring instrumentation, unilateral	REMOVE IMPACTED EAR WAX UNI
170	69501	Transmastoid antrotomy (simple mastoidectomy)	MASTOIDECTOMY
171	69662	Revision of stapedectomy or stapedotomy	REVISE MIDDLE EAR BONE
172	69720	Decompression facial nerve, intratemporal; lateral to geniculate ganglion	RELEASE FACIAL NERVE
173	69955	Total facial nerve decompression and/or repair (may include graft)	RELEASE FACIAL NERVE
174	70150	Radiologic examination, facial bones; complete, minimum of 3 views	X-RAY EXAM OF FACIAL BONES
175	70488	Computed tomography, maxillofacial area; without contrast material, followed by contrast material(s) and further sections	CT MAXILLOFACIAL W/O & W/DY
176	70490	Computed tomography, soft tissue neck; without contrast material	CT SOFT TISSUE NECK W/O DYE
177	70547	Magnetic resonance angiography, neck; without contrast material(s)	MR ANGIOGRAPHY NECK W/O DYE
178	70549	Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences	MR ANGIOGRAPH NECK W/O&W/DY
179	70555	Magnetic resonance imaging, brain, functional MRI; requiring physician or psychologist administration of entire neurofunctional testing	FMRI BRAIN BY PHYS/PSYCH
180	71045	Radiologic examination, chest; single view	X-RAY EXAM CHEST 1 VIEW
181	71555	Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)	MRI ANGIO CHEST W OR W/O DY
182	72050	Radiologic examination, spine, cervical; 4 or 5 views	X-RAY EXAM NECK SPINE 4/5VW
183	72114	Radiologic examination, spine, lumbosacral; complete, including bending views, minimum of 6 views	X-RAY EXAM L-S SPINE BENDIN
184	72130	Computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and further sections	CT CHEST SPINE W/O & W/DYE
185	72156	Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical	MRI NECK SPINE W/O & W/DYE
186	72197	Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences	MRI PELVIS W/O & W/DYE
187	73110	Radiologic examination, wrist; complete, minimum of 3 views	X-RAY EXAM OF WRIST
188	73525	Radiologic examination, hip, arthrography, radiological supervision and interpretation	CONTRAST X-RAY OF HIP
189	73551	Radiologic examination, femur; 1 view	X-RAY EXAM OF FEMUR 1
190	73630	Radiologic examination, foot; complete, minimum of 3 views	X-RAY EXAM OF FOOT
191	74190	Peritoneogram (eg, after injection of air or contrast), radiological supervision and interpretation	X-RAY EXAM OF PERITONEUM
192	74300	Cholangiography and/or pancreatography; intraoperative, radiological supervision and interpretation	X-RAY BILE DUCTS/PANCREAS
193	74340	Introduction of long gastrointestinal tube (eg, Miller-Abbott), including multiple fluoroscopies and images, radiological supervision and interpretation	X-RAY GUIDE FOR GI TUBE
194	74470	Radiologic examination, renal cyst study, translumbar, contrast visualization, radiological supervision and interpretation	X-RAY EXAM OF KIDNEY LESION
195	75605	Aortography, thoracic, by serialography, radiological supervision and interpretation	CONTRAST EXAM THORACIC AORT
196	75705	Angiography, spinal, selective, radiological supervision and interpretation	ARTERY X-RAYS SPINE
197	75710	Angiography, extremity, unilateral, radiological supervision and interpretation	ARTERY X-RAYS ARM/LEG
198	75736	Angiography, pelvic, selective or supraselective, radiological supervision and interpretation	ARTERY X-RAYS PELVIS
199	75901	Mechanical removal of pericatheter obstructive material (eg, fibrin sheath) from central venous device via separate venous access, radiologic supervision and interpretation	REMOVE CVA DEVICE OBSTRUCT
200	75957	Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus descending thoracic aortic extension(s), if required, to level of celiac artery origin, radiological supervision and interpretation	XRAY ENDOVASC THOR AO REPR
201	L5628	ADDITION TO LOWER EXTREMITY, TEST SOCKET, HEMIPELVECTOMY	Test socket hemipelvectomy
202	L5678	ADDITIONS TO LOWER EXTREMITY, BELOW KNEE, JOINT COVERS, PAIR	Bk joint covers pair
203	L5686	ADDITION TO LOWER EXTREMITY, BELOW KNEE, BACK CHECK (EXTENSION CONTROL)	Bk back check
204	L5695	ADDITION TO LOWER EXTREMITY, ABOVE KNEE, PELVIC CONTROL, SLEEVE SUSPENSION, NEOPRENE OR EQUAL, EACH	Ak sleeve susp neoprene/equa
205	L5785	ADDITION, EXOSKELETAL SYSTEM, BELOW KNEE, ULTRA-LIGHT MATERIAL (TITANIUM, CARBON FIBER OR EQUAL)	Exoskeletal bk ultralt mater
206	L5840	ADDITION, ENDOSKELETAL KNEE/SHIN SYSTEM, 4-BAR LINKAGE OR MULTIAXIAL, PNEUMATIC SWING PHASE CONTROL	Multi-axial knee/shin system
207	L5845	ADDITION, ENDOSKELETAL, KNEE-SHIN SYSTEM, STANCE FLEXION FEATURE, ADJUSTABLE	Knee-shin sys stance flexion
208	L6616	UPPER EXTREMITY ADDITION, ADDITIONAL DISCONNECT INSERT FOR LOCKING WRIST UNIT, EACH	Disconnect insert locking wr
209	L6641	UPPER EXTREMITY ADDITION, EXCURSION AMPLIFIER, PULLEY TYPE	Excursion amplifier pulley t
210	L6895	ADDITION TO UPPER EXTREMITY PROSTHESIS, GLOVE FOR TERMINAL DEVICE, ANY MATERIAL, CUSTOM FABRICATED	Custom glove for term device
211	L6920	WRIST DISARTICULATION, EXTERNAL POWER, SELF-SUSPENDED INNER SOCKET, REMOVABLE FOREARM SHELL, OTTO BOCK OR EQUAL, SWITCH, CABLES, TWO BATTERIES AND ONE CHARGER, SWITCH CONTROL OF TERMINAL DEVICE	Wrist disarticul switch ctrl
212	L7259	ELECTRONIC WRIST ROTATOR, ANY TYPE	Electronic wrist rotator any
213	L7405	ADDITION TO UPPER EXTREMITY PROSTHESIS, SHOULDER DISARTICULATION/INTERSCAPULAR THORACIC, ACRYLIC MATERIAL	Add UE prost s/d acrylic
214	L8310	TRUSS, DOUBLE WITH STANDARD PADS	Truss double w/ standard pad
215	L8320	TRUSS, ADDITION TO STANDARD PAD, WATER PAD	Truss addition to std pad wa
216	L8417	PROSTHETIC SHEATH/SOCK, INCLUDING A GEL CUSHION LAYER, BELOW KNEE OR ABOVE KNEE, EACH	Pros sheath/sock w gel cushn
217	L8420	PROSTHETIC SOCK, MULTIPLE PLY, BELOW KNEE, EACH	Prosthetic sock multi ply BK
218	L8465	PROSTHETIC SHRINKER, UPPER LIMB, EACH	Shrinker upper limb
219	L8514	TRACHEOESOPHAGEAL PUNCTURE DILATOR, REPLACEMENT ONLY, EACH	Repl trach puncture dilator
220	L8621	ZINC AIR BATTERY FOR USE WITH COCHLEAR IMPLANT DEVICE AND AUDITORY OSSEOINTEGRATED SOUND PROCESSORS, REPLACEMENT, EACH	Repl zinc air battery
221	L8690	AUDITORY OSSEOINTEGRATED DEVICE, INCLUDES ALL INTERNAL AND EXTERNAL COMPONENTS	Aud osseo dev, int/ext comp
222	L8692	AUDITORY OSSEOINTEGRATED DEVICE, EXTERNAL SOUND PROCESSOR, USED WITHOUT OSSEOINTEGRATION, BODY WORN, INCLUDES HEADBAND OR OTHER MEANS OF EXTERNAL ATTACHMENT	Non-osseointegrated snd proc
223	L8699	PROSTHETIC IMPLANT, NOT OTHERWISE SPECIFIED	Prosthetic implant NOS
224	M0100	INTRAGASTRIC HYPOTHERMIA USING GASTRIC FREEZING	Intragastric hypothermia
225	M1004	Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)	Doc med rsn no srn tb
226	M1014	Patient treatment and final evaluation complete	Pt tx and final eval comp
227	M1016	Female patients unable to bear children	Pt dx meop or sur steri
228	M1037	Patients with a diagnosis of lumbar spine region cancer at the time of the procedure	Pt dx lum sp reg cacr
229	P9034	PLATELETS, PHERESIS, EACH UNIT	Platelets, pheresis
230	P9036	PLATELETS, PHERESIS, IRRADIATED, EACH UNIT	Platelet pheresis irradiated
231	P9060	FRESH FROZEN PLASMA, DONOR RETESTED, EACH UNIT	Fr frz plasma donor retested
232	P9603	TRAVEL ALLOWANCE ONE WAY IN CONNECTION WITH MEDICALLY NECESSARY LABORATORY SPECIMEN COLLECTION DRAWN FROM HOME BOUND OR NURSING HOME BOUND PATIENT; PRORATED MILES ACTUALLY TRAVELLED.	One-way allow prorated miles
233	Q0167	DRONABINOL, 2.5 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN	Dronabinol 2.5mg oral
234	Q0490	EMERGENCY POWER SOURCE FOR USE WITH ELECTRIC VENTRICULAR ASSIST DEVICE, REPLACEMENT ONLY	Emr pwr source elec vad, rep
235	Q0508	Miscellaneous Supply or Accessory For Use With An Implanted Ventricular Assist Device	Misc sup/acc imp vad
236	94662	Continuous negative pressure ventilation (CNP), initiation and management	NEG PRESS VENTILATION CNP
237	94726	Plethysmography for determination of lung volumes and, when performed, airway resistance	PULM FUNCT TST PLETHYSMOGRA
238	94770	Carbon dioxide, expired gas determination by infrared analyzer	EXHALED CARBON DIOXIDE TEST
239	94799	Unlisted pulmonary service or procedure	PULMONARY SERVICE/PROCEDURE
240	95117	Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections	IMMUNOTHERAPY INJECTIONS
241	95873	Electrical stimulation for guidance in conjunction with chemodenervation (List separately in addition to code for primary procedure)	GUIDE NERV DESTR ELEC STIM
242	95912	Nerve conduction studies; 11-12 studies	NRV CNDJ TEST 11-12 STUDIES
243	L2580	ADDITION TO LOWER EXTREMITY, PELVIC CONTROL, PELVIC SLING	Pelvic control pelvic sling
244	L2680	ADDITION TO LOWER EXTREMITY, THORACIC CONTROL, LATERAL SUPPORT UPRIGHTS	Thorac cont lat support upri
245	L2755	ADDITION TO LOWER EXTREMITY ORTHOSIS, HIGH STRENGTH, LIGHTWEIGHT MATERIAL, ALL HYBRID LAMINATION/PREPREG COMPOSITE, PER SEGMENT, FOR CUSTOM FABRICATED ORTHOSIS ONLY	Carbon graphite lamination
246	L3224	ORTHOPEDIC FOOTWEAR, WOMAN'S SHOE, OXFORD, USED AS AN INTEGRAL PART OF A BRACE (ORTHOSIS)	Woman's shoe oxford brace
247	L3630	TRANSFER OF AN ORTHOSIS FROM ONE SHOE TO ANOTHER, SOLID STIRRUP, NEW	Trans shoe solid stirrup new
248	L3660	SHOULDER ORTHOSIS, FIGURE OF EIGHT DESIGN ABDUCTION RESTRAINER, CANVAS AND WEBBING, PREFABRICATED, OFF-THE-SHELF	So 8 ab rstr can/web pre ots
249	L3933	FINGER ORTHOSIS, WITHOUT JOINTS, MAY INCLUDE SOFT INTERFACE, CUSTOM FABRICATED, INCLUDES FITTING AND ADJUSTMENT	FO w/o joints CF
250	L3935	FINGER ORTHOSIS, NONTORSION JOINT, MAY INCLUDE SOFT INTERFACE, CUSTOM FABRICATED, INCLUDES FITTING AND ADJUSTMENT	FO nontorsion joint CF
251	L3977	SHOULDER ELBOW WRIST HAND FINGER ORTHOSIS, SHOULDER CAP DESIGN, INCLUDES ONE OR MORE NONTORSION JOINTS, ELASTIC BANDS, TURNBUCKLES, MAY INCLUDE SOFT INTERFACE, STRAPS, CUSTOM FABRICATED, INCLUDES FITTING AND ADJUSTMENT	SEWHFO cap desgn w/jnt(s) CF
252	L4361	WALKING BOOT, PNEUMATIC AND/OR VACUUM, WITH OR WITHOUT JOINTS, WITH OR WITHOUT INTERFACE MATERIAL, PREFABRICATED, OFF-THE-SHELF	Pneuma/vac walk boot pre ots
253	L4392	REPLACEMENT, SOFT INTERFACE MATERIAL, STATIC AFO	Replace AFO soft interface
254	L5420	IMMEDIATE POST SURGICAL OR EARLY FITTING, APPLICATION OF INITIAL RIGID DRESSING, INCLUDING FITTING, ALIGNMENT AND SUSPENSION AND ONE CAST CHANGE 'AK' OR KNEE DISARTICULATION	Postop dsg & 1 cast chg ak/d
255	L5652	ADDITION TO LOWER EXTREMITY, SUCTION SUSPENSION, ABOVE KNEE OR KNEE DISARTICULATION SOCKET	Suction susp ak/knee disart
256	L5676	ADDITIONS TO LOWER EXTREMITY, BELOW KNEE, KNEE JOINTS, SINGLE AXIS, PAIR	Bk knee joints single axis p
257	L5781	ADDITION TO LOWER LIMB PROSTHESIS, VACUUM PUMP, RESIDUAL LIMB VOLUME MANAGEMENT AND MOISTURE EVACUATION SYSTEM	Lower limb pros vacuum pump
258	L5810	ADDITION, ENDOSKELETAL KNEE-SHIN SYSTEM, SINGLE AXIS, MANUAL LOCK	Endoskel knee-shin mnl lock
259	L5812	ADDITION, ENDOSKELETAL KNEE-SHIN SYSTEM, SINGLE AXIS, FRICTION SWING AND STANCE PHASE CONTROL (SAFETY KNEE)	Endo knee-shin frct swg & st
260	L5859	ADDITION TO LOWER EXTREMITY PROSTHESIS, ENDOSKELETAL KNEE-SHIN SYSTEM, POWERED AND PROGRAMMABLE FLEXION/EXTENSION ASSIST CONTROL, INCLUDES ANY TYPE MOTOR(S)	Knee-shin pro flex/ext cont
261	L5966	ADDITION, ENDOSKELETAL SYSTEM, HIP DISARTICULATION, FLEXIBLE PROTECTIVE OUTER SURFACE COVERING SYSTEM	Hip flexible cover system
262	L5990	ADDITION TO LOWER EXTREMITY PROSTHESIS, USER ADJUSTABLE HEEL HEIGHT	User adjustable heel height
263	L6100	BELOW ELBOW, MOLDED SOCKET, FLEXIBLE ELBOW HINGE, TRICEPS PAD	Elb mold sock flex hinge pad
264	L6250	ABOVE ELBOW, MOLDED DOUBLE WALL SOCKET, INTERNAL LOCKING ELBOW, FOREARM	Elbow inter loc elbow forarm
265	L6655	UPPER EXTREMITY ADDITION, STANDARD CONTROL CABLE, EXTRA	Standard control cable extra
266	L6706	TERMINAL DEVICE, HOOK, MECHANICAL, VOLUNTARY OPENING, ANY MATERIAL, ANY SIZE, LINED OR UNLINED	Term dev mech hook vol open
267	L6970	INTERSCAPULAR-THORACIC, EXTERNAL POWER, MOLDED INNER SOCKET, REMOVABLE SHOULDER SHELL, SHOULDER BULKHEAD, HUMERAL SECTION, MECHANICAL ELBOW, FOREARM, OTTO BOCK OR EQUAL SWITCH, CABLES, TWO BATTERIES AND ONE CHARGER, SWITCH CONTROL OF TERMINAL DEVICE	Interscapular-thor switch ct
268	L7191	ELECTRONIC ELBOW, CHILD, VARIETY VILLAGE OR EQUAL, MYOELECTRONICALLY CONTROLLED	Elbow child myoelectronic ct
269	L8002	BREAST PROSTHESIS, MASTECTOMY BRA, WITH INTEGRATED BREAST PROSTHESIS FORM, BILATERAL, ANY SIZE, ANY TYPE	Brst prsth bra & bilat form
270	L8010	BREAST PROSTHESIS, MASTECTOMY SLEEVE	Mastectomy sleeve
271	L8045	AURICULAR PROSTHESIS, PROVIDED BY A NON-PHYSICIAN	Auricular prosthesis
272	L8047	NASAL SEPTAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN	Nasal septal prosthesis
273	J7211	Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.	Inj, kovaltry, 1 i.u.
274	J7304	CONTRACEPTIVE SUPPLY, HORMONE CONTAINING PATCH, EACH	Contraceptive hormone patch
275	J7322	HYALURONAN OR DERIVATIVE, SYNVISC, FOR INTRA-ARTICULAR INJECTION, PER DOSE	Synvisc inj per dose
276	J7324	HYALURONAN OR DERIVATIVE, ORTHOVISC, FOR INTRA-ARTICULAR INJECTION, PER DOSE	Orthovisc inj per dose
277	J7345	DERMAL (SUBSTITUTE) TISSUE OF NON-HUMAN ORIGIN, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, WITHOUT METABOLICALLY ACTIVE ELEMENTS, PER SQUARE CENTIMETER	Non-human, non-metab tissue
278	J7503	TACROLIMUS, EXTENDED RELEASE, (ENVARSUS XR), ORAL, 0.25 MG	Tacrol envarsus ex rel oral
279	J7505	MUROMONAB-CD3, PARENTERAL, 5 MG	Monoclonal antibodies
280	J7506	PREDNISONE, ORAL, PER 5MG	Prednisone oral
281	J7614	LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 0.5 MG	Levalbuterol non-comp unit
282	J7627	BUDESONIDE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, UP TO 0.5 MG	Budesonide comp unit
283	J7633	BUDESONIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER 0.25 MILLIGRAM	Budesonide non-comp con
284	J7644	IPRATROPIUM BROMIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM	Ipratropium bromide non-comp
285	J8562	FLUDARABINE PHOSPHATE, ORAL, 10 MG	Oral fludarabine phosphate
286	J8600	MELPHALAN; ORAL, 2 MG	Melphalan oral 2 MG
287	J8655	NETUPITANT 300 MG AND PALONOSETRON 0.5 MG, ORAL	Oral netupitant, palonosetro
288	J9000	INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG	Doxorubicin hcl injection
289	J9119	Injection, cemiplimab-rwlc, 1 mg	INJ., CEMIPLIMAB-RWLC, 1 MG
290	J9120	INJECTION, DACTINOMYCIN, 0.5 MG	Dactinomycin injection
291	J9219	LEUPROLIDE ACETATE IMPLANT, 65 MG	Leuprolide acetate implant
292	J9225	HISTRELIN IMPLANT (VANTAS), 50 MG	Vantas implant
293	J9295	INJECTION, NECITUMUMAB, 1 MG	Injection, necitumumab, 1 mg
294	J9325	INJECTION, TALIMOGENE LAHERPAREPVEC, PER 1 MILLION PLAQUE FORMING UNITS	Inj talimogene laherparepvec
295	K0001	STANDARD WHEELCHAIR	Standard wheelchair
296	K0040	ADJUSTABLE ANGLE FOOTPLATE, EACH	Adjustable angle footplate
297	K0065	SPOKE PROTECTORS, EACH	Spoke protectors
298	K0070	REAR WHEEL ASSEMBLY, COMPLETE, WITH PNEUMATIC TIRE, SPOKES OR MOLDED, EACH	Rear whl compl pneum tire
299	K0744	ABSORPTIVE WOUND DRESSING FOR USE WITH SUCTION PUMP, HOME MODEL, PORTABLE, PAD SIZE 16 SQUARE INCHES OR LESS	Absorp drg <= 16 suc pump
300	K0746	ABSORPTIVE WOUND DRESSING FOR USE WITH SUCTION PUMP, HOME MODEL, PORTABLE, PAD SIZE GREATER THAN 48 SQUARE INCHES	Absorp drg >48 suc pump
301	K0806	POWER OPERATED VEHICLE, GROUP 2 STANDARD, PATIENT WEIGHT CAPACITY UP TO AND INCLUDING 300 POUNDS	POV group 2 std up to 300lbs
302	K0857	POWER WHEELCHAIR, GROUP 3 STANDARD, SINGLE POWER OPTION, CAPTAINS CHAIR, PATIENT WEIGHT CAPACITY UP TO AND INCLUDING 300 POUNDS	PWC gp3 std sing pow opt cap
303	K0863	POWER WHEELCHAIR, GROUP 3 VERY HEAVY DUTY, MULTIPLE POWER OPTION, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY 451 TO 600 POUNDS	PWC gp3 vhd mult pow opt s/b
304	K0891	POWER WHEELCHAIR, GROUP 5 PEDIATRIC, MULTIPLE POWER OPTION, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY UP TO AND INCLUDING 125 POUNDS	PWC gp5 ped mult pow opt s/b
305	L0170	CERVICAL, COLLAR, MOLDED TO PATIENT MODEL	Cervical collar molded to pt
306	L0180	CERVICAL, MULTIPLE POST COLLAR, OCCIPITAL/MANDIBULAR SUPPORTS, ADJUSTABLE	Cer post col occ/man sup adj
307	L0810	HALO PROCEDURE, CERVICAL HALO INCORPORATED INTO JACKET VEST	Halo cervical into jckt vest
308	L1000	CERVICAL-THORACIC-LUMBAR-SACRAL ORTHOSIS (CTLSO) (MILWAUKEE), INCLUSIVE OF FURNISHING INITIAL ORTHOSIS, INCLUDING MODEL	Ctlso milwauke initial model
309	L1010	ADDITION TO CERVICAL-THORACIC-LUMBAR-SACRAL ORTHOSIS (CTLSO) OR SCOLIOSIS ORTHOSIS, AXILLA SLING	Ctlso axilla sling
310	L1200	THORACIC-LUMBAR-SACRAL-ORTHOSIS (TLSO), INCLUSIVE OF FURNISHING INITIAL ORTHOSIS ONLY	Furnsh initial orthosis only
311	L1660	HIP ORTHOSIS, ABDUCTION CONTROL OF HIP JOINTS, STATIC, PLASTIC, PREFABRICATED, INCLUDES FITTING AND ADJUSTMENT	HO abduction static plastic
312	L1700	LEGG PERTHES ORTHOSIS, (TORONTO TYPE), CUSTOM-FABRICATED	Leg perthes orth toronto typ
313	L1833	KNEE ORTHOSIS, ADJUSTABLE KNEE JOINTS (UNICENTRIC OR POLYCENTRIC), POSITIONAL ORTHOSIS, RIGID SUPPORT, PREFABRICATED, OFF-THE SHELF	Ko adj jnt pos r sup pre ots
314	L1900	ANKLE FOOT ORTHOSIS, SPRING WIRE, DORSIFLEXION ASSIST CALF BAND, CUSTOM-FABRICATED	Afo sprng wir drsflx calf bd
315	L2038	KNEE ANKLE FOOT ORTHOSIS, FULL PLASTIC, WITH OR WITHOUT FREE MOTION KNEE, MULTI-AXIS ANKLE, CUSTOM FABRICATED	Kafo w/o joint multi-axis an
316	L2128	KNEE ANKLE FOOT ORTHOSIS, FRACTURE ORTHOSIS, FEMORAL FRACTURE CAST ORTHOSIS, CUSTOM-FABRICATED	Kafo fem fx cast molded to p
317	L2184	ADDITION TO LOWER EXTREMITY FRACTURE ORTHOSIS, LIMITED MOTION KNEE JOINT	Limited motion knee joint
318	L2300	ADDITION TO LOWER EXTREMITY, ABDUCTION BAR (BILATERAL HIP INVOLVEMENT), JOINTED, ADJUSTABLE	Abduction bar jointed adjust
319	L2335	ADDITION TO LOWER EXTREMITY, ANTERIOR SWING BAND	Anterior swing band
320	L2350	ADDITION TO LOWER EXTREMITY, PROSTHETIC TYPE, (BK) SOCKET, MOLDED TO PATIENT MODEL, (USED FOR 'PTB' 'AFO' ORTHOSES)	Prosthetic type socket molde
321	L2425	ADDITION TO KNEE JOINT, DISC OR DIAL LOCK FOR ADJUSTABLE KNEE FLEXION, EACH JOINT	Knee disc/dial lock/adj flex
322	L2628	ADDITION TO LOWER EXTREMITY, PELVIC CONTROL, METAL FRAME, RECIPROCATING HIP JOINT AND CABLES	Metal frame recipro hip & ca
323	L2760	ADDITION TO LOWER EXTREMITY ORTHOSIS, EXTENSION, PER EXTENSION, PER BAR (FOR LINEAL ADJUSTMENT FOR GROWTH)	Extension per extension per
324	L3225	ORTHOPEDIC FOOTWEAR, MAN'S SHOE, OXFORD, USED AS AN INTEGRAL PART OF A BRACE (ORTHOSIS)	Man's shoe oxford brace
325	L3320	LIFT, ELEVATION, HEEL AND SOLE, CORK, PER INCH	Shoe lift elev heel/sole cor
326	L3530	ORTHOPEDIC SHOE ADDITION, SOLE, HALF	Ortho shoe add half sole
327	L3595	ORTHOPEDIC SHOE ADDITION, MARCH BAR	Ortho shoe add march bar
328	L3760	ELBOW ORTHOSIS (EO), WITH ADJUSTABLE POSITION LOCKING JOINT(S), PREFABRICATED, ITEM THAT HAS BEEN TRIMMED, BENT, MOLDED, ASSEMBLED, OR OTHERWISE CUSTOMIZED TO FIT A SPECIFIC PATIENT BY AN INDIVIDUAL WITH EXPERTISE	EO withjoint, Prefabricated
329	L3916	WRIST HAND FINGER ORTHOSIS, WRIST EXTENSION COCK-UP WITH OUTRIGGER, PREFABRICATED, INCLUDES FITTING AND ADJUSTMENT	Whfo wrist extens w/ outrigg
330	L3917	HAND ORTHOSIS, METACARPAL FRACTURE ORTHOSIS, PREFABRICATED ITEM THAT HAS BEEN TRIMMED, BENT, MOLDED, ASSEMBLED, OR OTHERWISE CUSTOMIZED TO FIT A SPECIFIC PATIENT BY AN INDIVIDUAL WITH EXPERTISE	Metacarp fx orthosis pre cst
331	L3981	UPPER EXTREMITY FRACTURE ORTHOSIS, HUMERAL, PREFABRICATED, INCLUDES SHOULDER CAP DESIGN, WITH OR WITHOUT JOINTS, FOREARM SECTION, MAY INCLUDE SOFT INTERFACE, STRAPS, INCLUDES FITTING AND ADJUSTMENTS	Ue fx orth shoul cap forearm
332	L8612	AQUEOUS SHUNT	Aqueous shunt prosthesis
333	L8614	COCHLEAR DEVICE, INCLUDES ALL INTERNAL AND EXTERNAL COMPONENTS	Cochlear device
334	L8623	LITHIUM ION BATTERY FOR USE WITH COCHLEAR IMPLANT DEVICE SPEECH PROCESSOR, OTHER THAN EAR LEVEL, REPLACEMENT, EACH	Lith ion batt CID,non-earlvl
335	L8670	VASCULAR GRAFT MATERIAL, SYNTHETIC, IMPLANT	Vascular graft, synthetic
336	L8683	RADIOFREQUENCY TRANSMITTER (EXTERNAL) FOR USE WITH IMPLANTABLE NEUROSTIMULATOR RADIOFREQUENCY RECEIVER	Radiofq trsmtr for implt neu
337	M1008	<50% of total number of a patient's outpatient ra encounters assessed	<50% total pt outpt ra encts
338	M1143	Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment	NI REHAB MED CHIRO
339	Q0084	CHEMOTHERAPY ADMINISTRATION BY INFUSION TECHNIQUE ONLY, PER VISIT	Chemotherapy by infusion
340	Q0169	PROMETHAZINE HYDROCHLORIDE, 12.5 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN	Promethazine HCl 12.5mg oral
341	Q0512	PHARMACY SUPPLY FEE FOR ORAL ANTI-CANCER, ORAL ANTI-EMETIC OR IMMUNOSUPPRESSIVE DRUG(S); FOR A SUBSEQUENT PRESCRIPTION IN A 30-DAY PERIOD	Px sup fee anti-can sub pres
342	Q2035	INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO INDIVIDUALS 3 YEARS OF AGE AND OLDER, FOR INTRAMUSCULAR USE (AFLURIA)	Afluria vacc, 3 yrs & >, im
343	Q2037	INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO INDIVIDUALS 3 YEARS OF AGE AND OLDER, FOR INTRAMUSCULAR USE (FLUVIRIN)	Fluvirin vacc, 3 yrs & >, im
344	Q2041	AXICABTAGENE CILOLEUCEL, UP TO 200 MILLION AUTOLOGOUS ANTI-CD19 CAR POSITIVE VIABLE T CELLS, INCLUDING LEUKAPHERESIS AND DOSE PREPARATION PROCEDURES, PER THERAPEUTIC DOSE	Axicabtagene ciloleucel car+
345	Q3014	TELEHEALTH ORIGINATING SITE FACILITY FEE	Telehealth facility fee
346	Q3031	COLLAGEN SKIN TEST	Collagen skin test
347	Q4024	CAST SUPPLIES, SHORT ARM SPLINT, PEDIATRIC (0-10 YEARS), FIBERGLASS	Cast sup sht arm splnt ped f
348	Q4039	CAST SUPPLIES, SHORT LEG CAST, PEDIATRIC (0-10 YEARS), PLASTER	Cast sup shrt leg ped plster
349	Q5114	Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg	INJ OGIVRI 10 MG
350	Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	INJ., TRAZIMERA, 10 MG
351	Q9951	LOW OSMOLAR CONTRAST MATERIAL, 400 OR GREATER MG/ML IODINE CONCENTRATION, PER ML	LOCM >= 400 mg/ml iodine,1ml
352	Q9953	INJECTION, IRON-BASED MAGNETIC RESONANCE CONTRAST AGENT, PER ML	Inj Fe-based MR contrast,1ml
353	Q9959	HIGH OSMOLAR CONTRAST MATERIAL, 150-199 MG/ML IODINE CONCENTRATION, PER ML	HOCM 150-199mg/ml iodine,1ml
354	Q9963	HIGH OSMOLAR CONTRAST MATERIAL, 350-399 MG/ML IODINE CONCENTRATION, PER ML	HOCM 350-399 mg/ml iodine,1ml
355	Q9989	USTEKINUMAB, FOR INTRAVENOUS INJECTION, 1 MG	Ustekinumab IV Inj, 1 mg
356	Q9994	In-line cartridge containing digestive enzyme(s) for enteral feeding, each
357	R0070	TRANSPORTATION OF PORTABLE X-RAY EQUIPMENT AND PERSONNEL TO HOME OR NURSING HOME, PER TRIP TO FACILITY OR LOCATION, ONE PATIENT SEEN	Transport portable x-ray
358	S0088	IMATINIB, 100 MG	Imatinib 100 mg
359	S0091	GRANISETRON HYDROCHLORIDE, 1MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE Q0166)	Granisetron 1mg
360	S0122	INJECTION, MENOTROPINS, 75 IU	Inj menotropins 75 iu
361	S0272	PHYSICIAN MANAGEMENT OF PATIENT HOME CARE, EPISODIC CARE MONTHLY CASE RATE (PER 30 DAYS)	Home episodic case 30 days
362	S0320	TELEPHONE CALLS BY A REGISTERED NURSE TO A DISEASE MANAGEMENT PROGRAM MEMBER FOR MONITORING PURPOSES; PER MONTH	RN telephone calls to DMP
363	S2055	HARVESTING OF DONOR MULTIVISCERAL ORGANS, WITH PREPARATION AND MAINTENANCE OF ALLOGRAFTS; FROM CADAVER DONOR	Harvesting of donor multivis
364	S2202	ECHOSCLEROTHERAPY	Echosclerotherapy
365	S2230	IMPLANTATION OF MAGNETIC COMPONENT OF SEMI-IMPLANTABLE HEARING DEVICE ON OSSICLES IN MIDDLE EAR	Implant semi-imp hear
366	S2325	HIP CORE DECOMPRESSION	Hip core decompression
367	S2342	NASAL ENDOSCOPY FOR POST-OPERATIVE DEBRIDEMENT FOLLOWING FUNCTIONAL ENDOSCOPIC SINUS SURGERY, NASAL AND/OR SINUS CAVITY(S), UNILATERAL OR BILATERAL	Nasal endoscop po debrid
368	S2401	REPAIR, URINARY TRACT OBSTRUCTION IN THE FETUS, PROCEDURE PERFORMED IN UTERO	Fetal surg urin trac obstr
369	S3005	PERFORMANCE MEASUREMENT, EVALUATION OF PATIENT SELF ASSESSMENT, DEPRESSION	Eval self-assess depression
370	S3870	COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MICROARRAY TESTING FOR DEVELOPMENTAL DELAY, AUTISM SPECTRUM DISORDER AND/OR INTELLECTUAL DISABILITY	Cgh test developmental delay
371	S4014	COMPLETE CYCLE, ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), CASE RATE	Compl ZIFT case rate
372	S4981	INSERTION OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM	Insert levonorgestrel ius
373	S5102	DAY CARE SERVICES, ADULT; PER DIEM	Adult day care per diem
374	S5121	CHORE SERVICES; PER DIEM	Chore services per diem
375	S5151	UNSKILLED RESPITE CARE, NOT HOSPICE; PER DIEM	Unskilled respitecare /diem
376	S5165	HOME MODIFICATIONS; PER SERVICE	Home modifications per serv
377	S5501	HOME INFUSION THERAPY, CATHETER CARE / MAINTENANCE, COMPLEX (MORE THAN ONE LUMEN), INCLUDES ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT complex cath care
378	S5553	INSULIN, LONG ACTING; 5 UNITS	Insulin long acting 5 u
379	S8035	MAGNETIC SOURCE IMAGING	Magnetic source imaging
380	S8097	ASTHMA KIT (INCLUDING BUT NOT LIMITED TO PORTABLE PEAK EXPIRATORY FLOW METER, INSTRUCTIONAL VIDEO, BROCHURE, AND/OR SPACER)	Asthma kit
381	S8100	HOLDING CHAMBER OR SPACER FOR USE WITH AN INHALER OR NEBULIZER; WITHOUT MASK	Spacer without mask
382	S8185	FLUTTER DEVICE	Flutter device
383	S8262	MANDIBULAR ORTHOPEDIC REPOSITIONING DEVICE, EACH	Mandib ortho repos device
384	S8427	GRADIENT PRESSURE AID (GLOVE), READY MADE	Ready gradient glove
385	S9098	HOME VISIT, PHOTOTHERAPY SERVICES (E.G. BILI-LITE), INCLUDING EQUIPMENT RENTAL, NURSING SERVICES, BLOOD DRAW, SUPPLIES, AND OTHER SERVICES, PER DIEM	Home phototherapy visit
386	S9125	RESPITE CARE, IN THE HOME, PER DIEM	Respite care, in the home, p
387	S9127	SOCIAL WORK VISIT, IN THE HOME, PER DIEM	Social work visit, in the ho
388	S9326	HOME INFUSION THERAPY, CONTINUOUS (TWENTY-FOUR HOURS OR MORE) PAIN MANAGEMENT INFUSION; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT cont pain per diem
389	S9336	HOME INFUSION THERAPY, CONTINUOUS ANTICOAGULANT INFUSION THERAPY (E.G. HEPARIN), ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT cont anticoag diem
390	L4350	ANKLE CONTROL ORTHOSIS, STIRRUP STYLE, RIGID, INCLUDES ANY TYPE INTERFACE (E.G., PNEUMATIC, GEL), PREFABRICATED, OFF-THE-SHELF	Ankle control ortho pre ots
391	L4360	WALKING BOOT, PNEUMATIC AND/OR VACUUM, WITH OR WITHOUT JOINTS, WITH OR WITHOUT INTERFACE MATERIAL, PREFABRICATED ITEM THAT HAS BEEN TRIMMED, BENT, MOLDED, ASSEMBLED, OR OTHERWISE CUSTOMIZED TO FIT A SPECIFIC PATIENT BY AN INDIVIDUAL WITH EXPERTISE	Pneumat walking boot pre cst
392	L4370	PNEUMATIC FULL LEG SPLINT, PREFABRICATED, OFF-THE-SHELF	Pneum full leg splnt pre ots
393	L5460	IMMEDIATE POST SURGICAL OR EARLY FITTING, APPLICATION OF NON-WEIGHT BEARING RIGID DRESSING, ABOVE KNEE	Postop app non-wgt bear dsg
394	L5530	PREPARATORY, BELOW KNEE 'PTB' TYPE SOCKET, NON-ALIGNABLE SYSTEM, PYLON, NO COVER, SACH FOOT, THERMOPLASTIC OR EQUAL, MOLDED TO MODEL	Prep BK ptb thermopls molded
395	L5616	ADDITION TO LOWER EXTREMITY, ENDOSKELETAL SYSTEM, ABOVE KNEE, UNIVERSAL MULTIPLEX SYSTEM, FRICTION SWING PHASE CONTROL	Ak univ multiplex sys frict
396	L5646	ADDITION TO LOWER EXTREMITY, BELOW KNEE, AIR, FLUID, GEL OR EQUAL, CUSHION SOCKET	Below knee cushion socket
397	L5648	ADDITION TO LOWER EXTREMITY, ABOVE KNEE, AIR, FLUID, GEL OR EQUAL, CUSHION SOCKET	Above knee cushion socket
398	L5658	ADDITION TO LOWER EXTREMITY, SOCKET INSERT, ABOVE KNEE (KEMBLO, PELITE, ALIPLAST, PLASTAZOTE OR EQUAL)	Socket insert above knee
399	L5661	ADDITION TO LOWER EXTREMITY, SOCKET INSERT, MULTI-DUROMETER SYMES	Multi-durometer symes
400	L5666	ADDITION TO LOWER EXTREMITY, BELOW KNEE, CUFF SUSPENSION	Below knee cuff suspension
401	L5671	ADDITION TO LOWER EXTREMITY, BELOW KNEE / ABOVE KNEE SUSPENSION LOCKING MECHANISM (SHUTTLE, LANYARD OR EQUAL), EXCLUDES SOCKET INSERT	BK/AK locking mechanism
402	L5682	ADDITION TO LOWER EXTREMITY, BELOW KNEE, THIGH LACER, GLUTEAL/ISCHIAL, MOLDED	Bk thigh lacer glut/ischia m
403	L5930	ADDITION, ENDOSKELETAL SYSTEM, HIGH ACTIVITY KNEE CONTROL FRAME	High activity knee frame
404	L5979	ALL LOWER EXTREMITY PROSTHESIS, MULTI-AXIAL ANKLE, DYNAMIC RESPONSE FOOT, ONE PIECE SYSTEM	Multi-axial ankle/ft prosth
405	L5988	ADDITION TO LOWER LIMB PROSTHESIS, VERTICAL SHOCK REDUCING PYLON FEATURE	Vertical shock reducing pylo
406	L6384	IMMEDIATE POST SURGICAL OR EARLY FITTING, APPLICATION OF INITIAL RIGID DRESSING INCLUDING FITTING ALIGNMENT AND SUSPENSION OF COMPONENTS, AND ONE CAST CHANGE, SHOULDER DISARTICULATION OR INTERSCAPULAR THORACIC	Postop dsg cast chg shlder/t
407	L6635	UPPER EXTREMITY ADDITION, LIFT ASSIST FOR ELBOW	Lift assist for elbow
408	L6637	UPPER EXTREMITY ADDITION, NUDGE CONTROL ELBOW LOCK	Nudge control elbow lock
409	L6648	UPPER EXTREMITY ADDITION, SHOULDER LOCK MECHANISM, EXTERNAL POWERED ACTUATOR	Ext pwrd shlder lock/unlock
410	L6672	UPPER EXTREMITY ADDITION, HARNESS, CHEST OR SHOULDER, SADDLE TYPE	Harness chest/shlder saddle
411	L6675	UPPER EXTREMITY ADDITION, HARNESS, (E.G. FIGURE OF EIGHT TYPE), SINGLE CABLE DESIGN	Harness figure of 8 sing con
412	L6690	UPPER EXTREMITY ADDITION, FRAME TYPE SOCKET, INTERSCAPULAR-THORACIC	Frame typ sock interscap-tho
413	L6703	TERMINAL DEVICE, PASSIVE HAND/MITT, ANY MATERIAL, ANY SIZE	Term dev, passive hand mitt
414	L6712	TERMINAL DEVICE, HOOK, MECHANICAL, VOLUNTARY CLOSING, ANY MATERIAL, ANY SIZE, LINED OR UNLINED, PEDIATRIC	Ped term dev, hook, vol clos
415	L6915	HAND RESTORATION (SHADING, AND MEASUREMENTS INCLUDED), REPLACEMENT GLOVE FOR ABOVE	Hand restoration replacmnt g
416	L6925	WRIST DISARTICULATION, EXTERNAL POWER, SELF-SUSPENDED INNER SOCKET, REMOVABLE FOREARM SHELL, OTTO BOCK OR EQUAL ELECTRODES, CABLES, TWO BATTERIES AND ONE CHARGER, MYOELECTRONIC CONTROL OF TERMINAL DEVICE	Wrist disart myoelectronic c
417	L6935	BELOW ELBOW, EXTERNAL POWER, SELF-SUSPENDED INNER SOCKET, REMOVABLE FOREARM SHELL, OTTO BOCK OR EQUAL ELECTRODES, CABLES, TWO BATTERIES AND ONE CHARGER, MYOELECTRONIC CONTROL OF TERMINAL DEVICE	Below elbow myoelectronic ct
418	L7040	PREHENSILE ACTUATOR, SWITCH CONTROLLED	Prehensile actuator
419	L7185	ELECTRONIC ELBOW, ADOLESCENT, VARIETY VILLAGE OR EQUAL, SWITCH CONTROLLED	Electron elbow adolescent sw
420	L7260	ELECTRONIC WRIST ROTATOR, OTTO BOCK OR EQUAL	Electron wrist rotator otto
421	L8042	ORBITAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN	Orbital prosthesis
422	L8044	HEMI-FACIAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN	Hemi-facial prosthesis
423	L8300	TRUSS, SINGLE WITH STANDARD PAD	Truss single w/ standard pad
424	L8410	PROSTHETIC SHEATH, ABOVE KNEE, EACH	Sheath above knee
425	L8603	INJECTABLE BULKING AGENT, COLLAGEN IMPLANT, URINARY TRACT, 2.5 ML SYRINGE, INCLUDES SHIPPING AND NECESSARY SUPPLIES	Collagen imp urinary 2.5 ml
426	L8613	OSSICULA IMPLANT	Ossicular implant
427	L8684	RADIOFREQUENCY TRANSMITTER (EXTERNAL) FOR USE WITH IMPLANTABLE SACRAL ROOT NEUROSTIMULATOR RECEIVER FOR BOWEL AND BLADDER MANAGEMENT, REPLACEMENT	Radiof trsmtr implt scrl neu
428	L8687	IMPLANTABLE NEUROSTIMULATOR PULSE GENERATOR, DUAL ARRAY, RECHARGEABLE, INCLUDES EXTENSION	Implt nrostm pls gen dua rec
429	M1020	Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5	Adl pt mj dep ds no rs 12 mo
430	M1111	The start of an episode of care documented in the medical record	START EOC DOC MED REC
431	M1127	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care	DOCU DX DEGEN NEURO
432	M1142	Emergent cases	EMERGE CASES
433	P9050	GRANULOCYTES, PHERESIS, EACH UNIT	Granulocytes, pheresis unit
434	P9056	WHOLE BLOOD, LEUKOCYTES REDUCED, IRRADIATED, EACH UNIT	Blood, l/r, irradiated
435	P9615	CATHETERIZATION FOR COLLECTION OF SPECIMEN (S) (MULTIPLE PATIENTS)	Urine specimen collect mult
436	Q0083	CHEMOTHERAPY ADMINISTRATION BY OTHER THAN INFUSION TECHNIQUE ONLY (EG SUBCUTANEOUS, INTRAMUSCULAR, PUSH), PER VISIT	Chemo by other than infusion
437	Q0085	CHEMOTHERAPY ADMINISTRATION BY BOTH INFUSION TECHNIQUE AND OTHER TECHIQUE(S) (EG SUBCUTANEOUS, INTRAMUSCULAR, PUSH), PER VISIT	Chemo by both infusion and o
438	Q2026	INJECTION, RADIESSE, 0.1 ML	Radiesse injection
439	Q2036	INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO INDIVIDUALS 3 YEARS OF AGE AND OLDER, FOR INTRAMUSCULAR USE (FLULAVAL)	Flulaval vacc, 3 yrs & >, im
440	Q2038	INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO INDIVIDUALS 3 YEARS OF AGE AND OLDER, FOR INTRAMUSCULAR USE (FLUZONE)	Fluzone vacc, 3 yrs & >, im
441	Q4005	CAST SUPPLIES, LONG ARM CAST, ADULT (11 YEARS +), PLASTER	Cast sup long arm adult plst
442	Q4081	INJECTION, EPOETIN ALFA, 100 UNITS (FOR ESRD ON DIALYSIS)	Epoetin alfa, 100 units ESRD
443	Q4119	MATRISTEM WOUND MATRIX, PER SQUARE CENTIMETER	Matristem wound matrix
444	Q5005	HOSPICE CARE PROVIDED IN INPATIENT HOSPITAL	Hospice, inpatient hospital
445	Q5007	HOSPICE CARE PROVIDED IN LONG TERM CARE FACILITY	Hospice in LTCH
446	Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	INJ., KANJINTI, 10 MG
447	S9346	HOME INFUSION THERAPY, ALPHA-1-PROTEINASE INHIBITOR (E.G., PROLASTIN); ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT alpha-1-proteinas diem
448	S9381	DELIVERY OR SERVICE TO HIGH RISK AREAS REQUIRING ESCORT OR EXTRA PROTECTION, PER VISIT	HIT high risk/escort
449	S9434	MODIFIED SOLID FOOD SUPPLEMENTS FOR INBORN ERRORS OF METABOLISM	Mod solid food suppl
450	S9470	NUTRITIONAL COUNSELING, DIETITIAN VISIT	Nutritional counseling, diet
451	S9485	CRISIS INTERVENTION MENTAL HEALTH SERVICES, PER DIEM	Crisis intervention mental h
452	S9558	HOME INJECTABLE THERAPY; GROWTH HORMONE, INCLUDING ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HT inj growth horm diem
453	S9560	HOME INJECTABLE THERAPY; HORMONAL THERAPY (E.G.; LEUPROLIDE, GOSERELIN), INCLUDING ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HT inj hormone diem
454	T1001	NURSING ASSESSMENT / EVALUATION	Nursing assessment/evaluatn
455	T1007	ALCOHOL AND/OR SUBSTANCE ABUSE SERVICES, TREATMENT PLAN DEVELOPMENT AND/OR MODIFICATION	Treatment Plan Development
456	T1018	SCHOOL-BASED INDIVIDUALIZED EDUCATION PROGRAM (IEP) SERVICES, BUNDLED	School-based IEP ser bundled
457	T1020	PERSONAL CARE SERVICES, PER DIEM, NOT FOR AN INPATIENT OR RESIDENT OF A HOSPITAL, NURSING FACILITY, ICF/MR OR IMD, PART OF THE INDIVIDUALIZED PLAN OF TREATMENT (CODE MAY NOT BE USED TO IDENTIFY SERVICES PROVIDED BY HOME HEALTH AIDE OR CERTIFIED NURSE ASSISTANT)	Personal care ser per diem
458	T2025	WAIVER SERVICES; NOT OTHERWISE SPECIFIED (NOS)	Waiver service, nos
459	T2027	SPECIALIZED CHILDCARE, WAIVER; PER 15 MINUTES	Spec childcare waiver 15 min
460	T4536	INCONTINENCE PRODUCT, PROTECTIVE UNDERWEAR/PULL-ON, REUSABLE, ANY SIZE, EACH	Reusable pull-on any size
461	V2111	SPHEROCYLINDER, SINGLE VISION, PLUS OR MINUS 7.25 TO PLUS OR MINUS 12.00D SPHERE, .25 TO 2.25D CYLINDER, PER LENS	Spherocylindr 7.25d/.25-2.25
462	V2113	SPHEROCYLINDER, SINGLE VISION, PLUS OR MINUS 7.25 TO PLUS OR MINUS 12.00D SPHERE, 4.25 TO 6.00D CYLINDER, PER LENS	Spherocylindr 7.25d/4.25-6d
463	V2314	SPHEROCYLINDER, TRIFOCAL, SPHERE OVER PLUS OR MINUS 12 .00D, PER LENS	Lens sphcyl trifocal over 12
464	V2503	CONTACT LENS, PMMA, COLOR VISION DEFICIENCY, PER LENS	Cntct lens pmma color vision
465	V2623	PROSTHETIC EYE, PLASTIC, CUSTOM	Plastic eye prosth custom
466	V2750	ANTI-REFLECTIVE COATING, PER LENS	Anti-reflective coating
467	V5100	HEARING AID, BILATERAL, BODY WORN	Body-worn bilat hearing aid
468	V5243	HEARING AID, ANALOG, MONAURAL, ITC (IN THE CANAL)	Hearing aid, monaural, itc
469	V5245	HEARING AID, DIGITALLY PROGRAMMABLE, ANALOG, MONAURAL, ITC	Hearing aid, prog, mon, itc
470	V5260	HEARING AID, DIGITAL, BINAURAL, ITE	Hearing aid, digit, bin, ite
471	V5270	ASSISTIVE LISTENING DEVICE, TELEVISION AMPLIFIER, ANY TYPE	ALD, TV amplifier, any type
472	V5283	ASSISTIVE LISTENING DEVICE, PERSONAL FM/DM NECK, LOOP INDUCTION RECEIVER	Ald neck, loop ind receiver
473	V5298	HEARING AID, NOT OTHERWISE CLASSIFIED	Hearing aid noc
474	Q9950	LOW OSMOLAR CONTRAST MATERIAL, 350-399 MG/ML IODINE CONCENTRATION, PER ML	LOCM 350-399mg/ml iodine, 1ml
475	Q9968	INJECTION, NON-RADIOACTIVE, NON-CONTRAST, VISUALIZATION ADJUNCT (E.G., METHYLENE BLUE, ISOSULFAN BLUE), 1 MG	Visualization adjunct
476	Q9969	TC-99M FROM NON-HIGHLY ENRICHED URANIUM SOURCE, FULL COST RECOVERY ADD-ON, PER STUDY DOSE	Non-HEU TC-99M add-on/dose
477	0124A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
478	0134A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
479	0115U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
480	0116U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
481	0117U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
482	0122U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
483	0123U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
484	0130U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
485	0131U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
486	0135U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
487	0138U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
488	0140U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
489	0141U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
490	0143U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
491	0145U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
492	0174U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
493	0176U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
494	0179U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
495	0180U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
496	0181U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
497	0182U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
498	0186U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
499	0188U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
500	0191U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
501	0196U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
502	0197U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
503	0199U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
504	0200U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
505	0201U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
506	0202U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
507	0203U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
508	0256U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
509	0259U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
510	0260U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
511	0261U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
512	0262U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
513	0263U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
514	0266U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
515	0297T	External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; scanning analysis with report	EXT ECG SCAN W/REPORT
516	0405T	Oversight of the care of an extracorporeal liver assist system patient requiring review of status, review of laboratories and other studies, and revision of orders and liver assist care plan (as appropriate), within a calendar month, 30 minutes or more of non-face-to-face time	OVRSGHT XTRCORP LIV ASST PA
517	0184T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
518	0198T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
519	0200T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
520	0201T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
521	0202T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
522	0267T	Under Carotid Sinus Baroreflex Activation Device Procedures	Under Carotid Sinus Baroreflex Activation Device Procedures
523	0500F	Initial prenatal care visit (report at first prenatal encounter with health care professional providing obstetrical care. Report also date of visit and, in a separate field, the date of the last menstrual period [LMP]) (Prenatal)	INITIAL PRENATAL CARE VISIT
524	0517F	Glaucoma plan of care documented (EC)	GLAUCOMA PLAN OF CARE DOCD
525	0575F	HIV RNA control plan of care, documented (HIV)	HIV RNA PLAN CARE DOCD
526	7010F	Patient information entered into a recall system that includes: target date for the next exam specified and a process to follow up with patients regarding missed or unscheduled appointments (ML)	PT INFO INTO RECALL SYSTEM
527	Q9975	INJECTION, FACTOR VIII FC FUSION PROTEIN (RECOMBINANT), PER IU	Factor VIII FC Fusion Recomb
528	S0182	PROCARBAZINE HYDROCHLORIDE, ORAL, 50MG	Procarbazine 5 mg
529	S0342	LIFESTYLE MODIFICATION PROGRAM FOR MANAGEMENT OF CORONARY ARTERY DISEASE, INCLUDING ALL SUPPORTIVE SERVICES; FOURTH QUARTER / STAGE	Lifestyle mod 4th stage
530	S0395	IMPRESSION CASTING OF A FOOT PERFORMED BY A PRACTITIONER OTHER THAN THE MANUFACTURER OF THE ORTHOTIC	Impression casting ft
531	S0512	DAILY WEAR SPECIALTY CONTACT LENS, PER LENS	Daily cont lens
532	S0514	COLOR CONTACT LENS, PER LENS	Color cont lens
533	S1031	CONTINUOUS NONINVASIVE GLUCOSE MONITORING DEVICE, RENTAL, INCLUDING SENSOR, SENSOR REPLACEMENT, AND DOWNLOAD TO MONITOR (FOR PHYSICIAN INTERPRETATION OF DATA, USE CPT CODE)	Gluc monitor rental
534	S2402	REPAIR, CONGENITAL CYSTIC ADENOMATOID MALFORMATION IN THE FETUS, PROCEDURE PERFORMED IN UTERO	Fetal surg cong cyst malf
535	S2404	REPAIR, MYELOMENINGOCELE IN THE FETUS, PROCEDURE PERFORMED IN UTERO	Fetal surg myelomeningo
536	S3890	DNA ANALYSIS, FECAL, FOR COLORECTAL CANCER SCREENING	Fecal DNA analysis
537	S4025	DONOR SERVICES FOR IN VITRO FERTILIZATION (SPERM OR EMBRYO), CASE RATE	Donor serv IVF case rate
538	S5012	5% DEXTROSE WITH POTASSIUM CHLORIDE, 1000 ML	5% dextrose with potassium
539	S5013	5% DEXTROSE/0.45% NORMAL SALINE WITH POTASSIUM CHLORIDE AND MAGNESIUM SULFATE, 1000 ML	5%dextrose/0.45%saline1000ml
540	S5101	DAY CARE SERVICES, ADULT; PER HALF DAY	Adult day care per half day
541	S5126	ATTENDANT CARE SERVICES; PER DIEM	Attendant care service /diem
542	S5150	UNSKILLED RESPITE CARE, NOT HOSPICE; PER 15 MINUTES	Unskilled respite care /15m
543	S5199	PERSONAL CARE ITEM, NOS, EACH	Personal care item nos each
544	S5566	INSULIN CARTRIDGE FOR USE IN INSULIN DELIVERY DEVICE OTHER THAN PUMP; 300 UNITS	Insulin cartridge 300 u
545	S8101	HOLDING CHAMBER OR SPACER FOR USE WITH AN INHALER OR NEBULIZER; WITH MASK	Spacer with mask
546	S8120	OXYGEN CONTENTS, GASEOUS, 1 UNIT EQUALS 1 CUBIC FOOT	O2 contents gas cubic ft
547	S8186	SWIVEL ADAPTER	Swivel adaptor
548	S8210	MUCUS TRAP	Mucus trap
549	S8948	APPLICATION OF A MODALITY (REQUIRING CONSTANT PROVIDER ATTENDANCE) TO ONE OR MORE AREAS; LOW-LEVEL LASER; EACH 15 MINUTES	Low-level laser trmt 15 min
550	S8999	RESUSCITATION BAG (FOR USE BY PATIENT ON ARTIFICIAL RESPIRATION DURING POWER FAILURE OR OTHER CATASTROPHIC EVENT)	Resuscitation bag
551	S9128	SPEECH THERAPY, IN THE HOME, PER DIEM	Speech therapy, in the home,
552	S9212	HOME MANAGEMENT OF POSTPARTUM HYPERTENSION, INCLUDES ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM (DO NOT USE THIS CODE WITH ANY HOME INFUSION PER DIEM CODE)	Hm postpar hyper per diem
553	S9327	HOME INFUSION THERAPY, INTERMITTENT (LESS THAN TWENTY-FOUR HOURS) PAIN MANAGEMENT INFUSION; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT int pain per diem
554	S9349	HOME INFUSION THERAPY, TOCOLYTIC INFUSION THERAPY; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT tocolysis diem
555	S9435	MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM	Medical foods for inborn err
556	S9436	CHILDBIRTH PREPARATION/LAMAZE CLASSES, NON-PHYSICIAN PROVIDER, PER SESSION	Lamaze class
557	S9438	CESAREAN BIRTH CLASSES, NON-PHYSICIAN PROVIDER, PER SESSION	Cesarean birth class
558	S9449	WEIGHT MANAGEMENT CLASSES, NON-PHYSICIAN PROVIDER, PER SESSION	Weight mgmt class
559	S9529	ROUTINE VENIPUNCTURE FOR COLLECTION OF SPECIMEN(S), SINGLE HOME BOUND, NURSING HOME, OR SKILLED NURSING FACILITY PATIENT	Venipuncture home/snf
560	S9537	HOME THERAPY; HEMATOPOIETIC HORMONE INJECTION THERAPY (E.G.ERYTHROPOIETIN, G-CSF, GM-CSF); ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HT hem horm inj diem
561	T1006	ALCOHOL AND/OR SUBSTANCE ABUSE SERVICES, FAMILY/COUPLE COUNSELING	Family/Couple Counseling
562	T1022	CONTRACTED HOME HEALTH AGENCY SERVICES, ALL SERVICES PROVIDED UNDER CONTRACT, PER DAY	Contracted services per day
563	T1041	MEDICAID CERTIFIED COMMUNITY BEHAVIORAL HEALTH CLINIC SERVICES, PER MONTH	Comm bh clinic svc per month
564	T2010	PREADMISSION SCREENING AND RESIDENT REVIEW (PASRR) LEVEL I IDENTIFICATION SCREENING, PER SCREEN	PASRR Level I
565	T2012	HABILITATION, EDUCATIONAL; WAIVER, PER DIEM	Habil ed waiver, per diem
566	T2026	SPECIALIZED CHILDCARE, WAIVER; PER DIEM	Special childcare waiver/d
567	T4540	INCONTINENCE PRODUCT, PROTECTIVE UNDERPAD, REUSABLE, CHAIR SIZE, EACH	Reusable underpad chair size
568	V2199	NOT OTHERWISE CLASSIFIED, SINGLE VISION LENS	Lens single vision not oth c
569	V2301	SPHERE, TRIFOCAL, PLUS OR MINUS 4.12 TO PLUS OR MINUS 7.00D, PER LENS	Lens sphere trifocal 4.12-7.
570	V2499	VARIABLE SPHERICITY LENS, OTHER TYPE	Variable asphericity lens
571	V2790	AMNIOTIC MEMBRANE FOR SURGICAL RECONSTRUCTION, PER PROCEDURE	Amniotic membrane
572	V5244	HEARING AID, DIGITALLY PROGRAMMABLE ANALOG, MONAURAL, CIC	Hearing aid, prog, mon, cic
573	V5263	HEARING AID, DISPOSABLE, ANY TYPE, BINAURAL	Hearing aid, disp, binaural
574	G0439	ANNUAL WELLNESS VISIT, INCLUDES A PERSONALIZED PREVENTION PLAN OF SERVICE (PPS), SUBSEQUENT VISIT	PPPS, subseq visit
575	J7632	CROMOLYN SODIUM, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER 10 MILLIGRAMS	Cromolyn sodium comp unit
576	J7683	TRIAMCINOLONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM	Triamcinolone comp con
577	J7699	NOC DRUGS, INHALATION SOLUTION ADMINISTERED THROUGH DME	Inhalation solution for DME
578	J8610	METHOTREXATE; ORAL, 2.5 MG	Methotrexate oral 2.5 MG
579	J9175	INJECTION, ELLIOTTS' B SOLUTION, 1 ML	Elliotts b solution per ml
580	J9207	INJECTION, IXABEPILONE, 1 MG	Ixabepilone injection
581	J9210	Injection, emapalumab-lzsg, 1 mg	INJ., EMAPALUMAB-LZSG, 1 MG
582	J9263	INJECTION, OXALIPLATIN, 0.5 MG	Oxaliplatin
583	J9285	Injection, olaratumab, 10 mg	Inj, olaratumab, 10 mg
584	J9309	Injection, polatuzumab vedotin-piiq, 1 mg	INJ, POLATUZUMAB VEDOTIN 1M
585	J9340	INJECTION, THIOTEPA, 15 MG	Thiotepa injection
586	J9354	INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG	Inj, ado-trastuzumab emt 1mg
587	K0015	DETACHABLE, NON-ADJUSTABLE HEIGHT ARMREST, EACH	Detach non-adjus hght armrst
588	K0105	IV HANGER, EACH	Iv hanger
589	K0822	POWER WHEELCHAIR, GROUP 2 STANDARD, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY UP TO AND INCLUDING 300 POUNDS	PWC gp 2 std seat/back
590	K0870	POWER WHEELCHAIR, GROUP 4 HEAVY DUTY, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY 301 TO 450 POUNDS	PWC gp 4 hd seat/back
591	L0130	CERVICAL, FLEXIBLE, THERMOPLASTIC COLLAR, MOLDED TO PATIENT	Flex thermoplastic collar mo
592	L0190	CERVICAL, MULTIPLE POST COLLAR, OCCIPITAL/MANDIBULAR SUPPORTS, ADJUSTABLE CERVICAL BARS (SOMI, GUILFORD, TAYLOR TYPES)	Cerv collar supp adj cerv ba
593	L0464	TLSO, TRIPLANAR CONTROL, MODULAR SEGMENTED SPINAL SYSTEM, FOUR RIGID PLASTIC SHELLS, POSTERIOR EXTENDS FROM SACROCOCCYGEAL JUNCTION AND TERMINATES JUST INFERIOR TO SCAPULAR SPINE, ANTERIOR EXTENDS FROM SYMPHYSIS PUBIS TO THE STERNAL NOTCH, SOFT LINER, RESTRICTS GROSS TRUNK MOTION IN SAGITTAL, CORONAL, AND TRANSVERSE PLANES, LATERAL STRENGTH IS PROVIDED BY OVERLAPPING PLASTIC AND STABILIZING CLOSURES, INCLUDES STRAPS AND CLOSURES, PREFABRICATED, INCLUDES FITTING AND ADJUSTMENT	TLSO 4Mod sacro-scap pre
594	L0492	TLSO, SAGITTAL-CORONAL CONTROL, MODULAR SEGMENTED SPINAL SYSTEM, THREE RIGID PLASTIC SHELLS, POSTERIOR EXTENDS FROM THE SACROCOCCYGEAL JUNCTION AND TERMINATES JUST INFERIOR TO THE SCAPULAR SPINE, ANTERIOR EXTENDS FROM THE SYMPHYSIS PUBIS TO THE XIPHOID, SOFT LINER, RESTRICTS GROSS TRUNK MOTION IN THE SAGITTAL AND CORONAL PLANES, LATERAL STRENGTH IS PROVIDED BY OVERLAPPING PLASTIC AND STABILIZING CLOSURES, INCLUDES STRAPS AND CLOSURES, PREFABRICATED, INCLUDES FITTING AND ADJUSTMENT	TLSO 3 piece rigid shell
595	90832	Psychotherapy, 30 minutes with patient	PSYTX W PT 30 MINUTES
596	90833	Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)	PSYTX W PT W E/M 30 MIN
597	90839	Psychotherapy for crisis; first 60 minutes	PSYTX CRISIS INITIAL 60 MIN
598	90845	Psychoanalysis	PSYCHOANALYSIS
599	90868	Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; subsequent delivery and management, per session	TCRANIAL MAGN STIM TX DELI
600	90952	End-stage renal disease (ESRD) related services monthly, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2-3 face-to-face visits by a physician or other qualified health care professional per month	ESRD SERV 2-3 VSTS P MO <2Y
601	90958	End-stage renal disease (ESRD) related services monthly, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2-3 face-to-face visits by a physician or other qualified health care professional per month	ESRD SRV 2-3 VSTS P MO 12-1
602	90963	End-stage renal disease (ESRD) related services for home dialysis per full month, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents	ESRD HOME PT SERV P MO <2YR
603	90965	End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents	ESRD HOME PT SERV P MO 12-1
604	92072	Fitting of contact lens for management of keratoconus, initial fitting	FIT CONTAC LENS FOR MANAGMN
605	92134	Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina	CPTR OPHTH DX IMG POST SEGM
606	92136	Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation	OPHTHALMIC BIOMETRY
607	92230	Fluorescein angioscopy with interpretation and report	EYE EXAM WITH PHOTOS
608	92354	Fitting of spectacle mounted low vision aid; single element system	FIT SPECTACLES SINGLE SYSTE
609	92370	Repair and refitting spectacles; except for aphakia	REPAIR & ADJUST SPECTACLES
610	92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual	SPEECH/HEARING THERAPY
611	92512	Nasal function studies (eg, rhinomanometry)	NASAL FUNCTION STUDIES
612	92562	Loudness balance test, alternate binaural or monaural	LOUDNESS BALANCE TEST
613	92568	Acoustic reflex testing, threshold	ACOUSTIC REFL THRESHOLD TST
614	92614	Flexible endoscopic evaluation, laryngeal sensory testing by cine or video recording;	LARYNGOSCOPIC SENSORY VID
615	92700	Unlisted otorhinolaryngological service or procedure	ENT PROCEDURE/SERVICE
616	93229	External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional	REMOTE 30 DAY ECG TECH SUPP
617	93272	External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; review and interpretation by a physician or other qualified health care professional	ECG/REVIEW INTERPRET ONLY
618	93289	Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous implantable defibrillator system, including analysis of heart rhythm derived data elements	INTERROG DEVICE EVAL HEART
619	93315	Transesophageal echocardiography for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report	ECHO TRANSESOPHAGEAL
620	93351	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional	STRESS TTE COMPLETE
621	93619	Comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording, including insertion and repositioning of multiple electrode catheters, without induction or attempted induction of arrhythmia	ELECTROPHYSIOLOGY EVALUATIO
622	93620	Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording	ELECTROPHYSIOLOGY EVALUATIO
623	19126	Excision of breast lesion identified by preoperative placement of radiological marker, open; each additional lesion separately identified by a preoperative radiological marker (List separately in addition to code for primary procedure)	EXCISION ADDL BREAST LESION
624	19297	Placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; concurrent with partial mastectomy (List separately in addition to code for primary procedure)	PLACE BREAST CATH FOR RAD
625	A6213	FOAM DRESSING, WOUND COVER, STERILE, PAD SIZE MORE THAN 16 SQ. IN. BUT LESS THAN OR EQUAL TO 48 SQ. IN., WITH ANY SIZE ADHESIVE BORDER, EACH DRESSING	Foam drg >16<=48 sq in w/bdr
626	A6215	FOAM DRESSING, WOUND FILLER, STERILE, PER GRAM	Foam dressing wound filler
627	A6228	GAUZE, IMPREGNATED, WATER OR NORMAL SALINE, STERILE, PAD SIZE 16 SQ. IN. OR LESS, WITHOUT ADHESIVE BORDER, EACH DRESSING	Gauze <= 16 sq in water/sal
628	A6447	CONFORMING BANDAGE, NON-ELASTIC, KNITTED/WOVEN, STERILE, WIDTH GREATER THAN OR EQUAL TO FIVE INCHES, PER YARD	Conform band s w >=5”/yd
629	A6536	GRADIENT COMPRESSION STOCKING, FULL LENGTH/CHAP STYLE, 18-30 MMHG, EACH	Gc stocking full lngth 18-30
630	A7001	CANISTER, NON-DISPOSABLE, USED WITH SUCTION PUMP, EACH	Nondisposable pump canister
631	G8895	ORAL ASPIRIN OR OTHER ANTITHROMBOTIC THERAPY PRESCRIBED	Antrom prescribe
632	G8908	PATIENT DOCUMENTED TO HAVE RECEIVED A BURN PRIOR TO DISCHARGE	Pt doc w burn prior to D/C
633	G8913	PATIENT DOCUMENTED NOT TO HAVE EXPERIENCED A WRONG SITE, WRONG SIDE, WRONG PATIENT, WRONG PROCEDURE OR WRONG IMPLANT EVENT	Pt doc no wrong event
634	Q0500	FILTERS FOR USE WITH ELECTRIC OR ELECTRIC/PNEUMATIC VENTRICULAR ASSIST DEVICE, REPLACEMENT ONLY	Filters elec/combo vad, rep
635	Q4022	CAST SUPPLIES, SHORT ARM SPLINT, ADULT (11 YEARS +), FIBERGLASS	Cast sup sht arm splint fbrg
636	Q4043	CAST SUPPLIES, LONG LEG SPLINT, PEDIATRIC (0-10 YEARS), PLASTER	Cast sup lng leg splnt ped p
637	99392	Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years)	PREV VISIT EST AGE 1-4
638	99447	Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician, including a verbal and written report to the patient's treating/requesting physician or other qualified health care professional; 11-20 minutes of medical consultative discussion and review	NTRPROF PH1/NTRNET/EHR 11-2
639	A0080	NON-EMERGENCY TRANSPORTATION, PER MILE - VEHICLE PROVIDED BY VOLUNTEER (INDIVIDUAL OR ORGANIZATION), WITH NO VESTED INTEREST	Noninterest escort in non er
640	99463	Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant admitted and discharged on the same date	SAME DAY NB DISCHARGE
641	99476	Subsequent inpatient pediatric critical care, per day, for the evaluation and management of a critically ill infant or young child, 2 through 5 years of age	PED CRIT CARE AGE 2-5 SUBSQ
642	99478	Subsequent intensive care, per day, for the evaluation and management of the recovering very low birth weight infant (present body weight less than 1500 grams)	IC LBW INF < 1500 GM SUBSQ
643	99511	Home visit for fecal impaction management and enema administration	HOME VISIT FECAL/ENEMA MGMT
644	A4225	SUPPLIES FOR EXTERNAL INSULIN INFUSION PUMP, SYRINGE TYPE CARTRIDGE, STERILE, EACH	Sup/ext insulin inf pump syr
645	A4316	INSERTION TRAY WITH DRAINAGE BAG WITH INDWELLING CATHETER, FOLEY TYPE, THREE-WAY, FOR CONTINUOUS IRRIGATION	Cath w/drainage 3-way
646	A4352	INTERMITTENT URINARY CATHETER; COUDE (CURVED) TIP, WITH OR WITHOUT COATING (TEFLON, SILICONE, SILICONE ELASTOMERIC, OR HYDROPHILIC, ETC.), EACH	Coude tip urinary catheter
647	A4393	OSTOMY POUCH, URINARY, WITH EXTENDED WEAR BARRIER ATTACHED, WITH BUILT-IN CONVEXITY (1 PIECE), EACH	Urine pch w ex wear bar conv
648	A4395	OSTOMY DEODORANT FOR USE IN OSTOMY POUCH, SOLID, PER TABLET	Ostomy pouch solid deodorant
649	A6512	COMPRESSION BURN GARMENT, NOT OTHERWISE CLASSIFIED	Compres burn garment, noc
650	A7034	NASAL INTERFACE (MASK OR CANNULA TYPE) USED WITH POSITIVE AIRWAY PRESSURE DEVICE, WITH OR WITHOUT HEAD STRAP	Nasal application device
651	A8001	HELMET, PROTECTIVE, HARD, PREFABRICATED, INCLUDES ALL COMPONENTS AND ACCESSORIES	Hard protect helmet prefab
652	A8003	HELMET, PROTECTIVE, HARD, CUSTOM FABRICATED, INCLUDES ALL COMPONENTS AND ACCESSORIES	Hard protect helmet custom
653	A9272	WOUND SUCTION, DISPOSABLE, INCLUDES DRESSING, ALL ACCESSORIES AND COMPONENTS, ANY TYPE, EACH	Disp wound suct, drsg/access
654	A9274	EXTERNAL AMBULATORY INSULIN DELIVERY SYSTEM, DISPOSABLE, EACH, INCLUDES ALL SUPPLIES AND ACCESSORIES	Ext amb insulin delivery sys
655	A9280	ALERT OR ALARM DEVICE, NOT OTHERWISE CLASSIFIED	Alert device, noc
656	B4149	ENTERAL FORMULA, MANUFACTURED BLENDERIZED NATURAL FOODS WITH INTACT NUTRIENTS, INCLUDES PROTEINS, FATS, CARBOHYDRATES, VITAMINS AND MINERALS, MAY INCLUDE FIBER, ADMINISTERED THROUGH AN ENTERAL FEEDING TUBE, 100 CALORIES = 1 UNIT	EF blenderized foods
657	B4161	ENTERAL FORMULA, FOR PEDIATRICS, HYDROLYZED/AMINO ACIDS AND PEPTIDE CHAIN PROTEINS, INCLUDES FATS, CARBOHYDRATES, VITAMINS AND MINERALS, MAY INCLUDE FIBER, ADMINISTERED THROUGH AN ENTERAL FEEDING TUBE, 100 CALORIES = 1 UNIT	EF ped hydrolyzed/amino acid
658	C1714	CATHETER, TRANSLUMINAL ATHERECTOMY, DIRECTIONAL	Cath, trans atherectomy, dir
659	C1721	CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER (IMPLANTABLE)	AICD, dual chamber
660	C1767	GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), NON-RECHARGEABLE	Generator, neuro non-recharg
661	C1777	LEAD, CARDIOVERTER-DEFIBRILLATOR, ENDOCARDIAL SINGLE COIL (IMPLANTABLE)	Lead, AICD, endo single coil
662	C1780	LENS, INTRAOCULAR (NEW TECHNOLOGY)	Lens, intraocular (new tech)
663	C2619	PACEMAKER, DUAL CHAMBER, NON RATE-RESPONSIVE (IMPLANTABLE)	Pmkr, dual, non rate-resp
664	C2624	IMPLANTABLE WIRELESS PULMONARY ARTERY PRESSURE SENSOR WITH DELIVERY CATHETER, INCLUDING ALL SYSTEM COMPONENTS	Wireless pressure sensor
665	C8901	MAGNETIC RESONANCE ANGIOGRAPHY WITHOUT CONTRAST, ABDOMEN	MRA w/o cont, abd
666	C8912	MAGNETIC RESONANCE ANGIOGRAPHY WITH CONTRAST, LOWER EXTREMITY	MRA w/cont, lwr ext
667	C8914	MAGNETIC RESONANCE ANGIOGRAPHY WITHOUT CONTRAST FOLLOWED BY WITH CONTRAST, LOWER EXTREMITY	MRA w/o fol w/cont, lwr ext
668	C8928	TRANSTHORACIC ECHOCARDIOGRAPHY WITH CONTRAST, OR WITHOUT CONTRAST FOLLOWED BY WITH CONTRAST, REAL-TIME WITH IMAGE DOCUMENTATION (2D), INCLUDES M-MODE RECORDING, WHEN PERFORMED, DURING REST AND CARDIOVASCULAR STRESS TEST USING TREADMILL, BICYCLE EXERCISE AND/OR PHARMACOLOGICALLY INDUCED STRESS, WITH INTERPRETATION AND REPORT	TTE w or w/o fol w/con,stres
669	C9408	Iodine i-131 iobenguane, therapeutic, 1 millicurie	Iodine i-131 iobenguane, tx
670	C9452	INJECTION, CEFTOLOZANE 50 MG AND TAZOBACTAM 25 MG	Inj, ceftolozane/tazobactam
671	C9459	FLUTEMETAMOL F18, DIAGNOSTIC, PER STUDY DOSE, UP TO 5 MILLICURIES	Flutemetamol f18
672	C9481	INJECTION, RESLIZUMAB, 1 MG	Injection, reslizumab
673	C9497	LOXAPINE, INHALATION POWDER, 10 MG	Loxapine, inhalation powder
674	C9743	INJECTION/IMPLANTATION OF BULKING OR SPACER MATERIAL (ANY TYPE) WITH OR WITHOUT IMAGE GUIDANCE (NOT TO BE USED IF A MORE SPECIFIC CODE APPLIES)	Bulking/spacer material impl
675	C9750	Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)	Ins/rem-replace compl iims
676	E0199	DRY PRESSURE PAD FOR MATTRESS, STANDARD MATTRESS LENGTH AND WIDTH	Dry pressure pad for mattres
677	E0241	BATH TUB WALL RAIL, EACH	Bath tub wall rail
678	E0243	TOILET RAIL, EACH	Toilet rail
679	E0256	HOSPITAL BED, VARIABLE HEIGHT, HI-LO, WITH ANY TYPE SIDE RAILS, WITHOUT MATTRESS	Hospital bed var ht w/o matt
680	E0430	PORTABLE GASEOUS OXYGEN SYSTEM, PURCHASE; INCLUDES REGULATOR, FLOWMETER, HUMIDIFIER, CANNULA OR MASK, AND TUBING	Oxygen system gas portable
681	E0463	PRESSURE SUPPORT VENTILATOR WITH VOLUME CONTROL MODE, MAY INCLUDE PRESSURE CONTROL MODE, USED WITH INVASIVE INTERFACE (E.G. TRACHEOSTOMY TUBE)	Press supp vent invasive int
682	E0465	HOME VENTILATOR, ANY TYPE, USED WITH INVASIVE INTERFACE, (E.G., TRACHEOSTOMY TUBE)	Home vent invasive interface
683	E0484	OSCILLATORY POSITIVE EXPIRATORY PRESSURE DEVICE, NON-ELECTRIC, ANY TYPE, EACH	Non-elec oscillatory pep dvc
684	E0562	HUMIDIFIER, HEATED, USED WITH POSITIVE AIRWAY PRESSURE DEVICE	Humidifier heated used w PAP
685	E0607	HOME BLOOD GLUCOSE MONITOR	Blood glucose monitor home
686	E0619	APNEA MONITOR, WITH RECORDING FEATURE	Apnea monitor w recorder
687	E0641	STANDING FRAME/TABLE SYSTEM, MULTI-POSITION (E.G. THREE-WAY STANDER), ANY SIZE INCLUDING PEDIATRIC, WITH OR WITHOUT WHEELS	Multi-position stnd fram sys
688	E0666	NON-SEGMENTAL PNEUMATIC APPLIANCE FOR USE WITH PNEUMATIC COMPRESSOR, HALF LEG	Pneumatic appliance half leg
689	E0668	SEGMENTAL PNEUMATIC APPLIANCE FOR USE WITH PNEUMATIC COMPRESSOR, FULL ARM	Seg pneumatic appl full arm
690	E0730	TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICE, FOUR OR MORE LEADS, FOR MULTIPLE NERVE STIMULATION	Tens four lead
691	E0762	TRANSCUTANEOUS ELECTRICAL JOINT STIMULATION DEVICE SYSTEM, INCLUDES ALL ACCESSORIES	Trans elec jt stim dev sys
692	E0764	FUNCTIONAL NEUROMUSCULAR STIMULATION, TRANSCUTANEOUS STIMULATION OF SEQUENTIAL MUSCLE GROUPS OF AMBULATION WITH COMPUTER CONTROL, USED FOR WALKING BY SPINAL CORD INJURED, ENTIRE SYSTEM, AFTER COMPLETION OF TRAINING PROGRAM	Functional neuromuscularstim
693	E0840	TRACTION FRAME, ATTACHED TO HEADBOARD, CERVICAL TRACTION	Tract frame attach headboard
694	J0222	Injection, patisiran, 0.1 mg	INJ., PATISIRAN, 0.1 MG
695	J0275	ALPROSTADIL URETHRAL SUPPOSITORY (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)	Alprostadil urethral suppos
696	J0295	INJECTION, AMPICILLIN SODIUM/SULBACTAM SODIUM, PER 1.5 GM	Ampicillin sulbactam 1.5 gm
697	J0480	INJECTION, BASILIXIMAB, 20 MG	Basiliximab
698	J0588	INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT	Incobotulinumtoxin a
699	J0882	INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (FOR ESRD ON DIALYSIS)	Darbepoetin alfa, esrd use
700	J0900	INJECTION, TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE, UP TO 1 CC	Testosterone enanthate inj
701	J1320	INJECTION, AMITRIPTYLINE HCL, UP TO 20 MG	Amitriptyline injection
702	J1324	INJECTION, ENFUVIRTIDE, 1 MG	Enfuvirtide injection
703	J1410	INJECTION, ESTROGEN CONJUGATED, PER 25 MG	Inj estrogen conjugate 25 MG
704	J1451	INJECTION, FOMEPIZOLE, 15 MG	Fomepizole, 15 mg
705	J1452	INJECTION, FOMIVIRSEN SODIUM, INTRAOCULAR, 1.65 MG	Intraocular Fomivirsen na
706	J1590	INJECTION, GATIFLOXACIN, 10MG	Gatifloxacin injection
707	J1595	INJECTION, GLATIRAMER ACETATE, 20 MG	Injection glatiramer acetate
708	J1740	INJECTION, IBANDRONATE SODIUM, 1 MG	Ibandronate sodium injection
709	J1833	INJECTION, ISAVUCONAZONIUM, 1 MG	Injection, isavuconazonium
710	J2704	INJECTION, PROPOFOL, 10 MG	Inj, propofol, 10 mg
711	J2724	INJECTION, PROTEIN C CONCENTRATE, INTRAVENOUS, HUMAN, 10 IU	Protein c concentrate
712	J2730	INJECTION, PRALIDOXIME CHLORIDE, UP TO 1 GM	Pralidoxime chloride inj
713	J2760	INJECTION, PHENTOLAMINE MESYLATE, UP TO 5 MG	Phentolaine mesylate inj
714	J2788	INJECTION, RHO D IMMUNE GLOBULIN, HUMAN, MINIDOSE, 50 MICROGRAMS (250 I.U.)	Rho d immune globulin 50 mcg
715	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	Ropivacaine HCl injection
716	J2941	INJECTION, SOMATROPIN, 1 MG	Somatropin injection
717	J2997	INJECTION, ALTEPLASE RECOMBINANT, 1 MG	Alteplase recombinant
718	J3260	INJECTION, TOBRAMYCIN SULFATE, UP TO 80 MG	Tobramycin sulfate injection
719	J3303	INJECTION, TRIAMCINOLONE HEXACETONIDE, PER 5MG	Triamcinolone hexacetonl inj
720	J3420	INJECTION, VITAMIN B-12 CYANOCOBALAMIN, UP TO 1000 MCG	Vitamin b12 injection
721	J3490	UNCLASSIFIED DRUGS	Drugs unclassified injection
722	J7209	INJECTION, FACTOR VIII, (ANTIHEMOPHILIC FACTOR, RECOMBINANT), (NUWIQ), 1 I.U.	Factor viii nuwiq recomb 1iu
723	J7307	ETONOGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM, INCLUDING IMPLANT AND SUPPLIES	Etonogestrel implant system
724	J7329	Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg	Inj, trivisc 1 mg
725	J7504	LYMPHOCYTE IMMUNE GLOBULIN, ANTITHYMOCYTE GLOBULIN, EQUINE, PARENTERAL, 250 MG	Lymphocyte immune globulin
726	J7511	LYMPHOCYTE IMMUNE GLOBULIN, ANTITHYMOCYTE GLOBULIN, RABBIT, PARENTERAL, 25MG	Antithymocyte globuln rabbit
727	J7608	ACETYLCYSTEINE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER GRAM	Acetylcysteine non-comp unit
728	J7682	TOBRAMYCIN, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, UNIT DOSE FORM, ADMINISTERED THROUGH DME, PER 300 MILLIGRAMS	Tobramycin non-comp unit
729	J8501	APREPITANT, ORAL, 5 MG	Oral aprepitant
730	J8515	CABERGOLINE, ORAL, 0.25 MG	Cabergoline, oral 0.25mg
731	J9015	INJECTION, ALDESLEUKIN, PER SINGLE USE VIAL	Aldesleukin injection
732	J9019	INJECTION, ASPARAGINASE (ERWINAZE), 1,000 IU	Erwinaze injection
733	J9025	INJECTION, AZACITIDINE, 1 MG	Azacitidine injection
734	J9034	INJECTION, BENDAMUSTINE HCL (BENDEKA), 1 MG	Inj., bendeka 1 mg
735	J9098	INJECTION, CYTARABINE LIPOSOME, 10 MG	Cytarabine liposome inj
736	J9130	DACARBAZINE, 100 MG	Dacarbazine 100 mg inj
737	J9208	INJECTION, IFOSFAMIDE, 1 GRAM	Ifosfamide injection
738	J9302	INJECTION, OFATUMUMAB, 10 MG	Ofatumumab injection
739	J9320	INJECTION, STREPTOZOCIN, 1 GRAM	Streptozocin injection
740	J9999	NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS	Chemotherapy drug
741	K0056	SEAT HEIGHT LESS THAN 17" OR EQUAL TO OR GREATER THAN 21" FOR A HIGH STRENGTH, LIGHTWEIGHT, OR ULTRALIGHTWEIGHT WHEELCHAIR	Seat ht <17 or >=21 ltwt wc
742	K0077	FRONT CASTER ASSEMBLY, COMPLETE, WITH SOLID TIRE, REPLACEMENT ONLY, EACH	Fr cstr asmb sol tire rep ea
743	K0745	ABSORPTIVE WOUND DRESSING FOR USE WITH SUCTION PUMP, HOME MODEL, PORTABLE, PAD SIZE MORE THAN 16 SQUARE INCHES BUT LESS THAN OR EQUAL TO 48 SQUARE INCHES	Absorp drg >16 <=48 suc pump
744	K0828	POWER WHEELCHAIR, GROUP 2 EXTRA HEAVY DUTY, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY 601 POUNDS OR MORE	PWC gp 2 xtra hd seat/back
745	K0856	POWER WHEELCHAIR, GROUP 3 STANDARD, SINGLE POWER OPTION, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY UP TO AND INCLUDING 300 POUNDS	PWC gp3 std sing pow opt s/b
746	K0860	POWER WHEELCHAIR, GROUP 3 VERY HEAVY DUTY, SINGLE POWER OPTION, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY 451 TO 600 POUNDS	PWC gp3 vhd sing pow opt s/b
747	K0880	POWER WHEELCHAIR, GROUP 4 VERY HEAVY DUTY, SINGLE POWER OPTION, SLING/SOLID SEAT/BACK, PATIENT WEIGHT 451 TO 600 POUNDS	PWC gp4 vhd sing pow opt s/b
748	V2615	TELESCOPIC AND OTHER COMPOUND LENS SYSTEM, INCLUDING DISTANCE VISION TELESCOPIC, NEAR VISION TELESCOPES AND COMPOUND MICROSCOPIC LENS SYSTEM	Telescop/othr compound lens
749	V2715	PRISM, PER LENS	Prism lens/es
750	V2797	VISION SUPPLY, ACCESSORY AND/OR SERVICE COMPONENT OF ANOTHER HCPCS VISION CODE	Vis item/svc in other code
751	V5030	HEARING AID, MONAURAL, BODY WORN, AIR CONDUCTION	Body-worn hearing aid air
752	V5140	BINAURAL, BEHIND THE EAR	Behind ear binaur hearing ai
753	V5150	BINAURAL, GLASSES	Glasses binaural hearing aid
754	V5172	Hearing aid, contralateral routing device, monaural, in the canal (itc)	Hearing aid monaural itc
755	V5215	Hearing aid, contralateral routing system, binaural, itc/bte	Hearing aid binaural itc/bte
756	V5240	DISPENSING FEE, CONTRALATERAL ROUTING SYSTEM, BINAURAL	Disp fee contralateral binau
757	V5254	HEARING AID, DIGITAL, MONAURAL, CIC	Hearing id, digit, mon, cic
758	A4706	BICARBONATE CONCENTRATE, SOLUTION, FOR HEMODIALYSIS, PER GALLON	Bicarbonate conc sol per gal
759	A4740	SHUNT ACCESSORY, FOR HEMODIALYSIS, ANY TYPE, EACH	Shunt accessory
760	A4766	DIALYSATE CONCENTRATE, SOLUTION, ADDITIVE FOR PERITONEAL DIALYSIS, PER 10 ML	Dialysate conc sol add 10 ml
761	A6207	CONTACT LAYER, STERILE, MORE THAN 16 SQ. IN. BUT LESS THAN OR EQUAL TO 48 SQ. IN., EACH DRESSING	Contact layer >16<= 48 sq in
762	A6234	HYDROCOLLOID DRESSING, WOUND COVER, STERILE, PAD SIZE 16 SQ. IN. OR LESS, WITHOUT ADHESIVE BORDER, EACH DRESSING	Hydrocolld drg <=16 w/o bdr
763	A6236	HYDROCOLLOID DRESSING, WOUND COVER, STERILE, PAD SIZE MORE THAN 48 SQ. IN., WITHOUT ADHESIVE BORDER, EACH DRESSING	Hydrocolld drg > 48 in w/o b
764	A6253	SPECIALTY ABSORPTIVE DRESSING, WOUND COVER, STERILE, PAD SIZE MORE THAN 48 SQ. IN., WITHOUT ADHESIVE BORDER, EACH DRESSING	Absorpt drg > 48 sq in w/o b
765	A6260	WOUND CLEANSERS, ANY TYPE, ANY SIZE	Wound cleanser any type/size
766	A6410	EYE PAD, STERILE, EACH	Sterile eye pad
767	A7012	WATER COLLECTION DEVICE, USED WITH LARGE VOLUME NEBULIZER	Nebulizer water collec devic
768	A7030	FULL FACE MASK USED WITH POSITIVE AIRWAY PRESSURE DEVICE, EACH	CPAP full face mask
769	A8000	HELMET, PROTECTIVE, SOFT, PREFABRICATED, INCLUDES ALL COMPONENTS AND ACCESSORIES	Soft protect helmet prefab
770	A9281	REACHING/GRABBING DEVICE, ANY TYPE, ANY LENGTH, EACH	Reaching/grabbing device
771	A9999	MISCELLANEOUS DME SUPPLY OR ACCESSORY, NOT OTHERWISE SPECIFIED	DME supply or accessory, nos
772	B4152	ENTERAL FORMULA, NUTRITIONALLY COMPLETE, CALORICALLY DENSE (EQUAL TO OR GREATER THAN 1.5 KCAL/ML) WITH INTACT NUTRIENTS, INCLUDES PROTEINS, FATS, CARBOHYDRATES, VITAMINS AND MINERALS, MAY INCLUDE FIBER, ADMINISTERED THROUGH AN ENTERAL FEEDING TUBE, 100 CALORIES = 1 UNIT	EF calorie dense>/=1.5Kcal
773	B4157	ENTERAL FORMULA, NUTRITIONALLY COMPLETE, FOR SPECIAL METABOLIC NEEDS FOR INHERITED DISEASE OF METABOLISM, INCLUDES PROTEINS, FATS, CARBOHYDRATES, VITAMINS AND MINERALS, MAY INCLUDE FIBER, ADMINISTERED THROUGH AN ENTERAL FEEDING TUBE, 100 CALORIES = 1 UNIT	EF special metabolic inherit
774	B4164	PARENTERAL NUTRITION SOLUTION: CARBOHYDRATES (DEXTROSE), 50% OR LESS (500 ML = 1 UNIT) - HOMEMIX	Parenteral 50% dextrose solu
775	B4189	PARENTERAL NUTRITION SOLUTION; COMPOUNDED AMINO ACID AND CARBOHYDRATES WITH ELECTROLYTES, TRACE ELEMENTS, AND VITAMINS, INCLUDING PREPARATION, ANY STRENGTH, 10 TO 51 GRAMS OF PROTEIN - PREMIX	Parenteral sol amino acid &
776	B4220	PARENTERAL NUTRITION SUPPLY KIT; PREMIX, PER DAY	Parenteral supply kit premix
777	B4222	PARENTERAL NUTRITION SUPPLY KIT; HOME MIX, PER DAY	Parenteral supply kit homemi
778	B5100	PARENTERAL NUTRITION SOLUTION COMPOUNDED AMINO ACID AND CARBOHYDRATES WITH ELECTROLYTES, TRACE ELEMENTS, AND VITAMINS, INCLUDING PREPARATION, ANY STRENGTH, HEPATIC, HEPATAMINE-PREMIX	Parenteral solution hepatic
779	C1300	HYPERBARIC OXYGEN UNDER PRESSURE, FULL BODY CHAMBER, PER 30 MINUTE INTERVAL	HYPERBARIC Oxygen
780	C1724	CATHETER, TRANSLUMINAL ATHERECTOMY, ROTATIONAL	Cath, trans atherec,rotation
781	C1749	ENDOSCOPE, RETROGRADE IMAGING/ILLUMINATION COLONOSCOPE DEVICE (IMPLANTABLE)	Endo, colon, retro imaging
782	C1776	JOINT DEVICE (IMPLANTABLE)	Joint device (implantable)
783	C1888	CATHETER, ABLATION, NON-CARDIAC, ENDOVASCULAR (IMPLANTABLE)	Endovas non-cardiac abl cath
784	C1893	INTRODUCER/SHEATH, GUIDING, INTRACARDIAC ELECTROPHYSIOLOGICAL, FIXED-CURVE, OTHER THAN PEEL-AWAY	Intro/sheath, fixed,non-peel
785	C2616	BRACHYTHERAPY SOURCE, NON-STRANDED, YTTRIUM-90, PER SOURCE	Brachytx, non-str,Yttrium-90
786	C2627	CATHETER, SUPRAPUBIC/CYSTOSCOPIC	Cath, suprapubic/cystoscopic
787	C5274	APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; EACH ADDITIONAL 100 SQ CM WOUND SURFACE AREA, OR PART THEREOF, OR EACH ADDITIONAL 1% OF BODY AREA OF INFANTS AND CHILDREN, OR	Low cost skin substitute app
788	C5276	APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; EACH ADDITIONAL 25 SQ CM WOUND SURFACE AREA, OR PART THEREOF (LIST	Low cost skin substitute app
789	C8957	INTRAVENOUS INFUSION FOR THERAPY/DIAGNOSIS; INITIATION OF PROLONGED INFUSION (MORE THAN 8 HOURS), REQUIRING USE OF PORTABLE OR IMPLANTABLE PUMP	Prolonged IV inf, req pump
790	C9030	Injection, copanlisib, 1 mg	Inj copanlisib
791	C9135	FACTOR IX (ANTIHEMOPHILIC FACTOR, RECOMBINANT), ALPROLIX, PER 10 I.U.	Factor ix (Alprolix)
792	C9460	INJECTION, CANGRELOR, 1 MG	Injection, cangrelor
793	C9734	FOCUSED ULTRASOUND ABLATION/THERAPEUTIC INTERVENTION, OTHER THAN UTERINE LEIOMYOMATA, WITH MAGNETIC RESONANCE (MR) GUIDANCE	U/S trtmt, not leiomyomata
794	E0959	MANUAL WHEELCHAIR ACCESSORY, ADAPTER FOR AMPUTEE, EACH	Amputee adapter
795	E0981	WHEELCHAIR ACCESSORY, SEAT UPHOLSTERY, REPLACEMENT ONLY, EACH	Seat upholstery, replacement
796	E1005	WHEELCHAIR ACCESSORY, POWER SEATNG SYSTEM, RECLINE ONLY, WITH POWER SHEAR REDUCTION	Pwr seat recline pwr
797	E1089	HIGH STRENGTH LIGHTWEIGHT WHEELCHAIR, FIXED LENGTH ARMS, SWING AWAY DETACHABLE FOOTREST	Wheelchair lightwt fixed arm
798	E1161	MANUAL ADULT SIZE WHEELCHAIR, INCLUDES TILT IN SPACE	Manual adult wc w tiltinspac
799	E1310	WHIRLPOOL, NON-PORTABLE (BUILT-IN TYPE)	Whirlpool non-portable
800	E1399	DURABLE MEDICAL EQUIPMENT, MISCELLANEOUS	Durable medical equipment mi
801	E1610	REVERSE OSMOSIS WATER PURIFICATION SYSTEM, FOR HEMODIALYSIS	Reverse osmosis h2o puri sys
802	E2225	MANUAL WHEELCHAIR ACCESSORY, CASTER WHEEL EXCLUDES TIRE, ANY SIZE, REPLACEMENT ONLY, EACH	Caster wheel excludes tire
803	E2323	POWER WHEELCHAIR ACCESSORY, SPECIALTY JOYSTICK HANDLE FOR HAND CONTROL INTERFACE, PREFABRICATED	Special joystick handle
804	69661	Stapedectomy or stapedotomy with reestablishment of ossicular continuity, with or without use of foreign material; with footplate drill out	REVISE MIDDLE EAR BONE
805	69949	Unlisted procedure, inner ear	INNER EAR SURGERY PROCEDURE
806	70120	Radiologic examination, mastoids; less than 3 views per side	X-RAY EXAM OF MASTOIDS
807	70330	Radiologic examination, temporomandibular joint, open and closed mouth; bilateral	X-RAY EXAM OF JAW JOINTS
808	70336	Magnetic resonance (eg, proton) imaging, temporomandibular joint(s)	MAGNETIC IMAGE JAW JOINT
809	70380	Radiologic examination, salivary gland for calculus	X-RAY EXAM OF SALIVARY GLAN
810	71250	Computed tomography, thorax; without contrast material	CT THORAX W/O DYE
811	72020	Radiologic examination, spine, single view, specify level	X-RAY EXAM OF SPINE 1 VIEW
812	72192	Computed tomography, pelvis; without contrast material	CT PELVIS W/O DYE
813	72220	Radiologic examination, sacrum and coccyx, minimum of 2 views	X-RAY EXAM SACRUM TAILBONE
814	72270	Myelography, 2 or more regions (eg, lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical), radiological supervision and interpretation	MYELOGPHY 2/> SPINE REGIONS
815	72285	Discography, cervical or thoracic, radiological supervision and interpretation	DISCOGRAPHY CERV/THOR SPINE
816	73522	Radiologic examination, hips, bilateral, with pelvis when performed; 3-4 views	X-RAY EXAM HIPS BI 3-4 VIEW
817	73564	Radiologic examination, knee; complete, 4 or more views	X-RAY EXAM KNEE 4 OR MORE
818	73590	Radiologic examination; tibia and fibula, 2 views	X-RAY EXAM OF LOWER LEG
819	98968	Telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion	HC PRO PHONE CALL 21-30 MIN
820	99195	Phlebotomy, therapeutic (separate procedure)	PHLEBOTOMY
821	G8450	BETA-BLOCKER THERAPY PRESCRIBED FOR PATIENTS WITH LEFT VENTRICULAR EJECTION FRACTION (LVEF) <40% OR DOCUMENTATION AS MODERATELY OR SEVERELY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION	Beta-bloc rx pt w/abn lvef
822	99282	Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity.	EMERGENCY DEPT VISIT
823	G8487	I INTEND TO REPORT THE CHRONIC KIDNEY DISEASE (CKD) MEASURES GROUP	Report CKD Measures
824	N1	Group 1 oxygen coverage criteria met	Group 1 oxygen coverage criteria met
825	N3	Group 3 oxygen coverage criteria met	Group 3 oxygen coverage criteria met
826	JZ	Zero drug amount discarded/not administered to any patient	Zero drug amount discarded/not administered to any patient
827	AB	Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary	Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary
828	G8461	PATIENT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C DURING THE MEASUREMENT PERIOD	Pt rec antivir treat hep c
829	G8492	I INTEND TO REPORT THE PERIOPERATIVE CARE MEASURES GROUP	Periop Care measures grp
830	G8531	CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR AUTOGENOUS AV FISTULA	Pt inelig; auto AV fistula
831	G8541	FUNCTIONAL OUTCOME ASSESSMENT USING A STANDARDIZED TOOL NOT DOCUMENTED, REASON NOT GIVEN	No doc cur funct assess
832	G8575	DEVELOPED POSTOPERATIVE RENAL FAILURE OR REQUIRED DIALYSIS	Postop ren fail
833	G8582	BETA-BLOCKER AT DISCHARGE	Bblock disch
834	G8631	CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ORDERING PROPHYLACTIC PARENTERAL ANTIBIOTICS TO BE GIVEN WITHIN ONE HOUR (IF FLUOROQUINOLONE OR VANCOMYCIN, TWO HOURS) PRIOR TO SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED)	Pt no elg 4 order antbi give
835	G8752	MOST RECENT SYSTOLIC BLOOD PRESSURE < 140MMHG	Sys BP less 140
836	G8762	ALL QUALITY ACTIONS FOR THE APPLICABLE MEASURES IN THE PARKINSON'S DISEASE MEASURES GROUP HAVE BEEN PERFORMED FOR THIS PATIENT	PD MG qual act perform
837	G8779	DIABETES SCREENING TEST NOT PERFORMED, REASON NOT GIVEN	No diabetes screen
838	G8785	BLOOD PRESSURE READING NOT DOCUMENTED, REASON NOT GIVEN	BP scrn no perf at interval
839	G8834	PATIENT DISCHARGED TO HOME NO LATER THAN POST-OPERATIVE DAY #2 FOLLOWING CEA	Pt disch home day #2 CEA
840	G8860	PATIENTS WHO HAVE RECEIVED DOSE OF CORTICOSTEROIDS GREATER THAN OR EQUAL TO 10MG/DAY FOR 60 OR GREATER CONSECUTIVE DAYS	Corticosteroid 10 mg 60 days
841	G8906	I INTEND TO REPORT THE CATARACT MEASURES GROUP	Cataract Measures Group
842	G8880	DOCUMENTATION OF REASON(S) SENTINEL LYMPH NODE BIOPSY NOT PERFORMED (E.G., REASONS COULD INCLUDE BUT NOT LIMITED TO; NON-INVASIVE CANCER, INCIDENTAL DISCOVERY OF BREAST CANCER ON PROPHYLACTIC MASTECTOMY, INCIDENTAL DISCOVERY OF BREAST CANCER ON REDUCTION MAMMOPLASTY, PRE-OPERATIVE BIOPSY PROVEN LYMPH NODE (LN) METASTASES, INFLAMMATORY CARCINOMA, STAGE 3 LOCALLY ADVANCED CANCER, RECURRENT INVASIVE BREAST CANCER, CLINICALLY NODE POSITIVE AFTER NEOADJUVANT SYSTEMIC THERAPY, PATIENT REFUSAL AFTER INFORMED CONSENT, PATIENT WITH SIGNIFICANT AGE, COMORBIDITIES, OR LIMITED LIFE EXPECTANCY AND FAVORABLE TUMOR; ADJUVANT SYSTEMIC THERAPY UNLIKELY TO CHANGE)	Sen lym p node biop not perf
843	G8956	PATIENT RECEIVING MAINTENANCE HEMODIALYSIS IN AN OUTPATIENT DIALYSIS FACILITY	Pt rcv HeDia outpt dyls fac
844	G8977	I INTEND TO REPORT THE ONCOLOGY MEASURES GROUP	Oncology measures grp
845	G9003	COORDINATED CARE FEE, RISK ADJUSTED HIGH, INITIAL	MCCD, risk adj hi, initial
846	G9035	OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Oseltamivir phosp, brand
847	G9051	ONCOLOGY; PRIMARY FOCUS OF VISIT; TREATMENT DECISION-MAKING AFTER DISEASE IS STAGED OR RESTAGED, DISCUSSION OF TREATMENT OPTIONS, SUPERVISING/COORDINATING ACTIVE CANCER DIRECTED THERAPY OR MANAGING CONSEQUENCES OF CANCER DIRECTED THERAPY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Oncology tx decision-mgmt
848	G9065	ONCOLOGY; DISEASE STATUS; LIMITED TO NON-SMALL CELL LUNG CANCER; EXTENT OF DISEASE INITIALLY ESTABLISHED AS STAGE III A (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx nsclc stg3A no progre
849	G9089	ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx colon extent unknown
850	G9090	ONCOLOGY; DISEASE STATUS; RECTAL CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T1-2, N0, M0 (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx rectal T1-2 no progr
851	L0980	PERONEAL STRAPS, PREFABRICATED, OFF-THE-SHELF, PAIR	Peroneal straps pair pre ots
852	L0627	LUMBAR ORTHOSIS, SAGITTAL CONTROL, WITH RIGID ANTERIOR AND POSTERIOR PANELS, POSTERIOR EXTENDS FROM L-1 TO BELOW L-5 VERTEBRA, PRODUCES INTRACAVITARY PRESSURE TO REDUCE LOAD ON THE INTERVERTEBRAL DISCS, INCLUDES STRAPS, CLOSURES, MAY INCLUDE PADDING, SHOULDER STRAPS, PENDULOUS ABDOMEN DESIGN, PREFABRICATED ITEM THAT HAS BEEN TRIMMED, BENT, MOLDED, ASSEMBLED, OR OTHERWISE CUSTOMIZED TO FIT A SPECIFIC PATIENT BY AN INDIVIDUAL WITH EXPERTISE	Lo sag ri an/pos pnl pre cst
853	L0631	LUMBAR-SACRAL ORTHOSIS, SAGITTAL CONTROL, WITH RIGID ANTERIOR AND POSTERIOR PANELS, POSTERIOR EXTENDS FROM SACROCOCCYGEAL JUNCTION TO T-9 VERTEBRA, PRODUCES INTRACAVITARY PRESSURE TO REDUCE LOAD ON THE INTERVERTEBRAL DISCS, INCLUDES STRAPS, CLOSURES, MAY INCLUDE PADDING, SHOULDER STRAPS, PENDULOUS ABDOMEN DESIGN, PREFABRICATED ITEM THAT HAS BEEN TRIMMED, BENT, MOLDED, ASSEMBLED, OR OTHERWISE CUSTOMIZED TO FIT A SPECIFIC PATIENT BY AN INDIVIDUAL WITH EXPERTISE	Lso sag r an/pos pnl pre cst
854	L0638	LUMBAR-SACRAL ORTHOSIS, SAGITTAL-CORONAL CONTROL, WITH RIGID ANTERIOR AND POSTERIOR FRAME/PANELS, POSTERIOR EXTENDS FROM SACROCOCCYGEAL JUNCTION TO T-9 VERTEBRA, LATERAL STRENGTH PROVIDED BY RIGID LATERAL FRAME/PANELS, PRODUCES INTRACAVITARY PRESSURE TO REDUCE LOAD ON INTERVERTEBRAL DISCS, INCLUDES STRAPS, CLOSURES, MAY INCLUDE PADDING, SHOULDER STRAPS, PENDULOUS ABDOMEN DESIGN, CUSTOM FABRICATED	LSO sag-coronal panel custom
855	L1685	HIP ORTHOSIS, ABDUCTION CONTROL OF HIP JOINT, POSTOPERATIVE HIP ABDUCTION TYPE, CUSTOM FABRICATED	Post-op hip abduct custom fa
856	L1850	KNEE ORTHOSIS, SWEDISH TYPE, PREFABRICATED, OFF-THE-SHELF	Ko swedish type pre ots
857	L1940	ANKLE FOOT ORTHOSIS, PLASTIC OR OTHER MATERIAL, CUSTOM-FABRICATED	Afo molded to patient plasti
858	L2240	ADDITION TO LOWER EXTREMITY, ROUND CALIPER AND PLATE ATTACHMENT	Round caliper and plate atta
859	L2270	ADDITION TO LOWER EXTREMITY, VARUS/VALGUS CORRECTION ('T') STRAP, PADDED/LINED OR MALLEOLUS PAD	Varus/valgus strap padded/li
860	L2330	ADDITION TO LOWER EXTREMITY, LACER MOLDED TO PATIENT MODEL, FOR CUSTOM FABRICATED ORTHOSIS ONLY	Lacer molded to patient mode
861	L2520	ADDITION TO LOWER EXTREMITY, THIGH/WEIGHT BEARING, QUADRI- LATERAL BRIM, CUSTOM FITTED	Th/wght bear quad-lat brim c
862	L2780	ADDITION TO LOWER EXTREMITY ORTHOSIS, NON-CORROSIVE FINISH, PER BAR	Non-corrosive finish
863	L3010	FOOT, INSERT, REMOVABLE, MOLDED TO PATIENT MODEL, LONGITUDINAL ARCH SUPPORT, EACH	Foot longitudinal arch suppo
864	L3140	FOOT, ABDUCTION ROTATION BAR, INCLUDING SHOES	Abduction rotation bar shoe
865	L3209	SURGICAL BOOT, EACH, CHILD	Surgical boot each child
866	L3219	ORTHOPEDIC FOOTWEAR, MENS SHOE, OXFORD, EACH	Orthopedic mens shoes oxford
867	L3252	FOOT, SHOE MOLDED TO PATIENT MODEL, PLASTAZOTE (OR SIMILAR), CUSTOM FABRICATED, EACH	Shoe molded plastazote cust
868	L3254	NON-STANDARD SIZE OR WIDTH	Orth foot non-stndard size/w
869	L3265	PLASTAZOTE SANDAL, EACH	Plastazote sandal each
870	L3332	LIFT, ELEVATION, INSIDE SHOE, TAPERED, UP TO ONE-HALF INCH	Shoe lifts tapered to one-ha
871	93793	Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed	ANTICOAG MGMT PT WARFARIN
872	93880	Duplex scan of extracranial arteries; complete bilateral study	EXTRACRANIAL BILAT STUDY
873	93990	Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)	DOPPLER FLOW TESTING
874	94004	Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing; nursing facility, per day	VENT MGMT NF PER DAY
875	94011	Measurement of spirometric forced expiratory flows in an infant or child through 2 years of age	SPIROMETRY UP TO 2 YRS OLD
876	94013	Measurement of lung volumes (ie, functional residual capacity [FRC], forced vital capacity [FVC], and expiratory reserve volume [ERV]) in an infant or child through 2 years of age	MEAS LUNG VOL THRU 2 YRS
877	94621	Cardiopulmonary exercise testing, including measurements of minute ventilation, CO2 production, O2 uptake, and electrocardiographic recordings	CARDIOPULM EXERCISE TESTING
878	94644	Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour	CBT 1ST HOUR
879	96902	Microscopic examination of hairs plucked or clipped by the examiner (excluding hair collected by the patient) to determine telogen and anagen counts, or structural hair shaft abnormality	TRICHOGRAM
880	96933	Reflectance confocal microscopy (RCM) for cellular and sub-cellular imaging of skin; interpretation and report only, first lesion	RCM CELULR SUBCELULR IMG SK
881	96935	Reflectance confocal microscopy (RCM) for cellular and sub-cellular imaging of skin; image acquisition only, each additional lesion (List separately in addition to code for primary procedure)	RCM CELULR SUBCELULR IMG SK
882	97014	Application of a modality to 1 or more areas; electrical stimulation (unattended)	ELECTRIC STIMULATION THERAP
883	97016	Application of a modality to 1 or more areas; vasopneumatic devices	VASOPNEUMATIC DEVICE THERAP
884	78414	Determination of central c-v hemodynamics (non-imaging) (eg, ejection fraction with probe technique) with or without pharmacologic intervention or exercise, single or multiple determinations	NON-IMAGING HEART FUNCTION
885	78430	Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan	MYOCRD IMG PET RST/STRS W/C
886	78801	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, 2 or more areas (eg, abdomen and pelvis, head and chest), 1 or more days imaging or single area imaging over 2 or more days	RP LOCLZJ TUM 2+AREA 1+D IM
887	78806	Radiopharmaceutical localization of inflammatory process; whole body
888	80069	Renal function panel This panel must include the following: Albumin (82040) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphorus inorganic (phosphate) (84100) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520)	RENAL FUNCTION PANEL
889	81015	Urinalysis; microscopic only	MICROSCOPIC EXAM OF URINE
890	81025	Urine pregnancy test, by visual color comparison methods	URINE PREGNANCY TEST
891	91309	Under Vaccines, Toxoids	Under Vaccines, Toxoids
892	91310	Under Vaccines, Toxoids	Under Vaccines, Toxoids
893	91312	Under Vaccines, Toxoids	Under Vaccines, Toxoids
894	91313	Under Vaccines, Toxoids	Under Vaccines, Toxoids
895	91314	Under Vaccines, Toxoids	Under Vaccines, Toxoids
896	96202	Under Behavior Management Services	Under Behavior Management Services
897	0347U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
898	0349U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
899	0351U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
900	0353U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
901	0354U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
902	0357U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
903	0359U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
904	0360U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
905	0361U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
906	0334U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
907	0335U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
908	0336U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
909	0337U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
910	0341U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
911	0343U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
912	0346U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
913	0642T	Under Cellular Regeneration, Evaluation Study and Ablation Procedures	Under Cellular Regeneration, Evaluation Study and Ablation Procedures
914	0644T	Under Transcatheter Implantation and Removal Procedures	Under Transcatheter Implantation and Removal Procedures
915	0646T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
916	0652T	Under Transnasal EGD and Capsule Endoscopy Procedures	Under Transnasal EGD and Capsule Endoscopy Procedures
917	0654T	Under Transnasal EGD and Capsule Endoscopy Procedures	Under Transnasal EGD and Capsule Endoscopy Procedures
918	0655T	Under Transperineal Prostate Ablation Through Laser	Under Transperineal Prostate Ablation Through Laser
919	0656T	Under Vertebral Body Tethering Procedures	Under Vertebral Body Tethering Procedures
920	0657T	Under Vertebral Body Tethering Procedures	Under Vertebral Body Tethering Procedures
921	0658T	Under Impedance Spectroscopy and Intracoronary Infusion Procedures	Under Impedance Spectroscopy and Intracoronary Infusion Procedures
922	0659T	Under Impedance Spectroscopy and Intracoronary Infusion Procedures	Under Impedance Spectroscopy and Intracoronary Infusion Procedures
923	0660T	Under Drug-Eluting Implant Procedures in Eye	Under Drug-Eluting Implant Procedures in Eye
924	0661T	Under Drug-Eluting Implant Procedures in Eye	Under Drug-Eluting Implant Procedures in Eye
925	0662T	Under Scalp Cooling Procedures	Under Scalp Cooling Procedures
926	0663T	Under Scalp Cooling Procedures	Under Scalp Cooling Procedures
927	0668T	Under Uterine Allograft Preparation and Reconstruction Procedures Prior to Transplantation	Under Uterine Allograft Preparation and Reconstruction Procedures Prior to Transplantation
928	0670T	Under Uterine Allograft Preparation and Reconstruction Procedures Prior to Transplantation	Under Uterine Allograft Preparation and Reconstruction Procedures Prior to Transplantation
929	0711T	Under Noninvasive Arterial Plaque Analysis	Under Noninvasive Arterial Plaque Analysis
930	0714T	Under Prostate Ablation Procedure	Under Prostate Ablation Procedure
931	0751T	Under Digitization of Glass Microscope Slides for Surgical Pathology	Under Digitization of Glass Microscope Slides for Surgical Pathology
932	0753T	Under Digitization of Glass Microscope Slides for Surgical Pathology	Under Digitization of Glass Microscope Slides for Surgical Pathology
933	0756T	Under Digitization of Glass Microscope Slides for Special Stain	Under Digitization of Glass Microscope Slides for Special Stain
934	0757T	Under Digitization of Glass Microscope Slides for Special Stain	Under Digitization of Glass Microscope Slides for Special Stain
935	0763T	Under Digitization of Glass Microscope Slides for Immunohistochemistry or Immunocytochemistry	Under Digitization of Glass Microscope Slides for Immunohistochemistry or Immunocytochemistry
936	0765T	Under Risk-Based Assessment for Cardiac Dysfunction	Under Risk-Based Assessment for Cardiac Dysfunction
937	0766T	Under Transcutaneous Magnetic Stimulation of Peripheral Nerve	Under Transcutaneous Magnetic Stimulation of Peripheral Nerve
938	0770T	Under Virtual Reality Technology Services	Under Virtual Reality Technology Services
939	0771T	Under Virtual Reality Technology Services	Under Virtual Reality Technology Services
940	0772T	Under Virtual Reality Technology Services	Under Virtual Reality Technology Services
941	0773T	Under Virtual Reality Technology Services	Under Virtual Reality Technology Services
942	0775T	Under Sacroiliac Joint Arthrodesis Procedure	Under Sacroiliac Joint Arthrodesis Procedure
943	0777T	Under Pressure-Sensing Epidural Guidance System	Under Pressure-Sensing Epidural Guidance System
944	0780T	Under Fecal Microbiota Transplantation Procedure	Under Fecal Microbiota Transplantation Procedure
945	0671T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
946	0674T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
947	0675T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
948	0676T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
949	0679T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
950	0680T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
951	0682T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
952	0684T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
953	0685T	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads	Under Insertion, Replacement, Repositioning, Removal and Evaluation of Diaphragmatic Stimulation System and Leads
954	0686T	Under Malignant Hepatocellular Histotripsy Procedure	Under Malignant Hepatocellular Histotripsy Procedure
955	0687T	Under Treatment of Amblyopia using Online Digital Program	Under Treatment of Amblyopia using Online Digital Program
956	0688T	Under Treatment of Amblyopia using Online Digital Program	Under Treatment of Amblyopia using Online Digital Program
957	0689T	Under Quantitative Ultrasound Tissue Characterization	Under Quantitative Ultrasound Tissue Characterization
958	0690T	Under Quantitative Ultrasound Tissue Characterization	Under Quantitative Ultrasound Tissue Characterization
959	0691T	Under Automated Analysis of Vertebral Fracture	Under Automated Analysis of Vertebral Fracture
960	0694T	Under 3-dimensional Imaging and Reconstruction of Breast or Axillary Lymph Node Tissue	Under 3-dimensional Imaging and Reconstruction of Breast or Axillary Lymph Node Tissue
961	0695T	Under Mapping of Pacemaker or Pacing Cardioverter-Defibrillator Leads	Under Mapping of Pacemaker or Pacing Cardioverter-Defibrillator Leads
962	0696T	Under Mapping of Pacemaker or Pacing Cardioverter-Defibrillator Leads	Under Mapping of Pacemaker or Pacing Cardioverter-Defibrillator Leads
963	0701T	Under Molecular Fluorescent Imaging of Suspicious Nevus	Under Molecular Fluorescent Imaging of Suspicious Nevus
964	0717T	Under ARPC Therapy For Partial Thickness Rotator Cuff Tear	Under ARPC Therapy For Partial Thickness Rotator Cuff Tear
965	0718T	Under ARPC Therapy For Partial Thickness Rotator Cuff Tear	Under ARPC Therapy For Partial Thickness Rotator Cuff Tear
966	0721T	Under Tissue Characterization by Quantitative CT	Under Tissue Characterization by Quantitative CT
967	0722T	Under Tissue Characterization by Quantitative CT	Under Tissue Characterization by Quantitative CT
968	0725T	Under Vestibular Device Procedures with Analysis and Programming	Under Vestibular Device Procedures with Analysis and Programming
969	0726T	Under Vestibular Device Procedures with Analysis and Programming	Under Vestibular Device Procedures with Analysis and Programming
970	0729T	Under Vestibular Device Procedures with Analysis and Programming	Under Vestibular Device Procedures with Analysis and Programming
971	0731T	Under AI-Based Facial Phenotype Analysis	Under AI-Based Facial Phenotype Analysis
972	0733T	Under Remote Body And Limb Kinematic Measurement-Based Therapy	Under Remote Body And Limb Kinematic Measurement-Based Therapy
973	0734T	Under Remote Body And Limb Kinematic Measurement-Based Therapy	Under Remote Body And Limb Kinematic Measurement-Based Therapy
974	0736T	Under Colonic Lavage with Insertion Of Rectal Catheter Procedure	Under Colonic Lavage with Insertion Of Rectal Catheter Procedure
975	0739T	Under Prostate Ablation Procedures including Planning	Under Prostate Ablation Procedures including Planning
976	0740T	Under Remote Insulin Dose Calculation and Monitoring System	Under Remote Insulin Dose Calculation and Monitoring System
977	0741T	Under Remote Insulin Dose Calculation and Monitoring System	Under Remote Insulin Dose Calculation and Monitoring System
978	0742T	Under Myocardial Perfusion Imaging Procedure	Under Myocardial Perfusion Imaging Procedure
979	0745T	Under Cardiac Radioablation Procedure for Arrhythmia	Under Cardiac Radioablation Procedure for Arrhythmia
980	0746T	Under Cardiac Radioablation Procedure for Arrhythmia	Under Cardiac Radioablation Procedure for Arrhythmia
981	0748T	Under Stem Cell Injection Procedures for Perianal Fistula Treatment	Under Stem Cell Injection Procedures for Perianal Fistula Treatment
982	0267U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
983	0207U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
984	0209U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
985	0210U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
986	0212U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
987	0217U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
988	0218U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
989	0219U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
990	0221U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
991	0223U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
992	0226U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
993	0230U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
994	0231U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
995	0232U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
996	0235U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
997	0310U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
998	0312U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
999	0314U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1000	0315U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1001	0317U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1002	0318U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1003	0320U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1004	0324U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1005	0327U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1006	0238U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1007	0240U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1008	0241U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1009	0242U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1010	0245U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1011	0249U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1012	0250U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1013	0252U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1014	0272U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1015	0273U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1016	0278U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1017	0280U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1018	0282U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1019	0283U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1020	0286U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1021	0287U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1022	0291U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1023	0293U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1024	0295U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1025	0297U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1026	0298U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1027	0303U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1028	0306U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1029	0308U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1030	0309U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1031	0329U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1032	0330U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1033	0048U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1034	0050U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1035	0051U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1036	0052A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1037	0052U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1038	0053U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1039	0054U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1040	0058U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1041	0059U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1042	0062U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1043	0063U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1044	0064A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1045	0064U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1046	0065U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1047	0066U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1048	0067U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1049	0068U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1050	0069U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1051	0070U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1052	0071A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1053	0071U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1054	0072A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1055	0082A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1056	0082U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1057	0083A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1058	0083U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1059	0086U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1060	0092U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1061	0093A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1062	0096U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1063	0102U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1064	0103U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1065	0104A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1066	0105U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1067	0106U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1068	0107U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1069	0111U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1070	0112U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1071	0113U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1072	0148U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1073	0150U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1074	0152U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1075	0158U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1076	0160U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1077	0162U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1078	0163U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1079	0004A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1080	0005U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1081	0007U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1082	0008U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1083	0009U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1084	0012A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1085	0018U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1086	0021A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1087	0021U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1088	0023U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1089	0025U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1090	0026U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1091	0027U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1092	0029U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1093	0031U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1094	0032U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1095	0036U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1096	0037U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1097	0040U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1098	0041A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1099	0041U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1100	0042U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1101	0043U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1102	0047U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1103	0072U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1104	0073U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1105	0075U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1106	0077U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1107	0078U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1108	0079U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1109	0080U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1110	0081A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1111	0001A	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1112	0001U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1113	0002U	Under Proprietary Laboratory Analyses	Under Proprietary Laboratory Analyses
1114	0205T	Intravascular catheter-based coronary vessel or graft spectroscopy (eg, infrared) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation, and report, each vessel (List separately in addition to code for primary procedure)
1115	0268T	Under Carotid Sinus Baroreflex Activation Device Procedures	Under Carotid Sinus Baroreflex Activation Device Procedures
1116	0212T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1117	0213T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1118	0214T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1119	0215T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1120	0219T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1121	0220T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1122	0221T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1123	0222T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1124	0232T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1125	0235T	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries
1126	0631T	Under Hyperspectral Imaging Measurement of Hemoglobin	Under Hyperspectral Imaging Measurement of Hemoglobin
1127	0633T	Under CT Breast (with/without Contrast)	Under CT Breast (with/without Contrast)
1128	0635T	Under CT Breast (with/without Contrast)	Under CT Breast (with/without Contrast)
1129	0636T	Under CT Breast (with/without Contrast)	Under CT Breast (with/without Contrast)
1130	0637T	Under CT Breast (with/without Contrast)	Under CT Breast (with/without Contrast)
1131	0638T	Under CT Breast (with/without Contrast)	Under CT Breast (with/without Contrast)
1132	0639T	Under CSF Shunt Analysis	Under CSF Shunt Analysis
1133	0582T	Under Ablation Procedures	Under Ablation Procedures
1134	0587T	Under Neurostimulation Procedures	Under Neurostimulation Procedures
1135	0588T	Under Neurostimulation Procedures	Under Neurostimulation Procedures
1136	0593T	Under Health And Well-Being Coaching	Under Health And Well-Being Coaching
1137	0596T	Under Female Voiding Prosthesis Procedures	Under Female Voiding Prosthesis Procedures
1138	0602T	Under Transdermal GFR Measurement and Monitoring	Under Transdermal GFR Measurement and Monitoring
1139	0603T	Under Transdermal GFR Measurement and Monitoring	Under Transdermal GFR Measurement and Monitoring
1140	0608T	Under Remote Monitoring of Pulmonary System	Under Remote Monitoring of Pulmonary System
1141	0609T	Under Magnetic Resonance Spectroscopy Imaging	Under Magnetic Resonance Spectroscopy Imaging
1142	0611T	Under Magnetic Resonance Spectroscopy Imaging	Under Magnetic Resonance Spectroscopy Imaging
1143	0613T	Under Cardiac Implantation and Replacement Procedures	Under Cardiac Implantation and Replacement Procedures
1144	0617T	Under Procedures Performed on Eyes	Under Procedures Performed on Eyes
1145	0618T	Under Procedures Performed on Eyes	Under Procedures Performed on Eyes
1146	0416T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1147	0417T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1148	0418T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1149	0419T	Under Neurofibroma Destruction Procedure	Under Neurofibroma Destruction Procedure
1150	0486T	Under Diagnostic Procedures	Under Diagnostic Procedures
1151	0490T	Under Cellular Regeneration, Evaluation Study and Ablation Procedures	Under Cellular Regeneration, Evaluation Study and Ablation Procedures
1152	0496T	Under Organ Transplantation Procedures	Under Organ Transplantation Procedures
1153	0500T	Under Human Papillomavirus (HPV) Analysis	Under Human Papillomavirus (HPV) Analysis
1154	0501T	Under Coronary Artery Disease (CAD) Analysis	Under Coronary Artery Disease (CAD) Analysis
1155	0502T	Under Coronary Artery Disease (CAD) Analysis	Under Coronary Artery Disease (CAD) Analysis
1156	0503T	Under Coronary Artery Disease (CAD) Analysis	Under Coronary Artery Disease (CAD) Analysis
1157	0506T	Under Other Diagnostic and Therapeutic Procedures	Under Other Diagnostic and Therapeutic Procedures
1158	0508T	Under Other Diagnostic and Therapeutic Procedures	Under Other Diagnostic and Therapeutic Procedures
1159	0512T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1160	0513T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1161	0517T	Under Cardiac Device Implantation, Analysis and Removal Procedures	Under Cardiac Device Implantation, Analysis and Removal Procedures
1162	0518T	Under Cardiac Device Implantation, Analysis and Removal Procedures	Under Cardiac Device Implantation, Analysis and Removal Procedures
1163	0519T	Under Cardiac Device Implantation, Analysis and Removal Procedures	Under Cardiac Device Implantation, Analysis and Removal Procedures
1164	0522T	Under Cardiac Device Implantation, Analysis and Removal Procedures	Under Cardiac Device Implantation, Analysis and Removal Procedures
1165	0524T	Under Ablation Procedures	Under Ablation Procedures
1166	0525T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1167	0527T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1168	0528T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1169	0529T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1170	0530T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1171	0531T	Under Intracardiac Ischemia Monitoring Procedures	Under Intracardiac Ischemia Monitoring Procedures
1172	0536T	Under Movement Disorder Analysis	Under Movement Disorder Analysis
1173	0537T	Under Cellular Therapy Procedures	Under Cellular Therapy Procedures
1174	0539T	Under Cellular Therapy Procedures	Under Cellular Therapy Procedures
1175	0540T	Under Cellular Therapy Procedures	Under Cellular Therapy Procedures
1176	0541T	Under Cardiac Muscle Imaging	Under Cardiac Muscle Imaging
1177	0543T	Under Cardiac Valve Repair Procedures	Under Cardiac Valve Repair Procedures
1178	0544T	Under Cardiac Valve Repair Procedures	Under Cardiac Valve Repair Procedures
1179	0545T	Under Cardiac Valve Repair Procedures	Under Cardiac Valve Repair Procedures
1180	0547T	Under Radiofrequency Spectrometry Assessment and Bone Quality Testing Procedures	Under Radiofrequency Spectrometry Assessment and Bone Quality Testing Procedures
1181	0552T	Under Laser Therapy and Implant Procedures	Under Laser Therapy and Implant Procedures
1182	0553T	Under Laser Therapy and Implant Procedures	Under Laser Therapy and Implant Procedures
1183	0554T	Under Bone Strength And Fracture Risk Assessment	Under Bone Strength And Fracture Risk Assessment
1184	0555T	Under Bone Strength And Fracture Risk Assessment	Under Bone Strength And Fracture Risk Assessment
1185	0557T	Under Bone Strength And Fracture Risk Assessment	Under Bone Strength And Fracture Risk Assessment
1186	0558T	Under Computed Tomography Analysis	Under Computed Tomography Analysis
1187	0559T	Under Anatomic Model And Guide Creation	Under Anatomic Model And Guide Creation
1188	0561T	Under Anatomic Model And Guide Creation	Under Anatomic Model And Guide Creation
1189	0564T	Under Chemo Drug Essay, Implant and Other Procedures	Under Chemo Drug Essay, Implant and Other Procedures
1190	0565T	Under Chemo Drug Essay, Implant and Other Procedures	Under Chemo Drug Essay, Implant and Other Procedures
1191	0567T	Under Chemo Drug Essay, Implant and Other Procedures	Under Chemo Drug Essay, Implant and Other Procedures
1192	0568T	Under Chemo Drug Essay, Implant and Other Procedures	Under Chemo Drug Essay, Implant and Other Procedures
1193	0569T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
1194	0572T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
1195	0573T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
1196	0577T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
1197	0579T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
1198	0581T	Under Ablation Procedures	Under Ablation Procedures
1199	0620T	Under Other Diagnostic and Therapeutic Procedures	Under Other Diagnostic and Therapeutic Procedures
1200	0621T	Under Trabeculostomy Procedure by Laser (Ab Interno)	Under Trabeculostomy Procedure by Laser (Ab Interno)
1201	0625T	Under Coronary Artery Disease (CAD) Analysis	Under Coronary Artery Disease (CAD) Analysis
1202	0627T	Under Percutaneous Lumbar Intravertebral Disc Injection Procedure	Under Percutaneous Lumbar Intravertebral Disc Injection Procedure
1203	0629T	Under Percutaneous Lumbar Intravertebral Disc Injection Procedure	Under Percutaneous Lumbar Intravertebral Disc Injection Procedure
1204	0348T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1205	0351T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1206	0352T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1207	0353T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1208	0358T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1209	0394T	Under High Dose Rate Electronic Brachytherapy Procedures	Under High Dose Rate Electronic Brachytherapy Procedures
1210	0395T	Under High Dose Rate Electronic Brachytherapy Procedures	Under High Dose Rate Electronic Brachytherapy Procedures
1211	0397T	Under ERCP with Endomicroscopy Procedure	Under ERCP with Endomicroscopy Procedure
1212	0398T	Under Stereotactic Intracranial Lesion Ablation Procedure	Under Stereotactic Intracranial Lesion Ablation Procedure
1213	0402T	Under Procedures performed on Cornea	Under Procedures performed on Cornea
1214	0408T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1215	0409T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1216	0410T	Under Permanent Cardiac Contractility Modulation System Procedures	Under Permanent Cardiac Contractility Modulation System Procedures
1217	0420T	Under Neurofibroma Destruction Procedure	Under Neurofibroma Destruction Procedure
1218	0421T	Under Prostate Ablation Procedure	Under Prostate Ablation Procedure
1219	0424T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1220	0427T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1221	0428T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1222	0433T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1223	0434T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1224	0440T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1225	0441T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1226	0443T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1227	0445T	Under Phrenic Nerve Stimulation System Procedures	Under Phrenic Nerve Stimulation System Procedures
1228	0472T	Under Imaging, Evaluation, Programming and Recording Procedures	Under Imaging, Evaluation, Programming and Recording Procedures
1229	0479T	Under Laser Ablation Procedures	Under Laser Ablation Procedures
1230	0483T	Under Cardiac Diagnostic Imaging and Surgical Procedures	Under Cardiac Diagnostic Imaging and Surgical Procedures
1231	0236T	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries
1232	0237T	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries
1233	0238T	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries	Under Atherectomy (Open or Percutaneous) for Supra-Inguinal Arteries
1234	0271T	Under Carotid Sinus Baroreflex Activation Device Procedures	Under Carotid Sinus Baroreflex Activation Device Procedures
1235	0272T	Under Carotid Sinus Baroreflex Activation Device Procedures	Under Carotid Sinus Baroreflex Activation Device Procedures
1236	0273T	Under Carotid Sinus Baroreflex Activation Device Procedures	Under Carotid Sinus Baroreflex Activation Device Procedures
1237	0274T	Under Percutaneous Decompressive Laminotomy/Laminectomy Procedures through Interlaminar Approach	Under Percutaneous Decompressive Laminotomy/Laminectomy Procedures through Interlaminar Approach
1238	0275T	Under Percutaneous Decompressive Laminotomy/Laminectomy Procedures through Interlaminar Approach	Under Percutaneous Decompressive Laminotomy/Laminectomy Procedures through Interlaminar Approach
1239	0278T	Under Transcutaneous Electrical Modulation Pain Reprocessing Treatment	Under Transcutaneous Electrical Modulation Pain Reprocessing Treatment
1240	0331T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1241	0332T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1242	0335T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1243	0338T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1244	0339T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1245	0345T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1246	0347T	Under Imaging, Testing, Implantation and Other Services	Under Imaging, Testing, Implantation and Other Services
1247	0054T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1248	0055T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1249	0095T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1250	0098T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1251	0101T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1252	0107T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1253	0109T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1254	0072T	Under Various Services - Category III Codes	Under Various Services - Category III Codes
1255	3551F	Intermediate risk for thromboembolism (AFIB)	INTRMED RSK THROMBOEMBOLISM
1256	81107	Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-3a/b (I843S)	HPA-3 GENOTYPING
1257	81170	ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain	ABL1 GENE
1258	J1165	INJECTION, PHENYTOIN SODIUM, PER 50 MG	Phenytoin sodium injection
1259	J1200	INJECTION, DIPHENHYDRAMINE HCL, UP TO 50 MG	Diphenhydramine hcl injectio
1260	J1444	Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron	FE PYRO CIT POW 0.1 MG IRON
1261	J1457	INJECTION, GALLIUM NITRATE, 1 MG	Gallium nitrate injection
1262	J1562	INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG	Vivaglobin, inj
1263	J1620	INJECTION, GONADORELIN HYDROCHLORIDE, PER 100 MCG	Gonadorelin hydroch/ 100 mcg
1264	J1729	Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg	Inj hydroxyprogst capoat nos
1265	J1817	INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS	Insulin for insulin pump use
1266	J1890	INJECTION, CEPHALOTHIN SODIUM, UP TO 1 GRAM	Cephalothin sodium injection
1267	J2250	INJECTION, MIDAZOLAM HYDROCHLORIDE, PER 1 MG	Inj midazolam hydrochloride
1268	J2355	INJECTION, OPRELVEKIN, 5 MG	Oprelvekin injection
1269	J2357	INJECTION, OMALIZUMAB, 5 MG	Omalizumab injection
1270	J2460	INJECTION, OXYTETRACYCLINE HCL, UP TO 50 MG	Oxytetracycline injection
1271	J2562	INJECTION, PLERIXAFOR, 1 MG	Plerixafor injection
1272	J2597	INJECTION, DESMOPRESSIN ACETATE, PER 1 MCG	Inj desmopressin acetate
1273	J2792	INJECTION, RHO D IMMUNE GLOBULIN, INTRAVENOUS, HUMAN, SOLVENT DETERGENT, 100 IU	Rho(D) immune globulin h, sd
1274	J2794	INJECTION, RISPERIDONE, LONG ACTING, 0.5 MG	Risperidone, long acting
1275	J2840	INJECTION, SEBELIPASE ALFA, 1 MG	Inj sebelipase alfa 1 mg
1276	G9094	ONCOLOGY; DISEASE STATUS; RECTAL CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx rectal M1 w/mets prog
1277	G9097	ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T4, ANY N, M0 (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx esophageal t4 no prog
1278	G9106	ONCOLOGY; DISEASE STATUS; PANCREATIC CANCER, LIMITED TO ADENOCARCINOMA; POST R1 OR R2 RESECTION WITH NO EVIDENCE OF DISEASE PROGRESSION, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx pancreatc p R1/R2 no
1279	G9109	ONCOLOGY; DISEASE STATUS; HEAD AND NECK CANCER, LIMITED TO CANCERS OF ORAL CAVITY, PHARYNX AND LARYNX WITH SQUAMOUS CELL AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T1-T2 AND N0, M0 (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx head/neck T1-T2no prg
1280	G9126	ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; IN HEMATOLOGIC, CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx CML remission
1281	G9131	ONCOLOGY; DISEASE STATUS; INVASIVE FEMALE BREAST CANCER (DOES NOT INCLUDE DUCTAL CARCINOMA IN SITU); ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx brst unknown NOS
1282	G9148	NATIONAL COMMITTEE FOR QUALITY ASSURANCE – LEVEL 1 MEDICAL HOME	Medical Home Level I
1283	G9149	NATIONAL COMMITTEE FOR QUALITY ASSURANCE – LEVEL 2 MEDICAL HOME	Medical Home Level II
1284	76519	Ophthalmic biometry by ultrasound echography, A-scan; with intraocular lens power calculation	ECHO EXAM OF EYE
1285	76812	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)	OB US DETAILED ADDL FETUS
1286	76828	Doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; follow-up or repeat study	ECHO EXAM OF FETAL HEART
1287	76999	Unlisted ultrasound procedure (eg, diagnostic, interventional)	ECHO EXAMINATION PROCEDURE
1288	77299	Unlisted procedure, therapeutic radiology clinical treatment planning	RADIATION THERAPY PLANNING
1289	77767	Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter up to 2.0 cm or 1 channel	HDR RDNCL SKN SURF BRACHYTX
1290	77772	Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channels	HDR RDNCL NTRSTL/ICAV BRCHT
1291	78018	Thyroid carcinoma metastases imaging; whole body	THYROID MET IMAGING BODY
1292	78104	Bone marrow imaging; whole body	BONE MARROW IMAGING BODY
1293	78122	Whole blood volume determination, including separate measurement of plasma volume and red cell volume (radiopharmaceutical volume-dilution technique)	BLOOD VOLUME
1294	78226	Hepatobiliary system imaging, including gallbladder when present;	HEPATOBILIARY SYSTEM IMAGIN
1295	99285	Emergency department visit for the evaluation and management of a patient, which requires these 3 key components within the constraints imposed by the urgency of the patient's clinical condition and/or mental status: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of high severity and pose an immediate significant threat to life or physiologic function.	EMERGENCY DEPT VISIT
1296	G0343	LAPAROTOMY FOR ISLET CELL TRANSPLANT, INCLUDES PORTAL VEIN CATHETERIZATION AND INFUSION	Laparotomy islet cell transp
1297	84238	Receptor assay; non-endocrine (specify receptor)	ASSAY NONENDOCRINE RECEPTOR
1298	84449	Transcortin (cortisol binding globulin)	ASSAY OF TRANSCORTIN
1299	84577	Urobilinogen, feces, quantitative	ASSAY OF FECES/UROBILINOGEN
1300	85032	Blood count; manual cell count (erythrocyte, leukocyte, or platelet) each	MANUAL CELL COUNT EACH
1301	85303	Clotting inhibitors or anticoagulants; protein C, activity	CLOT INHIBIT PROT C ACTIVIT
1302	85362	Fibrin(ogen) degradation (split) products (FDP) (FSP); agglutination slide, semiquantitative	FIBRIN DEGRADATION PRODUCTS
1303	95813	Electroencephalogram (EEG) extended monitoring; 61-119 minutes	EEG EXTND MNTR 61-119 MIN
1304	95867	Needle electromyography; cranial nerve supplied muscle(s), unilateral	MUSCLE TEST CRAN NERV UNILA
1305	95874	Needle electromyography for guidance in conjunction with chemodenervation (List separately in addition to code for primary procedure)	GUIDE NERV DESTR NEEDLE EMG
1306	95991	Refilling and maintenance of implantable pump or reservoir for drug delivery, spinal (intrathecal, epidural) or brain (intraventricular), includes electronic analysis of pump, when performed; requiring skill of a physician or other qualified health care professional	SPIN/BRAIN PUMP REFIL & MAI
1307	95972	Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with complex spinal cord or peripheral nerve (eg, sacral nerve) neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional	ALYS CPLX SP/PN NPGT W/PRGR
1308	95983	Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with brain neurostimulator pulse generator/transmitter programming, first 15 minutes face-to-face time with physician or other qualified health care professional	ALYS BRN NPGT PRGRMG 15 MIN
1309	96130	Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour	PSYCL TST EVAL PHYS/QHP 1ST
1310	96165	Health behavior intervention, group (2 or more patients), face-to-face; each additional 15 minutes (List separately in addition to code for primary service)	HLTH BHV IVNTJ GRP EA ADDL
1311	96167	Health behavior intervention, family (with the patient present), face-to-face; initial 30 minutes	HLTH BHV IVNTJ FAM 1ST 30
1312	96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	HYDRATION IV INFUSION INIT
1313	96411	Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separately in addition to code for primary procedure)	CHEMO IV PUSH ADDL DRUG
1314	96420	Chemotherapy administration, intra-arterial; push technique	CHEMO IA PUSH TECNIQUE
1315	96422	Chemotherapy administration, intra-arterial; infusion technique, up to 1 hour	CHEMO IA INFUSION UP TO 1 H
1316	96574	Debridement of premalignant hyperkeratotic lesion(s) (ie, targeted curettage, abrasion) followed with photodynamic therapy by external application of light to destroy premalignant lesions of the skin and adjacent mucosa with application and illumination/activation of photosensitizing drug(s) provided by a physician or other qualified health care professional, per day	DBRDMT PRMLG LES W/PDT
1317	96922	Laser treatment for inflammatory skin disease (psoriasis); over 500 sq cm	LASER TX SKIN >500 SQ CM
1318	97537	Community/work reintegration training (eg, shopping, transportation, money management, avocational activities and/or work environment/modification analysis, work task analysis, use of assistive technology device/adaptive equipment), direct one-on-one contact, each 15 minutes	COMMUNITY/WORK REINTEGRATIO
1319	97602	Removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (eg, wet-to-moist dressings, enzymatic, abrasion, larval therapy), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session	WOUND(S) CARE NON-SELECTIVE
1320	97750	Physical performance test or measurement (eg, musculoskeletal, functional capacity), with written report, each 15 minutes	PHYSICAL PERFORMANCE TEST
1321	97813	Acupuncture, 1 or more needles; with electrical stimulation, initial 15 minutes of personal one-on-one contact with the patient	ACUPUNCT W/STIMUL 15 MIN
1322	80360	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1323	80362	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1324	80365	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1325	80367	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1326	80368	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1327	80370	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1328	80372	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1329	80374	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1330	80376	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1331	81418	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays
1332	81441	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays
1333	81456	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays	Under Genomic Sequencing Procedures and Other Molecular Multianalyte Assays
1334	81479	Under Tier 2 Molecular Pathology Procedures	Under Tier 2 Molecular Pathology Procedures
1335	87467	Under Infectious Agent Antigen Detection	Under Infectious Agent Antigen Detection
1336	87468	Under Infectious Agent Antigen Detection	Under Infectious Agent Antigen Detection
1337	87469	Under Infectious Agent Antigen Detection	Under Infectious Agent Antigen Detection
1338	90460	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1339	90472	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1340	90473	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1341	90474	Under Immunization Administration for Vaccines/Toxoids	Under Immunization Administration for Vaccines/Toxoids
1342	91300	Under Vaccines, Toxoids	Under Vaccines, Toxoids
1343	91301	Under Vaccines, Toxoids	Under Vaccines, Toxoids
1344	91302	Under Vaccines, Toxoids	Under Vaccines, Toxoids
1345	91303	Under Vaccines, Toxoids	Under Vaccines, Toxoids
1346	C1826	Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system	Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system
1347	C7502	Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)	Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)
1348	C7503	Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed	Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed
1349	C7505	Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance	Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance
1350	C7507	Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance	Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance
1351	C7509	Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed	Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed
1352	Q4137	Amnioexcel, amnioexcel plus or biodexcel, per square centimeter	Amnioexcel, amnioexcel plus or biodexcel, per square centimeter
1353	Q4140	Biodfence, per square centimeter	Biodfence, per square centimeter
1354	Q4141	AlloSkin AC, per square centimeter	AlloSkin AC, per square centimeter
1355	Q4143	Repriza, per square centimeter	Repriza, per square centimeter
1356	Q4145	EpiFix, injectable, 1 mg	EpiFix, injectable, 1 mg
1357	Q4149	Excellagen, 0.1 cc	Excellagen, 0.1 cc
1358	Q4150	Allowrap DS or Dry, per square centimeter	Allowrap DS or Dry, per square centimeter
1359	Q4151	AmnioBand or Guardian, per square centimeter	AmnioBand or Guardian, per square centimeter
1360	Q4152	DermaPure, per square centimeter	DermaPure, per square centimeter
1361	Q4153	Dermavest and plurivest, per square centimeter	Dermavest and plurivest, per square centimeter
1362	Q4154	Biovance, per square centimeter	Biovance, per square centimeter
1363	Q4156	NEOX 100 or CLARIX 100, per square centimeter	NEOX 100 or CLARIX 100, per square centimeter
1364	Q4157	Revitalon, per square centimeter	Revitalon, per square centimeter
1365	Q4158	Kerecis Omega3, per square centimeter	Kerecis Omega3, per square centimeter
1366	Q4159	Affinity, per square centimeter	Affinity, per square centimeter
1367	Q4161	Bio-ConneKt wound matrix, per square centimeter	Bio-ConneKt wound matrix, per square centimeter
1368	Q4163	WoundEx, BioSkin, per square centimeter	WoundEx, BioSkin, per square centimeter
1369	Q4166	Cytal, per square centimeter	Cytal, per square centimeter
1370	Q4169	Artacent wound, per square centimeter	Artacent wound, per square centimeter
1371	Q4171	Interfyl, 1 mg	Interfyl, 1 mg
1372	Q4173	Palingen or palingen xplus, per square centimeter	Palingen or palingen xplus, per square centimeter
1373	Q4174	Palingen or promatrx, 0.36 mg per 0.25 cc	Palingen or promatrx, 0.36 mg per 0.25 cc
1374	Q4175	Miroderm, per square centimeter	Miroderm, per square centimeter
1375	Q4177	Floweramnioflo, 0.1 cc	Floweramnioflo, 0.1 cc
1376	Q4178	Floweramniopatch, per square centimeter	Floweramniopatch, per square centimeter
1377	Q4180	Revita, per square centimeter	Revita, per square centimeter
1378	Q4181	Amnio wound, per square centimeter	Amnio wound, per square centimeter
1379	Q4182	Transcyte, per square centimeter	Transcyte, per square centimeter
1380	Q4183	Surgigraft, per square centimeter	Surgigraft, per square centimeter
1381	Q4184	Cellesta or cellesta duo, per square centimeter	Cellesta or cellesta duo, per square centimeter
1382	Q4185	Cellesta flowable amnion (25 mg per cc); per 0.5 cc	Cellesta flowable amnion (25 mg per cc); per 0.5 cc
1383	Q4187	Epicord, per square centimeter	Epicord, per square centimeter
1384	Q4189	Artacent ac, 1 mg	Artacent ac, 1 mg
1385	95807	Sleep study, simultaneous recording of ventilation, respiratory effort, ECG or heart rate, and oxygen saturation, attended by a technologist	SLEEP STUDY ATTENDED
1386	95810	Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist	POLYSOM 6/> YRS 4/> PARAM
1387	95822	Electroencephalogram (EEG); recording in coma or sleep only	EEG COMA OR SLEEP ONLY
1388	95872	Needle electromyography using single fiber electrode, with quantitative measurement of jitter, blocking and/or fiber density, any/all sites of each muscle studied	MUSCLE TEST ONE FIBER
1389	95926	Short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in lower limbs	SOMATOSENSORY TESTING
1390	95941	Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby) or for monitoring of more than one case while in the operating room, per hour (List separately in addition to code for primary procedure)	IONM REMOTE/>1 PT OR PER HR
1391	96156	Health behavior assessment, or re-assessment (ie, health-focused clinical interview, behavioral observations, clinical decision making)	HLTH BHV ASSMT/REASSESSMENT
1392	96373	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intra-arterial	THER/PROPH/DIAG INJ IA
1393	96522	Refilling and maintenance of implantable pump or reservoir for drug delivery, systemic (eg, intravenous, intra-arterial)	REFILL/MAINT PUMP/RESVR SYS
1394	98927	Osteopathic manipulative treatment (OMT); 5-6 body regions involved	OSTEOPATH MANJ 5-6 REGIONS
1395	98940	Chiropractic manipulative treatment (CMT); spinal, 1-2 regions	CHIROPRACT MANJ 1-2 REGIONS
1396	99002	Handling, conveyance, and/or any other service in connection with the implementation of an order involving devices (eg, designing, fitting, packaging, handling, delivery or mailing) when devices such as orthotics, protectives, prosthetics are fabricated by an outside laboratory or shop but which items have been designed, and are to be fitted and adjusted by the attending physician or other qualified health care professional	DEVICE HANDLING PHYS/QHP
1397	99026	Hospital mandated on call service; in-hospital, each hour	IN-HOSPITAL ON CALL SERVICE
1398	C9489	INJECTION, NUSINERSEN, 0.1 MG	Injection, nusinersen
1399	C9479	INSTILLATION, CIPROFLOXACIN OTIC SUSPENSION, 6 MG	Instill, ciprofloxacin otic
1400	C9487	USTEKINUMAB, FOR INTRAVENOUS INJECTION, 1 MG	Ustekinumab IV inj, 1 mg
1401	99235	Observation or inpatient hospital care, for the evaluation and management of a patient including admission and discharge on the same date, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually the presenting problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.	OBSERV/HOSP SAME DATE
1402	C9726	PLACEMENT AND REMOVAL (IF PERFORMED) OF APPLICATOR INTO BREAST FOR INTRAOPERATIVE RADIATION THERAPY, ADD-ON TO PRIMARY BREAST PROCEDURE	Rxt breast appl place/remov
1403	C9737	LAPAROSCOPY, SURGICAL, ESOPHAGEAL SPHINCTER AUGMENTATION WITH DEVICE (EG, MAGNETIC BAND)	Lap esoph augmentation
1404	C9604	PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF OR THROUGH CORONARY ARTERY BYPASS GRAFT (INTERNAL MAMMARY, FREE ARTERIAL, VENOUS), ANY COMBINATION OF DRUG-ELUTING INTRACORONARY STENT, ATHERECTOMY AND ANGIOPLASTY, INCLUDING DISTAL PROTECTION WHEN PERFORMED; SINGLE VESSEL	Perc d-e cor revasc t cabg s
1405	C9608	PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF CHRONIC TOTAL OCCLUSION, CORONARY ARTERY, CORONARY ARTERY BRANCH, OR CORONARY ARTERY BYPASS GRAFT, ANY COMBINATION OF DRUG-ELUTING INTRACORONARY STENT, ATHERECTOMY AND ANGIOPLASTY; EACH ADDITIONAL CORONARY ARTERY, CORONARY ARTERY BRANCH, OR BYPASS GRAFT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)	Perc d-e cor revasc chro add
1406	E0165	COMMODE CHAIR, STATIONARY, WITH DETACHABLE ARMS	Commode chair stationry det
1407	E0168	COMMODE CHAIR, EXTRA WIDE AND/OR HEAVY DUTY, STATIONARY OR MOBILE, WITH OR WITHOUT ARMS, ANY TYPE, EACH	Heavyduty/wide commode chair
1408	E0175	FOOT REST, FOR USE WITH COMMODE CHAIR, EACH	Commode chair foot rest
1409	E0194	AIR FLUIDIZED BED	Air fluidized bed
1410	E0203	THERAPEUTIC LIGHTBOX, MINIMUM 10,000 LUX, TABLE TOP MODEL	Therapeutic lightbox tabletp
1411	E0217	WATER CIRCULATING HEAT PAD WITH PUMP	Water circ heat pad w pump
1412	E0245	TUB STOOL OR BENCH	Tub stool or bench
1413	E0247	TRANSFER BENCH FOR TUB OR TOILET WITH OR WITHOUT COMMODE OPENING	Trans bench w/wo comm open
1414	E0261	HOSPITAL BED, SEMI-ELECTRIC (HEAD AND FOOT ADJUSTMENT), WITH ANY TYPE SIDE RAILS, WITHOUT MATTRESS	Hosp bed semi-electr w/o mat
1415	E0277	POWERED PRESSURE-REDUCING AIR MATTRESS	Powered pres-redu air mattrs
1416	E0480	PERCUSSOR, ELECTRIC OR PNEUMATIC, HOME MODEL	Percussor elect/pneum home m
1417	E0487	SPIROMETER, ELECTRONIC, INCLUDES ALL ACCESSORIES	Electronic spirometer
1418	E0603	BREAST PUMP, ELECTRIC (AC AND/OR DC), ANY TYPE	Electric breast pump
1419	E0605	VAPORIZER, ROOM TYPE	Vaporizer room type
1420	E0629	SEAT LIFT MECHANISM, NON-ELECTRIC, ANY TYPE	Seat lift mech, non-electric
1421	E0639	PATIENT LIFT, MOVEABLE FROM ROOM TO ROOM WITH DISASSEMBLY AND REASSEMBLY, INCLUDES ALL COMPONENTS/ACCESSORIES	Moveable patient lift system
1422	E0651	PNEUMATIC COMPRESSOR, SEGMENTAL HOME MODEL WITHOUT CALIBRATED GRADIENT PRESSURE	Pneum compressor segmental
1423	E0747	OSTEOGENESIS STIMULATOR, ELECTRICAL, NON-INVASIVE, OTHER THAN SPINAL APPLICATIONS	Elec osteogen stim not spine
1424	E0760	OSTEOGENESIS STIMULATOR, LOW INTENSITY ULTRASOUND, NON-INVASIVE	Osteogen ultrasound stimltor
1425	E0786	IMPLANTABLE PROGRAMMABLE INFUSION PUMP, REPLACEMENT (EXCLUDES IMPLANTABLE INTRASPINAL CATHETER)	Implantable pump replacement
1426	E0855	CERVICAL TRACTION EQUIPMENT NOT REQUIRING ADDITIONAL STAND OR FRAME	Cervical traction equipment
1427	E0954	SEMI-PNEUMATIC CASTER, EACH	Wheelchair semi-pneumatic ca
1428	E0967	MANUAL WHEELCHAIR ACCESSORY, HAND RIM WITH PROJECTIONS, ANY TYPE, REPLACEMENT ONLY, EACH	Man wc rim/projection rep ea
1429	E0969	NARROWING DEVICE, WHEELCHAIR	Wheelchair narrowing device
1430	E1036	MULTI-POSITIONAL PATIENT TRANSFER SYSTEM, EXTRA-WIDE, WITH INTEGRATED SEAT, OPERATED BY CAREGIVER, PATIENT WEIGHT CAPACITY GREATER THAN 300 LBS	Patient transfer system >300
1431	E1140	WHEELCHAIR, DETACHABLE ARMS, DESK OR FULL LENGTH, SWING AWAY DETACHABLE FOOTRESTS	Wheelchair standard detach a
1432	E1180	AMPUTEE WHEELCHAIR, DETACHABLE ARMS (DESK OR FULL LENGTH) SWING AWAY DETACHABLE FOOTRESTS	Wheelchair amputee w/ foot r
1433	E1232	WHEELCHAIR, PEDIATRIC SIZE, TILT-IN-SPACE, FOLDING, ADJUSTABLE, WITH SEATING SYSTEM	Folding ped wc tilt-in-space
1434	E1250	LIGHTWEIGHT WHEELCHAIR, FIXED FULL LENGTH ARMS, SWING AWAY DETACHABLE FOOTREST	Wheelchair lightwt fixed arm
1435	E1632	WEARABLE ARTIFICIAL KIDNEY, EACH	Wearable artificial kidney
1436	E1806	STATIC PROGRESSIVE STRETCH WRIST DEVICE, FLEXION AND/OR EXTENSION, WITH OR WITHOUT RANGE OF MOTION ADJUSTMENT, INCLUDES ALL COMPONENTS AND ACCESSORIES	SPS wrist device
1437	E1840	DYNAMIC ADJUSTABLE SHOULDER FLEXION / ABDUCTION / ROTATION DEVICE, INCLUDES SOFT INTERFACE MATERIAL	Adj shoulder ext/flex device
1438	E2227	MANUAL WHEELCHAIR ACCESSORY, GEAR REDUCTION DRIVE WHEEL, EACH	Gear reduction drive wheel
1439	E2322	POWER WHEELCHAIR ACCESSORY, HAND CONTROL INTERFACE, MULTIPLE MECHANICAL SWITCHES, NONPROPORTIONAL, INCLUDING ALL RELATED ELECTRONICS, MECHANICAL STOP SWITCH, AND FIXED MOUNTING HARDWARE	Mult mech switches
1440	E2377	POWER WHEELCHAIR ACCESSORY, EXPANDABLE CONTROLLER, INCLUDING ALL RELATED ELECTRONICS AND MOUNTING HARDWARE, UPGRADE PROVIDED AT INITIAL ISSUE	Expandable controller, initl
1441	E2607	SKIN PROTECTION AND POSITIONING WHEELCHAIR SEAT CUSHION, WIDTH LESS THAN 22 INCHES, ANY DEPTH	Skin pro/pos wc cus wd <22in
1442	E2609	CUSTOM FABRICATED WHEELCHAIR SEAT CUSHION, ANY SIZE	Custom fabricate w/c cushion
1443	E2610	WHEELCHAIR SEAT CUSHION, POWERED	Powered w/c cushion
1444	E2613	POSITIONING WHEELCHAIR BACK CUSHION, POSTERIOR, WIDTH LESS THAN 22 INCHES, ANY HEIGHT, INCLUDING ANY TYPE MOUNTING HARDWARE	Position back cush wd <22in
1445	E2615	POSITIONING WHEELCHAIR BACK CUSHION, POSTERIOR-LATERAL, WIDTH LESS THAN 22 INCHES, ANY HEIGHT, INCLUDING ANY TYPE MOUNTING HARDWARE	Pos back post/lat wdth <22in
1446	C7529	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement
1447	C7531	Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation	Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
1448	C7532	Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation	Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
1449	C7534	Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation	Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
1450	C7537	Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system)	Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system)
1451	C7539	Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)	Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)
1452	A9512	Technetium Tc-99m pertechnetate, diagnostic, per millicurie	Technetium Tc-99m pertechnetate, diagnostic, per millicurie
1453	95132	Professional services for allergen immunotherapy in the office or institution of the prescribing physician or other qualified health care professional, including provision of allergenic extract; 3 stinging insect venoms	IMMNTX 3 STING INSECTS
1454	95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses)	ANTIGEN THERAPY SERVICES
1455	31576	Laryngoscopy, flexible; with biopsy(ies)	LARYNGOSCOPY WITH BIOPSY
1456	Q4172	PURAPLY OR PURAPLY AM, PER SQUARE CENTIMETER	Puraply or puraply am
1457	Q5112	Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg	INJ ONTRUZANT 10 MG
1458	S0144	INJECTION, PROPOFOL, 10MG	Inj, Propofol, 10mg
1459	S0178	LOMUSTINE, ORAL, 10MG	Lomustine 10 mg
1460	S0207	PARAMEDIC INTERCEPT, NON-HOSPITAL-BASED ALS SERVICE (NON-VOLUNTARY), NON-TRANSPORT	Paramedicintercep nonhospals
1461	S0341	LIFESTYLE MODIFICATION PROGRAM FOR MANAGEMENT OF CORONARY ARTERY DISEASE, INCLUDING ALL SUPPORTIVE SERVICES; SECOND OR THIRD QUARTER / STAGE	Lifestyle mod 2 or 3 stage
1462	S0506	BIFOCAL VISION PRESCRIPTION LENS (SAFETY, ATHLETIC, OR SUNGLASS), PER LENS	Bifoc prscp lens
1463	S1002	CUSTOMIZED ITEM (LIST IN ADDITION TO CODE FOR BASIC ITEM)	Custom item
1464	S1090	MOMETASONE FUROATE SINUS IMPLANT, 370 MICROGRAMS	Mometasone sinus implant
1465	S2061	DONOR LOBECTOMY (LUNG) FOR TRANSPLANTATION, LIVING DONOR	Donor lobectomy (lung)
1466	97172	Under Athletic Training Evaluations	Under Athletic Training Evaluations
1467	99310	Under Subsequent Nursing Facility Care	Under Subsequent Nursing Facility Care
1468	A9515	Choline c-11, diagnostic, per study dose up to 20 millicuries	Choline c-11, diagnostic, per study dose up to 20 millicuries
1469	A9563	Sodium phosphate P-32, therapeutic, per millicurie	Sodium phosphate P-32, therapeutic, per millicurie
1470	Q4190	Artacent ac, per square centimeter	Artacent ac, per square centimeter
1471	Q4191	Restorigin, per square centimeter	Restorigin, per square centimeter
1472	Q4195	Puraply, per square centimeter	Puraply, per square centimeter
1473	Q4196	Puraply am, per square centimeter	Puraply am, per square centimeter
1474	Q4197	Puraply xt, per square centimeter	Puraply xt, per square centimeter
1475	Q4198	Genesis amniotic membrane, per square centimeter	Genesis amniotic membrane, per square centimeter
1476	Q4199	Cygnus matrix, per square centimeter	Cygnus matrix, per square centimeter
1477	Q4200	Skin te, per square centimeter	Skin te, per square centimeter
1478	Q4201	Matrion, per square centimeter	Matrion, per square centimeter
1479	Q4203	Derma-gide, per square centimeter	Derma-gide, per square centimeter
1480	Q4204	Xwrap, per square centimeter	Xwrap, per square centimeter
1481	Q4208	Novafix, per square cenitmeter	Novafix, per square cenitmeter
1482	Q4212	Allogen, per cc	Allogen, per cc
1483	Q4215	Axolotl ambient or axolotl cryo, 0.1 mg	Axolotl ambient or axolotl cryo, 0.1 mg
1484	Q4216	Artacent cord, per square centimeter	Artacent cord, per square centimeter
1485	Q4217	Woundfix, BioWound, Woundfix Plus, BioWound Plus, Woundfix Xplus or BioWound Xplus, per square centimeter	Woundfix, BioWound, Woundfix Plus, BioWound Plus, Woundfix Xplus or BioWound Xplus, per square centimeter
1486	Q4218	Surgicord, per square centimeter	Surgicord, per square centimeter
1487	Q4221	Amniowrap2, per square centimeter	Amniowrap2, per square centimeter
1488	Q4229	Cogenex amniotic membrane, per square centimeter	Cogenex amniotic membrane, per square centimeter
1489	Q4230	Cogenex flowable amnion, per 0.5 cc	Cogenex flowable amnion, per 0.5 cc
1490	Q4231	Corplex p, per cc	Corplex p, per cc
1491	Q4235	Amniorepair or altiply, per square centimeter	Amniorepair or altiply, per square centimeter
1492	Q4237	Cryo-cord, per square centimeter	Cryo-cord, per square centimeter
1493	Q4238	Derm-maxx, per square centimeter	Derm-maxx, per square centimeter
1494	Q4239	Amnio-maxx or amnio-maxx lite, per square centimeter	Amnio-maxx or amnio-maxx lite, per square centimeter
1495	Q4246	Coretext or protext, per cc	Coretext or protext, per cc
1496	Q4247	Amniotext patch, per square centimeter	Amniotext patch, per square centimeter
1497	Q4248	Dermacyte amniotic membrane allograft, per square centimeter	Dermacyte amniotic membrane allograft, per square centimeter
1498	Q4250	Amnioamp-mp, per square centimeter	Amnioamp-mp, per square centimeter
1499	Q4255	Reguard, for topical use only, per square centimeter	Reguard, for topical use only, per square centimeter
1500	Q4259	Celera dual layer or celera dual membrane, per square centimeter	Celera dual layer or celera dual membrane, per square centimeter
1501	Q4262	Dual layer impax membrane, per square centimeter	Dual layer impax membrane, per square centimeter
1502	Q4263	Surgraft tl, per square centimeter	Surgraft tl, per square centimeter
1503	Q4264	Cocoon membrane, per square centimeter	Cocoon membrane, per square centimeter
1504	Q5125	Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram	Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
1505	T1033	Services performed by a doula birth worker, per diem	Services performed by a doula birth worker, per diem
1506	M1153	Patient with diagnosis of osteoporosis on date of encounter	Patient with diagnosis of osteoporosis on date of encounter
1507	M1154	Hospice services provided to patient any time during the measurement period	Hospice services provided to patient any time during the measurement period
1508	M1159	Hospice services provided to patient any time during the measurement period	Hospice services provided to patient any time during the measurement period
1509	M1162	Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday	Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
1510	M1165	Patients who use hospice services any time during the measurement period	Patients who use hospice services any time during the measurement period
1511	M1168	Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period	Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
1512	M1169	Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)	Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
1513	M1170	Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period	Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
1514	M1172	Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)	Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
1515	M1175	Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)	Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
1516	M1182	Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)	Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
1517	M1185	Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given	Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
1518	M1188	Patients with a diagnosis of chronic kidney disease (ckd) stage 5	Patients with a diagnosis of chronic kidney disease (ckd) stage 5
1519	M1192	Patients with an existing diagnosis of squamous cell carcinoma of the esophagus	Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
1520	M1193	Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both	Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
1521	M1195	Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given	Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
1522	M1196	Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4	Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
1523	M1199	Patients receiving rrt	Patients receiving rrt
1524	M1200	Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period	Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period
1525	M1201	Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)	Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)
1526	M1203	Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given	Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given
1527	M1209	At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses	At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses
1528	Q4101	Apligraf, per square centimeter	Apligraf, per square centimeter
1529	Q4103	Oasis burn matrix, per square centimeter	Oasis burn matrix, per square centimeter
1530	Q4104	Integra bilayer matrix wound dressing (BMWD), per square centimeter	Integra bilayer matrix wound dressing (BMWD), per square centimeter
1531	Q4106	Dermagraft, per square centimeter	Dermagraft, per square centimeter
1532	Q4107	GRAFTJACKET, per square centimeter	GRAFTJACKET, per square centimeter
1533	Q4110	PriMatrix, per square centimeter	PriMatrix, per square centimeter
1534	Q4115	AlloSkin, per square centimeter	AlloSkin, per square centimeter
1535	Q4116	AlloDerm, per square centimeter	AlloDerm, per square centimeter
1536	Q4118	MatriStem micromatrix, 1 mg	MatriStem micromatrix, 1 mg
1537	Q4123	AlloSkin RT, per square centimeter	AlloSkin RT, per square centimeter
1538	Q4130	Strattice TM, per square centimeter	Strattice TM, per square centimeter
1539	Q4132	Grafix CORE and GrafixPL CORE, per square centimeter	Grafix CORE and GrafixPL CORE, per square centimeter
1540	Q4133	Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter	Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter
1541	Q4134	Hmatrix, per square centimeter	Hmatrix, per square centimeter
1542	Q4136	E-Z Derm, per square centimeter	E-Z Derm, per square centimeter
1543	J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
1544	J0701	Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg	Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
1545	J0703	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
1546	J0891	Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)	Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
1547	J0892	Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)	Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
1548	J0898	Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)	Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
1549	J0899	Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)	Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
1550	J1302	Injection, sutimlimab-jome, 10 mg	Injection, sutimlimab-jome, 10 mg
1551	J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
1552	J2247	Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg	Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
1553	J2311	Injection, naloxone hydrochloride (zimhi), 1 mg	Injection, naloxone hydrochloride (zimhi), 1 mg
1554	J2401	Injection, chloroprocaine hydrochloride, per 1 mg	Injection, chloroprocaine hydrochloride, per 1 mg
1555	J9298	Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg	Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
1556	J9394	Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg	Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
1557	M0001	Advancing cancer care mips value pathways	Advancing cancer care mips value pathways
1558	M0002	Optimal care for kidney health mips value pathways	Optimal care for kidney health mips value pathways
1559	M0003	Optimal care for patients with episodic neurological conditions mips value pathways	Optimal care for patients with episodic neurological conditions mips value pathways
1560	A4235	Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each	Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each
1561	A9502	Technetium Tc-99m tetrofosmin, diagnostic, per study dose	Technetium Tc-99m tetrofosmin, diagnostic, per study dose
1562	C7521	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
1563	C7523	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervis
1564	C7524	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
1565	C7525	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or op
1566	C7526	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial c
1567	A9507	Indium In-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries	Indium In-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
1568	A9508	Iodine I-131 iobenguane sulfate, diagnostic, per 0.5 millicurie	Iodine I-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
1569	A9509	Iodine I-123 sodium iodide, diagnostic, per millicurie	Iodine I-123 sodium iodide, diagnostic, per millicurie
1570	A9510	Technetium Tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries	Technetium Tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
1571	C7541	Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)	Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
1572	C7542	Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)	Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
1573	C7543	Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)	Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
1574	C7544	Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)	Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
1575	C7546	Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation	Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation
1576	C7548	Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation	Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation
1577	C7549	Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation	Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation
1578	C7550	Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent	Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent
1579	C7551	Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle	Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle
1580	A9531	Iodine I-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)	Iodine I-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)
1581	C7553	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitro
1582	C7555	Thyroidectomy, total or complete with parathyroid autotransplantation	Thyroidectomy, total or complete with parathyroid autotransplantation
1583	G0321	Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system	Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system
1584	C7902	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)
1585	C9101	Injection, oliceridine, 0.1 mg	Injection, oliceridine, 0.1 mg
1586	C9143	Cocaine hydrochloride nasal solution (numbrino), 1 mg	Cocaine hydrochloride nasal solution (numbrino), 1 mg
1587	G0317	Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)	Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services
1588	G0322	The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)	The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)
1589	G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room
1590	G3002	Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)	Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic p
1591	A9538	Technetium Tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries	Technetium Tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries
1592	A9539	Technetium Tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries	Technetium Tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries
1593	A9542	Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries	Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries
1594	A9546	Cobalt Co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie	Cobalt Co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie
1595	A9552	Fluorodeoxyglucose F-18 FDG, diagnostic, per study dose, up to 45 millicuries	Fluorodeoxyglucose F-18 FDG, diagnostic, per study dose, up to 45 millicuries
1596	A9553	Chromium Cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries	Chromium Cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries
1597	A9554	Iodine I-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries	Iodine I-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries
1598	A9555	Rubidium Rb-82, diagnostic, per study dose, up to 60 millicuries	Rubidium Rb-82, diagnostic, per study dose, up to 60 millicuries
1599	A9556	Gallium Ga-67 citrate, diagnostic, per millicurie	Gallium Ga-67 citrate, diagnostic, per millicurie
1600	A9558	Xenon Xe-133 gas, diagnostic, per 10 millicuries	Xenon Xe-133 gas, diagnostic, per 10 millicuries
1601	A9559	Cobalt Co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie	Cobalt Co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie
1602	A9560	Technetium Tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries	Technetium Tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries
1603	A9561	Technetium Tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	Technetium Tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries
1604	A9564	Chromic phosphate P-32 suspension, therapeutic, per millicurie	Chromic phosphate P-32 suspension, therapeutic, per millicurie
1605	A9567	Technetium Tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries	Technetium Tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries
1606	A9570	Indium In-111 labeled autologous white blood cells, diagnostic, per study dose	Indium In-111 labeled autologous white blood cells, diagnostic, per study dose
1607	A9571	Indium In-111 labeled autologous platelets, diagnostic, per study dose	Indium In-111 labeled autologous platelets, diagnostic, per study dose
1608	A9575	Injection, gadoterate meglumine, 0.1 ml	Injection, gadoterate meglumine, 0.1 ml
1609	A9576	Injection, gadoteridol, (ProHance multipack), per ml	Injection, gadoteridol, (ProHance multipack), per ml
1610	A9578	Injection, gadobenate dimeglumine (MultiHance multipack), per ml	Injection, gadobenate dimeglumine (MultiHance multipack), per ml
1611	A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (NOS), per ml	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (NOS), per ml
1612	A9580	Sodium fluoride F-18, diagnostic, per study dose, up to 30 millicuries	Sodium fluoride F-18, diagnostic, per study dose, up to 30 millicuries
1613	A9581	Injection, gadoxetate disodium, 1 ml	Injection, gadoxetate disodium, 1 ml
1614	A9585	Injection, gadobutrol, 0.1 ml	Injection, gadobutrol, 0.1 ml
1615	A9586	Florbetapir F18, diagnostic, per study dose, up to 10 millicuries	Florbetapir F18, diagnostic, per study dose, up to 10 millicuries
1616	A9588	Fluciclovine f-18, diagnostic, 1 millicurie	Fluciclovine f-18, diagnostic, 1 millicurie
1617	A9589	Instillation, hexaminolevulinate hydrochloride, 100 mg	Instillation, hexaminolevulinate hydrochloride, 100 mg
1618	A9591	Fluoroestradiol f 18, diagnostic, 1 millicurie	Fluoroestradiol f 18, diagnostic, 1 millicurie
1619	A9595	Piflufolastat f-18, diagnostic, 1 millicurie	Piflufolastat f-18, diagnostic, 1 millicurie
1620	A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
1621	A9597	Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified	Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified
1622	A9600	Strontium Sr-89 chloride, therapeutic, per millicurie	Strontium Sr-89 chloride, therapeutic, per millicurie
1623	A9601	Flortaucipir f 18 injection, diagnostic, 1 millicurie	Flortaucipir f 18 injection, diagnostic, 1 millicurie
1624	A9604	Samarium Sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries	Samarium Sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
1625	A9606	Radium Ra-223 dichloride, therapeutic, per microcurie	Radium Ra-223 dichloride, therapeutic, per microcurie
1626	A9699	Radiopharmaceutical, therapeutic, not otherwise classified	Radiopharmaceutical, therapeutic, not otherwise classified
1627	A9700	Supply of injectable contrast material for use in echocardiography, per study	Supply of injectable contrast material for use in echocardiography, per study
1628	A9800	Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie	Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie
1629	C7513	Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report	Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, rad
1630	C7516	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
1631	C7517	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation	Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision a
1632	95919	Under Autonomic Function Testing Procedures	Under Autonomic Function Testing Procedures
1633	95922	Under Autonomic Function Testing Procedures	Under Autonomic Function Testing Procedures
1634	95924	Under Autonomic Function Testing Procedures	Under Autonomic Function Testing Procedures
1635	95938	Under Evoked Potentials and Reflex Testing Procedures	Under Evoked Potentials and Reflex Testing Procedures
1636	C7518	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report	Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or t
1637	G0320	Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system	Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system
1638	95955	Under Other EEG Testing Procedures	Under Other EEG Testing Procedures
1639	95957	Under Other EEG Testing Procedures	Under Other EEG Testing Procedures
1640	95961	Under Other EEG Testing Procedures	Under Other EEG Testing Procedures
1641	95966	Under MEG Testing Procedures	Under MEG Testing Procedures
1642	99223	Under New or Established Patient Initial Hospital Inpatient Care Services	Under New or Established Patient Initial Hospital Inpatient Care Services
1643	99245	Under New or Established Patient Office or Other Outpatient Consultation Services	Under New or Established Patient Office or Other Outpatient Consultation Services
1644	99252	Under New or Established Patient Initial Inpatient Consultation Services	Under New or Established Patient Initial Inpatient Consultation Services
1645	99253	Under New or Established Patient Initial Inpatient Consultation Services	Under New or Established Patient Initial Inpatient Consultation Services
1646	99254	Under New or Established Patient Initial Inpatient Consultation Services	Under New or Established Patient Initial Inpatient Consultation Services
1647	99304	Under New or Established Patient Comprehensive Nursing Facility Assessments	Under New or Established Patient Comprehensive Nursing Facility Assessments
1648	99305	Under New or Established Patient Comprehensive Nursing Facility Assessments	Under New or Established Patient Comprehensive Nursing Facility Assessments
1649	99306	Under New or Established Patient Comprehensive Nursing Facility Assessments	Under New or Established Patient Comprehensive Nursing Facility Assessments
1650	99307	Under Subsequent Nursing Facility Care	Under Subsequent Nursing Facility Care
1651	99308	Under Subsequent Nursing Facility Care	Under Subsequent Nursing Facility Care
1652	99315	Under Nursing Facility Discharge Services	Under Nursing Facility Discharge Services
1653	99359	Under Prolonged Service Without Direct Patient Contact	Under Prolonged Service Without Direct Patient Contact
1654	99360	Under Prolonged Standby Services	Under Prolonged Standby Services
1655	99401	Under Preventive Medicine, Individual Counseling Services	Under Preventive Medicine, Individual Counseling Services
1656	99403	Under Preventive Medicine, Individual Counseling Services	Under Preventive Medicine, Individual Counseling Services
1657	99406	Under Behavior Change Interventions, Individual Services	Under Behavior Change Interventions, Individual Services
1658	99412	Under Preventive Medicine, Group Counseling Services	Under Preventive Medicine, Group Counseling Services
1659	99415	Under Prolonged Clinical Staff Services With Physician or Other Qualified Health Care Professional Supervision	Under Prolonged Clinical Staff Services With Physician or Other Qualified Health Care Professional Supervision
1660	99416	Under Prolonged Clinical Staff Services With Physician or Other Qualified Health Care Professional Supervision	Under Prolonged Clinical Staff Services With Physician or Other Qualified Health Care Professional Supervision
1661	99417	Under Prolonged Service With or Without Direct Patient Contact on the Date of an Office or Other Outpatient Service	Under Prolonged Service With or Without Direct Patient Contact on the Date of an Office or Other Outpatient Service
1662	99418	Under Prolonged Service With or Without Direct Patient Contact on the Date of an Office or Other Outpatient Service	Under Prolonged Service With or Without Direct Patient Contact on the Date of an Office or Other Outpatient Service
1663	99421	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service
1664	99422	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service
1665	99423	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service	Under Non-Face-to-Face On-Line Digital Evaluation and Management Service
1666	99427	Under Principal Care Management Services	Under Principal Care Management Services
1667	99439	Under Chronic Care Evaluation and Management Services	Under Chronic Care Evaluation and Management Services
1668	99451	Under Interprofessional Telephone/Internet/Electronic Health Record Consultations	Under Interprofessional Telephone/Internet/Electronic Health Record Consultations
1669	99452	Under Interprofessional Telephone/Internet/Electronic Health Record Consultations	Under Interprofessional Telephone/Internet/Electronic Health Record Consultations
1670	99457	Under Remote Physiologic Monitoring Treatment Management Services	Under Remote Physiologic Monitoring Treatment Management Services
1671	99458	Under Remote Physiologic Monitoring Treatment Management Services	Under Remote Physiologic Monitoring Treatment Management Services
1672	99473	Under Digitally Stored Data and Remote Physiologic Monitoring Services	Under Digitally Stored Data and Remote Physiologic Monitoring Services
1673	99486	Under Pediatric Critical Care Patient Transport Services	Under Pediatric Critical Care Patient Transport Services
1674	99487	Under Complex Chronic Care Evaluation and Management Services	Under Complex Chronic Care Evaluation and Management Services
1675	99489	Under Complex Chronic Care Evaluation and Management Services	Under Complex Chronic Care Evaluation and Management Services
1676	99490	Under Chronic Care Evaluation and Management Services	Under Chronic Care Evaluation and Management Services
1677	A2001	Innovamatrix ac, per square centimeter	Innovamatrix ac, per square centimeter
1678	A2005	Microlyte matrix, per square centimeter	Microlyte matrix, per square centimeter
1679	A2008	Theragenesis, per square centimeter	Theragenesis, per square centimeter
1680	A2010	Apis, per square centimeter	Apis, per square centimeter
1681	A2011	Supra sdrm, per square centimeter	Supra sdrm, per square centimeter
1682	A2012	Suprathel, per square centimeter	Suprathel, per square centimeter
1683	A2014	Omeza collagen matrix, per 100 mg	Omeza collagen matrix, per 100 mg
1684	A2017	Permeaderm glove, each	Permeaderm glove, each
1685	A9520	Technetium Tc-99m, tilmanocept, diagnostic, up to 0.5 millicuries	Technetium Tc-99m, tilmanocept, diagnostic, up to 0.5 millicuries
1686	A9524	Iodine I-131 iodinated serum albumin, diagnostic, per 5 microcuries	Iodine I-131 iodinated serum albumin, diagnostic, per 5 microcuries
1687	A9527	Iodine I-125, sodium iodide solution, therapeutic, per millicurie	Iodine I-125, sodium iodide solution, therapeutic, per millicurie
1688	A9528	Iodine I-131 sodium iodide capsule(s), diagnostic, per millicurie	Iodine I-131 sodium iodide capsule(s), diagnostic, per millicurie
1689	A9529	Iodine I-131 sodium iodide solution, diagnostic, per millicurie	Iodine I-131 sodium iodide solution, diagnostic, per millicurie
1690	A9530	Iodine I-131 sodium iodide solution, therapeutic, per millicurie	Iodine I-131 sodium iodide solution, therapeutic, per millicurie
1691	92518	Under Vestibular Function Tests, With Recording (eg, ENG)	Under Vestibular Function Tests, With Recording (eg, ENG)
1692	92519	Under Vestibular Function Tests, With Recording (eg, ENG)	Under Vestibular Function Tests, With Recording (eg, ENG)
1693	92651	Under Audiologic Function Tests	Under Audiologic Function Tests
1694	92990	Under Other Therapeutic Cardiovascular Services and Procedures	Under Other Therapeutic Cardiovascular Services and Procedures
1695	92997	Under Other Therapeutic Cardiovascular Services and Procedures	Under Other Therapeutic Cardiovascular Services and Procedures
1696	93260	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations
1697	93261	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations
1698	93264	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations	Under Implantable, Insertable, and Wearable Cardiac Device Evaluations
1699	93565	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1700	93566	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1701	93567	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1702	93568	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1703	93569	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1704	93571	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1705	93573	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1706	93575	Under Injection Procedures During Cardiac Catheterizations	Under Injection Procedures During Cardiac Catheterizations
1707	95700	Under Long-term EEG Setup	Under Long-term EEG Setup
1708	95706	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1709	95708	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1710	95709	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1711	95710	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1712	95712	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1713	95714	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1714	95715	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1715	95717	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1716	95724	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1717	95725	Under Long-term EEG Monitoring	Under Long-term EEG Monitoring
1718	95886	Under Electromyography Procedures	Under Electromyography Procedures
1719	95887	Under Electromyography Procedures	Under Electromyography Procedures
1720	96125	Under Assessment of Aphasia and Cognitive Performance Testing	Under Assessment of Aphasia and Cognitive Performance Testing
1721	97153	Under Adaptive Behavior Treatment Procedures	Under Adaptive Behavior Treatment Procedures
1722	97154	Under Adaptive Behavior Treatment Procedures	Under Adaptive Behavior Treatment Procedures
1723	97164	Under Physical Therapy Evaluations	Under Physical Therapy Evaluations
1724	97166	Under Occupational Therapy Evaluations	Under Occupational Therapy Evaluations
1725	97167	Under Occupational Therapy Evaluations	Under Occupational Therapy Evaluations
1726	97168	Under Occupational Therapy Evaluations	Under Occupational Therapy Evaluations
1727	97170	Under Athletic Training Evaluations	Under Athletic Training Evaluations
1728	97171	Under Athletic Training Evaluations	Under Athletic Training Evaluations
1729	98976	Under Remote Therapeutic Monitoring Services	Under Remote Therapeutic Monitoring Services
1730	98977	Under Remote Therapeutic Monitoring Services	Under Remote Therapeutic Monitoring Services
1731	98978	Under Remote Therapeutic Monitoring Services	Under Remote Therapeutic Monitoring Services
1732	99091	Under Digitally Stored Data and Remote Physiologic Monitoring Services	Under Digitally Stored Data and Remote Physiologic Monitoring Services
1733	99221	Under New or Established Patient Initial Hospital Inpatient Care Services	Under New or Established Patient Initial Hospital Inpatient Care Services
1734	99222	Under New or Established Patient Initial Hospital Inpatient Care Services	Under New or Established Patient Initial Hospital Inpatient Care Services
1735	77385	Under Radiation Treatment Delivery	Under Radiation Treatment Delivery
1736	77386	Under Radiation Treatment Delivery	Under Radiation Treatment Delivery
1737	77424	Under Radiation Treatment Delivery	Under Radiation Treatment Delivery
1738	77425	Under Radiation Treatment Delivery	Under Radiation Treatment Delivery
1739	80143	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1740	80145	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1741	80150	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1742	80151	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1743	80158	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1744	80163	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1745	80168	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1746	80171	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1747	80173	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1748	80175	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1749	80204	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1750	80220	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1751	80235	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1752	80306	Under Presumptive Drug Class Screening Procedures	Under Presumptive Drug Class Screening Procedures
1753	80307	Under Presumptive Drug Class Screening Procedures	Under Presumptive Drug Class Screening Procedures
1754	80321	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1755	80322	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1756	80324	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1757	80325	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1758	80326	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1759	80328	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1760	80332	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1761	80339	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1762	80341	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1763	80342	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1764	80343	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1765	80346	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1766	80347	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1767	80348	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1768	80349	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1769	80350	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1770	80351	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1771	80352	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1772	80354	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1773	80355	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1774	80357	Under Definitive Drug Testing Procedures	Under Definitive Drug Testing Procedures
1775	92928	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1776	92929	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1777	92933	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1778	92934	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1779	92960	Under Other Therapeutic Cardiovascular Services and Procedures	Under Other Therapeutic Cardiovascular Services and Procedures
1780	92961	Under Other Therapeutic Cardiovascular Services and Procedures	Under Other Therapeutic Cardiovascular Services and Procedures
1781	92975	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1782	92977	Under Coronary Therapeutic Services and Procedures	Under Coronary Therapeutic Services and Procedures
1783	33984	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1784	33986	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1785	33988	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1786	37247	Under Endovascular Revascularization	Under Endovascular Revascularization
1787	37248	Under Endovascular Revascularization	Under Endovascular Revascularization
1788	43279	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1789	43280	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1790	43281	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1791	43282	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1792	43286	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1793	49492	Under Hernia Open Procedures	Under Hernia Open Procedures
1794	49505	Under Hernia Open Procedures	Under Hernia Open Procedures
1795	49520	Under Hernia Open Procedures	Under Hernia Open Procedures
1796	49525	Under Hernia Open Procedures	Under Hernia Open Procedures
1797	49550	Under Hernia Open Procedures	Under Hernia Open Procedures
1798	49555	Under Hernia Open Procedures	Under Hernia Open Procedures
1799	49591	Under Hernia Open Procedures	Under Hernia Open Procedures
1800	49605	Under Hernia Open Procedures	Under Hernia Open Procedures
1801	49606	Under Hernia Open Procedures	Under Hernia Open Procedures
1802	49611	Under Hernia Open Procedures	Under Hernia Open Procedures
1803	49617	Under Hernia Open Procedures	Under Hernia Open Procedures
1804	50430	Under Other Renal Introduction (Injection/Change/Removal) Procedures	Under Other Renal Introduction (Injection/Change/Removal) Procedures
1805	50431	Under Other Renal Introduction (Injection/Change/Removal) Procedures	Under Other Renal Introduction (Injection/Change/Removal) Procedures
1806	55866	Under Laparoscopic Procedures on the Prostate	Under Laparoscopic Procedures on the Prostate
1807	58674	Under Laparoscopic/Hysteroscopic Procedures on the Corpus Uteri	Under Laparoscopic/Hysteroscopic Procedures on the Corpus Uteri
1808	80184	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1809	80187	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1810	80188	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1811	80189	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1812	80192	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1813	80193	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1814	80194	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1815	80198	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1816	80200	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1817	80201	Under Therapeutic Drug Assays	Under Therapeutic Drug Assays
1818	15740	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1819	15750	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1820	15756	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1821	15758	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1822	15760	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1823	15771	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1824	15773	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1825	15774	Under Other Flaps and Grafts Procedures	Under Other Flaps and Grafts Procedures
1826	22860	Under Spinal Instrumentation Procedures on the Spine (Vertebral Column)	Under Spinal Instrumentation Procedures on the Spine (Vertebral Column)
1827	30469	Under Repair Procedures on the Nose	Under Repair Procedures on the Nose
1828	31551	Under Repair Procedures on the Larynx	Under Repair Procedures on the Larynx
1829	31553	Under Repair Procedures on the Larynx	Under Repair Procedures on the Larynx
1830	33263	Under Pacemaker or Implantable Defibrillator Procedures	Under Pacemaker or Implantable Defibrillator Procedures
1831	33264	Under Pacemaker or Implantable Defibrillator Procedures	Under Pacemaker or Implantable Defibrillator Procedures
1832	33270	Under Pacemaker or Implantable Defibrillator Procedures	Under Pacemaker or Implantable Defibrillator Procedures
1833	33271	Under Pacemaker or Implantable Defibrillator Procedures	Under Pacemaker or Implantable Defibrillator Procedures
1834	33895	Under Endovascular Repair of Congenital Heart and Vascular Defects	Under Endovascular Repair of Congenital Heart and Vascular Defects
1835	33900	Under Endovascular Repair of Congenital Heart and Vascular Defects	Under Endovascular Repair of Congenital Heart and Vascular Defects
1836	33901	Under Endovascular Repair of Congenital Heart and Vascular Defects	Under Endovascular Repair of Congenital Heart and Vascular Defects
1837	33902	Under Endovascular Repair of Congenital Heart and Vascular Defects	Under Endovascular Repair of Congenital Heart and Vascular Defects
1838	33962	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1839	33963	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1840	33965	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures	Under Extracorporeal Membrane Oxygenation or Extracorporeal Life Support Services and Procedures
1841	43288	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1842	43289	Under Laparoscopic Procedures on the Esophagus	Under Laparoscopic Procedures on the Esophagus
1843	43290	Under Esophagogastroduodenoscopy Procedures	Under Esophagogastroduodenoscopy Procedures
1844	45399	Under Other Procedures on the Colon and Rectum	Under Other Procedures on the Colon and Rectum
1845	46948	Under Excision Procedures on the Anus	Under Excision Procedures on the Anus
1846	S8425	GRADIENT PRESSURE AID (GLOVE), CUSTOM MADE, MEDIUM WEIGHT	Custom grad glove med
1847	S8460	CAMISOLE, POST-MASTECTOMY	Camisole post-mast
1848	S9056	COMA STIMULATION PER DIEM	Coma stimulation per diem
1849	S9083	GLOBAL FEE URGENT CARE CENTERS	Urgent care center global
1850	S9341	HOME THERAPY; ENTERAL NUTRITION VIA GRAVITY; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (ENTERAL FORMULA AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT enteral grav diem
1851	S9342	HOME THERAPY; ENTERAL NUTRITION VIA PUMP; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (ENTERAL FORMULA AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT enteral pump diem
1852	S9361	HOME INFUSION THERAPY, DIURETIC INTRAVENOUS THERAPY; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT diuretic infus diem
1853	S9368	HOME INFUSION THERAPY, TOTAL PARENTERAL NUTRITION (TPN); MORE THAN THREE LITERS PER DAY, ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT INCLUDING STANDARD TPN FORMULA (LIPIDS, SPECIALTY AMINO ACID FORMULAS, DRUGS OTHER THAN IN STANDARD FORMULA AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT tpn over 3l diem
1854	S9372	HOME THERAPY; INTERMITTENT ANTICOAGULANT INJECTION THERAPY (E.G. HEPARIN); ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM (DO NOT USE THIS CODE FOR FLUSHING OF INFUSION DEVICES WITH HEPARIN TO MAINTAIN PATENCY)	HT inj anticoag diem
1855	S9374	HOME INFUSION THERAPY, HYDRATION THERAPY; ONE LITER PER DAY, ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT hydra 1 liter diem
1856	S9430	PHARMACY COMPOUNDING AND DISPENSING SERVICES	Pharmacy comp/disp serv
1857	S9441	ASTHMA EDUCATION, NON-PHYSICIAN PROVIDER, PER SESSION	Asthma education
1858	S9446	PATIENT EDUCATION, NOT OTHERWISE CLASSIFIED, NON-PHYSICIAN PROVIDER, GROUP, PER SESSION	PT education noc group
1859	S9460	DIABETIC MANAGEMENT PROGRAM, NURSE VISIT	Diabetic Management Program,
1860	S9986	NOT MEDICALLY NECESSARY SERVICE (PATIENT IS AWARE THAT SERVICE NOT MEDICALLY NECESSARY)	Not medically necessary svc
1861	T1005	RESPITE CARE SERVICES, UP TO 15 MINUTES	Respite care service 15 min
1862	T1502	ADMINISTRATION OF ORAL, INTRAMUSCULAR AND/OR SUBCUTANEOUS MEDICATION BY HEALTH CARE AGENCY/PROFESSIONAL, PER VISIT	Medication admin visit
1863	T2011	PREADMISSION SCREENING AND RESIDENT REVIEW (PASRR) LEVEL II EVALUATION, PER EVALUATION	PASRR Level II
1864	G0427	TELEHEALTH CONSULTATION, EMERGENCY DEPARTMENT OR INITIAL INPATIENT, TYPICALLY 70 MINUTES OR MORE COMMUNICATING WITH THE PATIENT VIA TELEHEALTH	Inpt/ED teleconsult70
1865	G0429	DERMAL FILLER INJECTION(S) FOR THE TREATMENT OF FACIAL LIPODYSTROPHY SYNDROME (LDS) (E.G., AS A RESULT OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY)	Dermal filler injection(s)
1866	G0434	DRUG SCREEN, OTHER THAN CHROMATOGRAPHIC; ANY NUMBER OF DRUG CLASSES, BY CLIA WAIVED TEST OR MODERATE COMPLEXITY TEST, PER PATIENT ENCOUNTER	Drug screen multi drug class
1867	G0459	Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy	Telehealth inpt pharm mgmt
1868	G0490	FACE-TO-FACE HOME HEALTH NURSING VISIT BY A RURAL HEALTH CLINIC (RHC) OR FEDERALLY QUALIFIED HEALTH CENTER (FQHC) IN AN AREA WITH A SHORTAGE OF HOME HEALTH AGENCIES. (SERVICES LIMITED TO RN OR LPN ONLY)	Home visit RN, LPN by RHC/FQ
1869	G0492	DIALYSIS PROCEDURE WITH SINGLE EVALUATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL FOR ACUTE KIDNEY INJURY WITHOUT ESRD	Md/oth eval acut kid no esrd
1870	G0509	TELEHEALTH CONSULTATION, CRITICAL CARE, SUBSEQUENT, PHYSICIANS TYPICALLY SPEND 50 MINUTES COMMUNICATING WITH THE PATIENT AND PROVIDERS VIA TELEHEALTH	Crit care telehea consult 50
1871	G0516	Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)	insert drug implant,>=4
1872	G0916	SATISFACTION WITH CARE ACHIEVED WITHIN 90 DAYS FOLLOWING CATARACT SURGERY	Satisfy with care
1873	G2002	Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)	POST-D/C H VST NEW PT 30 M
1874	G2090	Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period	PT 66+ FRAILTY AND MED DEM
1875	G2096	Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given	NO RSN ACE ARB ARNI
1876	G2099	Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period	PT 66+ FRAILTY AND ADV ILL
1877	G2112	Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months	PRED<=5 MG RA GLU <6M
1878	G6031	ASSAY OF BENZODIAZEPINES	Assay of benzodiazepines
1879	G6037	ASSAY OF NORTRIPTYLINE	Assay of nortiptyline
1880	G6050	ASSAY OF ETHCHLORVYNOL	Assay of ethchlorvynol
1881	G8395	LEFT VENTRICULAR EJECTION FRACTION (LVEF) >= 40% OR DOCUMENTATION AS NORMAL OR MILDLY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION	LVEF>=40% doc normal or mild
1882	G8415	FOOTWEAR EVALUATION WAS NOT PERFORMED	Eval on foot not performed
1883	G8491	I INTEND TO REPORT THE HIV/AIDS MEASURES GROUP	HIV/AIDS measures grp
1884	G8497	ALL QUALITY ACTIONS FOR THE APPLICABLE MEASURES IN THE CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP HAVE BEEN PERFORMED FOR THIS PATIENT	CABG meas qual act perform
1885	G8549	ALL QUALITY ACTIONS FOR THE APPLICABLE MEASURES IN THE HEPATITIS C MEASURES GROUP HAVE BEEN PERFORMED FOR THIS PATIENT	HepC MG qual act perform
1886	G8560	PATIENT HAS A HISTORY OF ACTIVE DRAINAGE FROM THE EAR WITHIN THE PREVIOUS 90 DAYS	Pt hx act drain prev 90 days
1887	G8597	MOST RECENT LDL-C >= 100 MG/DL	Ldl >= 100
1888	G8630	DOCUMENTATION THAT ADMINISTRATION OF PROPHYLACTIC PARENTERAL ANTIBIOTICS WAS INITIATED WITHIN ONE HOUR (IF FLUOROQUINOLONE OR VANCOMYCIN, TWO HOURS) PRIOR TO SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED), AS ORDERED	Doc antibio given b/4 surg
1889	G8653	RISK-ADJUSTED FUNCTIONAL STATUS CHANGE RESIDUAL SCORES FOR THE HIP IMPAIRMENT NOT MEASURED BECAUSE THE PATIENT DID NOT COMPLETE THE FS STATUS SURVEY NEAR DISCHARGE, PATIENT NOT APPROPRIATE	Rafscrs hi no scor
1890	G8669	RISK-ADJUSTED FUNCTIONAL STATUS CHANGE RESIDUAL SCORE FOR THE ELBOW, WRIST OR HAND IMPAIRMENT NOT MEASURED BECAUSE THE PATIENT DID NOT COMPLETE THE FS STATUS SURVEY NEAR DISCHARGE, PATIENT NOT APPROPRIATE	Rafscrs
1891	G8979	MOBILITY: WALKING & MOVING AROUND FUNCTIONAL LIMITATION, PROJECTED GOAL STATUS, AT THERAPY EPISODE OUTSET, AT REPORTING INTERVALS, AND AT DISCHARGE OR TO END REPORTING	Mobility goal status
1892	G8984	CARRYING, MOVING & HANDLING OBJECTS FUNCTIONAL LIMITATION, CURRENT STATUS, AT THERAPY EPISODE OUTSET AND AT REPORTING INTERVALS	Carry current status
1893	G8986	CARRYING, MOVING & HANDLING OBJECTS FUNCTIONAL LIMITATION, DISCHARGE STATUS, AT DISCHARGE FROM THERAPY OR TO END REPORTING	Carry D/C status
1894	G9001	COORDINATED CARE FEE, INITIAL RATE	MCCD, initial rate
1895	G9061	ONCOLOGY; PRACTICE GUIDELINES; PATIENT'S CONDITION NOT ADDRESSED BY AVAILABLE GUIDELINES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc prac cond noadd by guide
1896	G9078	ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; T2 OR T3A GLEASON 8-10 OR PSA > 20 AT DIAGNOSIS WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx prostate T2no progres
1897	G9101	ONCOLOGY; DISEASE STATUS; GASTRIC CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; POST R1 OR R2 RESECTION (WITH OR WITHOUT NEOADJUVANT THERAPY) WITH NO EVIDENCE OF DISEASE PROGRESSION, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx gastric p R1-R2noprog
1898	G9116	ONCOLOGY; DISEASE STATUS; OVARIAN CANCER, LIMITED TO EPITHELIAL CANCER; EVIDENCE OF DISEASE PROGRESSION, OR RECURRENCE, AND/OR PLATINUM RESISTANCE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx ovarian recurrence
1899	G9140	FRONTIER EXTENDED STAY CLINIC DEMONSTRATION; FOR A PATIENT STAY IN A CLINIC APPROVED FOR THE CMS DEMONSTRATION PROJECT; THE FOLLOWING MEASURES SHOULD BE PRESENT: THE STAY MUST BE EQUAL TO OR GREATER THAN 4 HOURS; WEATHER OR OTHER CONDITIONS MUST PREVENT TRANSFER OR THE CASE FALLS INTO A CATEGORY OF MONITORING AND OBSERVATION CASES THAT ARE PERMITTED BY THE RULES OF THE DEMONSTRATION; THERE IS A MAXIMUM FRONTIER EXTENDED STAY CLINIC (FESC) VISIT OF 48 HOURS, EXCEPT IN THE CASE WHEN WEATHER OR OTHER CONDITIONS PREVENT TRANSFER; PAYMENT IS MADE ON EACH PERIOD UP TO 4 HOURS, AFTER THE FIRST 4 HOURS	Frontier extended stay demo
1900	G9159	SPOKEN LANGUAGE COMPREHENSION FUNCTIONAL LIMITATION, CURRENT STATUS AT THERAPY EPISODE OUTSET AND AT REPORTING INTERVALS	Lang comp current status
1901	G9163	SPOKEN LANGUAGE EXPRESSION FUNCTIONAL LIMITATION, PROJECTED GOAL STATUS AT THERAPY EPISODE OUTSET, AT REPORTING INTERVALS, AND AT DISCHARGE OR TO END REPORTING	Lang express goal status
1902	G9176	OTHER SPEECH LANGUAGE PATHOLOGY FUNCTIONAL LIMITATION, DISCHARGE STATUS AT DISCHARGE FROM THERAPY OR TO END REPORTING	Speech lang d/c status
1903	G9214	CD4+ CELL COUNT OR CD4+ CELL PERCENTAGE RESULTS DOCUMENTED	Cd4 count documented
1904	G9275	DOCUMENTATION THAT PATIENT IS A CURRENT NON-TOBACCO USER	Doc of non tobacco user
1905	G9277	DOCUMENTATION THAT THE PATIENT IS ON DAILY ASPIRIN OR ANTI-PLATELET OR HAS DOCUMENTATION OF A VALID CONTRAINDICATION OR EXCEPTION TO ASPIRIN/ANTI-PLATELET; CONTRAINDICATIONS/EXCEPTIONS INCLUDE ANTI-COAGULANT USE, ALLERGY TO ASPIRIN OR ANTI-PLATELETS, HISTORY OF GASTROINTESTINAL BLEED AND BLEEDING DISORDER; ADDITIONALLY, THE FOLLOWING EXCEPTIONS DOCUMENTED BY THE PHYSICIAN AS A REASON FOR NOT TAKING DAILY ASPIRIN OR ANTI-PLATELET ARE ACCEPTABLE (USE OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, DOCUMENTED RISK FOR DRUG INTERACTION, UNCONTROLLED HYPERTENSION DEFINED AS >180 SYSTOLIC OR >110 DIASTOLIC OR GASTROESOPHAGEAL REFLUX)	Doc daily aspirin or contra
1906	G9286	ANTIBIOTIC REGIMEN PRESCRIBED WITHIN10 DAYS AFTER ONSET OF SYMPTOMS	Antibio rx w in 10d of sympt
1907	G9288	DOCUMENTATION OF MEDICAL REASON(S) FOR NOT REPORTING THE HISTOLOGICAL TYPE OR NSCLC-NOS CLASSIFICATION WITH AN EXPLANATION (E.G., A SOLITARY FIBROUS TUMOR IN A PERSON WITH A HISTORY OF NON-SMALL CELL CARCINOMA OR OTHER DOCUMENTED MEDICAL REASONS )	Doc medrsn no hist type rpt
1908	G9312	SURGICAL SITE INFECTION	Surgical site infection
1909	G9314	AMOXICILLIN, WITH OR WITHOUT CLAVULANATE, NOT PRESCRIBED AS FIRST LINE ANTIBIOTIC AT THE TIME OF DIAGNOSIS, REASON NOT GIVEN	Norsn not first line amox
1910	G9358	POST-PARTUM SCREENINGS, EVALUATIONS AND EDUCATION NOT PERFORMED	Pp eval/edu not perf
1911	G9377	PATIENT DID NOT HAVE THE RETINA ATTACHED AFTER 6 MONTHS FOLLOWING ONLY ONE SURGERY	No ret attach after 6mt
1912	G9478	SERVICES PERFORMED BY OTHER QUALIFIED THERAPIST IN THE HOSPICE SETTING, EACH 15 MINUTES	Othe therapist at hospice
1913	G9502	DOCUMENTATION OF MEDICAL REASON FOR NOT PERFORMING FOOT EXAM (I.E., PATIENTS WHO HAVE HAD EITHER A BILATERAL AMPUTATION ABOVE OR BELOW THE KNEE, OR BOTH A LEFT AND RIGHT AMPUTATION ABOVE OR BELOW THE KNEE BEFORE OR DURING THE MEASUREMENT PERIOD)	Med reas no perf foot exam
1914	G9547	INCIDENTAL FINDING: LIVER LESION <= 0.5 CM, CYSTIC KIDNEY LESION < 1.0 CM OR ADRENAL LESION <= 1.0 CM	Incid finding liver/kid/adre
1915	G9553	PRIOR THYROID DISEASE DIAGNOSIS	Prior thyroid dise dx
1916	G9555	DOCUMENTATION OF MEDICAL REASON(S) FOR RECOMMENDING FOLLOW UP IMAGING (E.G., PATIENT HAS MULTIPLE ENDOCRINE NEOPLASIA, PATIENT HAS CERVICAL LYMPHADENOPATHY, OTHER MEDICAL REASON(S))	Doc med rsn for follup image
1917	G9745	DOCUMENTED REASON FOR NOT SCREENING OR RECOMMENDING A FOLLOW-UP FOR HIGH BLOOD PRESSURE	Doc rsn no hbp scrn or f/u
1918	V2218	ANISEIKONIC, PER LENS, BIFOCAL	Lens aniseikonic bifocal
1919	V2219	BIFOCAL SEG WIDTH OVER 28MM	Lens bifocal seg width over
1920	V2221	LENTICULAR LENS, PER LENS, BIFOCAL	Lenticular lens, bifocal
1921	V2306	SPHEROCYLINDER, TRIFOCAL, PLANO TO PLUS OR MINUS 4.00D SPHERE, OVER 6.00D CYLINDER, PER LENS	Lens sphcyl trifocal 4.00/>6
1922	G9622	PATIENT NOT IDENTIFIED AS AN UNHEALTHY ALCOHOL USER WHEN SCREENED FOR UNHEALTHY ALCOHOL USE USING A SYSTEMATIC SCREENING METHOD	No unheal etoh user
1923	G9681	ONSITE ACUTE CARE TREATMENT OF A RESIDENT WITH COPD OR ASTHMA. MAY ONLY BE BILLED ONCE PER DAY PER BENEFICIARY.	Acute care chronic obstructive pulmonary disease (COPD) /asthma
1924	G9686	ONSITE NURSING FACILITY CONFERENCE, THAT IS SEPARATE AND DISTINCT FROM AN EVALUATION AND MANAGEMENT VISIT, INCLUDING QUALIFIED PRACTITIONER AND AT LEAST ONE MEMBER OF THE NURSING FACILITY INTERDISCIPLINARY CARE TEAM	Nursing Facility Conference
1925	G9693	PATIENT USE OF HOSPICE SERVICES ANY TIME DURING THE MEASUREMENT PERIOD	Pt use hosp during msmt per
1926	G9695	LONG-ACTING INHALED BRONCHODILATOR PRESCRIBED	Long act inhal bronchdil pre
1927	G9723	HOSPICE SERVICES FOR PATIENT RECEIVED ANY TIME DURING THE MEASUREMENT PERIOD	Hosp recd by pt dur msmt per
1928	G9753	DOCUMENTATION OF MEDICAL REASON FOR NOT CONDUCTING A SEARCH FOR DICOM FORMAT IMAGES FOR PRIOR PATIENT CT IMAGING STUDIES COMPLETED AT NON-AFFILIATED EXTERNAL HEALTHCARE FACILITIES OR ENTITIES WITHIN THE PAST 12 MONTHS THAT ARE AVAILABLE THROUGH A SECURE, AUTHORIZED, MEDIA-FREE, SHARED ARCHIVE (E.G., TRAUMA, ACUTE MYOCARDIAL INFARCTION, STROKE, AORTIC ANEURYSM WHERE TIME IS OF THE ESSENCE)	Doc no dicom, ct other fac
1929	G9769	PATIENT HAD A BONE MINERAL DENSITY TEST IN THE PAST TWO YEARS OR RECEIVED OSTEOPOROSIS MEDICATION OR THERAPY IN THE PAST 12 MONTHS	Bn den 2yr/got ost med/ther
1930	T2040	FINANCIAL MANAGEMENT, SELF-DIRECTED, WAIVER; PER 15 MINUTES	Financial mgt waiver/15min
1931	T4524	ADULT SIZED DISPOSABLE INCONTINENCE PRODUCT, BRIEF/DIAPER, EXTRA LARGE, EACH	Adult size brief/diaper xl
1932	T4532	PEDIATRIC SIZED DISPOSABLE INCONTINENCE PRODUCT, PROTECTIVE UNDERWEAR/PULL-ON, LARGE SIZE, EACH	Ped size pull-on lg
1933	T4541	INCONTINENCE PRODUCT, DISPOSABLE UNDERPAD, LARGE, EACH	Large disposable underpad
1934	V2105	SPHEROCYLINDER, SINGLE VISION, PLANO TO PLUS OR MINUS 4.00D SPHERE, 4.25 TO 6.00D CYLINDER, PER LENS	Spherocylinder 4.00d/4.25-6d
1935	V2110	SPHEROCYLINDER, SINGLE VISION, PLUS OR MINUS 4.25 TO 7.00D SPHERE, OVER 6.00D CYLINDER, PER LENS	Spherocylinder 4.25d/over 6d
1936	V2205	SPHEROCYLINDER, BIFOCAL, PLANO TO PLUS OR MINUS 4.00D SPHERE, 4.25 TO 6.00D CYLINDER, PER LENS	Lens sphcy bifocal 4.00d/4.2
1937	V2310	SPHEROCYLINDER, TRIFOCAL, PLUS OR MINUS 4.25 TO PLUS OR MINUS 7.00D SPHERE, OVER 6.00D CYLINDER, PER LENS	Lens sphc trifocal 4.25-7/>6
1938	V2320	TRIFOCAL ADD OVER 3.25D	Lens trifocal add over 3.25d
1939	V2512	CONTACT LENS, GAS PERMEABLE, BIFOCAL, PER LENS	Cntct lens gas permbl bifocl
1940	V2513	CONTACT LENS, GAS PERMEABLE, EXTENDED WEAR, PER LENS	Contact lens extended wear
1941	V2700	BALANCE LENS, PER LENS	Balance lens
1942	V2783	LENS, INDEX GREATER THAN OR EQUAL TO 1.66 PLASTIC OR GREATER THAN OR EQUAL TO 1.80 GLASS, EXCLUDES POLYCARBONATE, PER LENS	Lens, >= 1.66 p/>=1.80 g
1943	V2788	PRESBYOPIA CORRECTING FUNCTION OF INTRAOCULAR LENS	Presbyopia-correct function
1944	V5040	HEARING AID, MONAURAL, BODY WORN, BONE CONDUCTION	Body-worn hearing aid bone
1945	V5220	HEARING AID, BICROS, BEHIND THE EAR	Behind ear bicros hearing ai
1946	V5273	ASSISTIVE LISTENING DEVICE, FOR USE WITH COCHLEAR IMPLANT	ALD for cochlear implant
1947	V5362	SPEECH SCREENING	Speech screening
1948	G8724	PT CATEGORY, PN CATEGORY AND HISTOLOGIC GRADE WERE NOT DOCUMENTED IN THE PATHOLOGY REPORT, REASON NOT GIVEN	Pt, pn, hist grade not doc
1949	G8738	LEFT VENTRICULAR EJECTION FRACTION (LVEF) < 40% OR DOCUMENTATION OF SEVERELY OR MODERATELY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION	Lvef < 40%
1950	G8753	MOST RECENT SYSTOLIC BLOOD PRESSURE >= 140MMHG	Sys BP > or = 140
1951	G8778	DOCUMENTATION OF MEDICAL REASON(S) FOR NOT PERFORMING DIABETES SCREENING TEST (E.G., PATIENTS WITH A DIAGNOSIS OF DIABETES, OR WITH PALLIATIVE GOALS OR FOR WHOM TREATMENT OF HYPERTENSION WITH STANDARD TREATMENT GOALS IS NOT CLINICALLY APPROPRIATE)	Doc med reas no diabete scrn
1952	G8797	SPECIMEN SITE OTHER THAN ANATOMIC LOCATION OF ESOPHAGUS	Specimen site not esophagus
1953	G8848	MILD OBSTRUCTIVE SLEEP APNEA (APNEA HYPOPNEA INDEX (AHI) OR RESPIRATORY DISTURBANCE INDEX (RDI) OF LESS THAN 15)	Mild OSA
1954	G8856	REFERRAL TO A PHYSICIAN FOR AN OTOLOGIC EVALUATION PERFORMED	Ref for oto eval
1955	G8858	REFERRAL TO A PHYSICIAN FOR AN OTOLOGIC EVALUATION NOT PERFORMED, REASON NOT GIVEN	Not ref for oto eval
1956	G8863	PATIENTS NOT ASSESSED FOR RISK OF BONE LOSS, REASON NOT GIVEN	No assess bone loss
1957	G8871	PATIENT NOT RECEIVING A FIRST COURSE OF ANTI-TNF THERAPY	No 1st antiTNF
1958	G8896	DOCUMENTATION OF MEDICAL REASON(S) FOR NOT PRESCRIBING ORAL ASPIRIN OR OTHER ANTTHROMBOTIC THERAPY (E. G. , PATIENT DOCUMENTED TO BE LOW RISK OR PATIENT WITH TERMINAL ILLNESS OR TREATMENT OF HYPERTENSION WITH STANDARD TREATMENT GOALS IS NOT CLINICALLY APPROPRIATE, OR FOR WHOM RISK OF ASPIRIN OR OTHER ANTITHROMBOTIC THERAPY EXCEEDS POTENTIAL BENEFITS SUCH AS FOR INDIVIDUALS WHOSE BLOOD PRESSURE IS POORLY CONTROLLED)	Doc med reas no antihtrom
1959	G8898	I INTEND TO REPORT THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MEASURES GROUP	COPD Measures Group
1960	G8905	I INTEND TO REPORT THE CARDIOVASCULAR PREVENTION MEASURES GROUP	Cardiovascular Prevention MG
1961	G8912	PATIENT DOCUMENTED TO HAVE EXPERIENCED A WRONG SITE, WRONG SIDE, WRONG PATIENT, WRONG PROCEDURE OR WRONG IMPLANT EVENT	Pt doc with wrong event
1962	G8944	AJCC MELANOMA CANCER STAGE 0 THROUGH IIC MELANOMA	AJCC Mel cnr stg 0 - IIC
1963	G9133	ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA; HORMONE-RESPONSIVE; CLINICAL METASTASES OR M1 AT DIAGNOSIS (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx prostate clinical met
1964	G9135	ONCOLOGY; DISEASE STATUS; NON-HODGKIN’S LYMPHOMA, ANY CELLULAR CLASSIFICATION; STAGE III, IV, NOT RELAPSED, NOT REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx NHL stg 3-4 not relap
1965	G8955	MOST RECENT ASSESSMENT OF ADEQUACY OF VOLUME MANAGEMENT DOCUMENTED	Most recent assess vol mgmt
1966	G9004	COORDINATED CARE FEE, RISK ADJUSTED LOW, INITIAL	MCCD, risk adj lo, initial
1967	G9011	COORDINATED CARE FEE, RISK ADJUSTED MAINTENANCE, LEVEL 5	MCCD, risk adj, level 5
1968	G9036	RIMANTADINE HYDROCHLORIDE, ORAL, BRAND, PER 100 MG (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Rimantadine HCL, brand
1969	G9052	ONCOLOGY; PRIMARY FOCUS OF VISIT; SURVEILLANCE FOR DISEASE RECURRENCE FOR PATIENT WHO HAS COMPLETED DEFINITIVE CANCER-DIRECTED THERAPY AND CURRENTLY LACKS EVIDENCE OF RECURRENT DISEASE; CANCER DIRECTED THERAPY MIGHT BE CONSIDERED IN THE FUTURE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc surveillance for disease
1970	G9068	ONCOLOGY; DISEASE STATUS; LIMITED TO SMALL CELL AND COMBINED SMALL CELL/NON-SMALL CELL; EXTENT OF DISEASE INITIALLY ESTABLISHED AS LIMITED WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx sclc/nsclc limited
1971	G9079	ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; T3B-T4, ANY N; ANY T, N1 AT DIAGNOSIS WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx prostate T3b-T4noprog
1972	G9091	ONCOLOGY; DISEASE STATUS; RECTAL CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T3, N0, M0 (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx rectal T3 N0 no prog
1973	G9098	ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx esophageal mets recur
1974	G9123	ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; CHRONIC PHASE NOT IN HEMATOLOGIC, CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx CML chronic phase
1975	G9138	ONCOLOGY; DISEASE STATUS; NON-HODGKIN’S LYMPHOMA, ANY CELLULAR CLASSIFICATION; DIAGNOSTIC EVALUATION, STAGE NOT DETERMINED, EVALUATION OF POSSIBLE RELAPSE OR NON-RESPONSE TO THERAPY, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)	Onc dx NHL stg unknown
1976	G9143	WARFARIN RESPONSIVENESS TESTING BY GENETIC TECHNIQUE USING ANY METHOD, ANY NUMBER OF SPECIMEN(S)	Warfarin respon genetic test
1977	G9160	SPOKEN LANGUAGE COMPREHENSION FUNCTIONAL LIMITATION, PROJECTED GOAL STATUS AT THERAPY EPISODE OUTSET, AT REPORTING INTERVALS, AND AT DISCHARGE OR TO END REPORTING	Lang comp goal status
1978	G9207	HEPATITIS C GENOTYPE TESTING DOCUMENTED AS PERFORMED WITHIN 12 MONTHS PRIOR TO INITIATION OF ANTIVIRAL TREATMENT FOR HEPATITIS C	Hep c genotype prior to med
1979	G9230	CHLAMYDIA, GONORRHEA, AND SYPHILIS NOT SCREENED, REASON NOT GIVEN	Norsn for gc chl syp test
1980	G9242	DOCUMENTATION OF VIRAL LOAD EQUAL TO OR GREATER THAN 200 COPIES/ML OR VIRAL LOAD NOT PERFORMED	Doc viral load >=200
1981	G9244	ANTIRETROVIRAL THEREAPY NOT PRESCRIBED	Antiviral not ordered
1982	G9249	PATIENT HAD A MEDICAL VISIT IN THE LAST 6 MONTHS	Med visit w in 6mo
1983	G9276	DOCUMENTATION THAT PATIENT IS A CURRENT TOBACCO USER	Doc of tobacco user
1984	G9290	NON SMALL CELL LUNG CANCER BIOPSY AND CYTOLOGY SPECIMEN REPORT DOES NOT DOCUMENT CLASSIFICATION INTO SPECIFIC HISTOLOGIC TYPE OR CLASSIFIED AS NSCLC-NOS WITH AN EXPLANATION	No doc type nsm lung ca
1985	G9311	NO SURGICAL SITE INFECTION	No surg site infection
1986	G9328	DICOM FORMAT IMAGE DATA AVAILABILITY NOT DOCUMENTED IN FINAL REPORT DUE TO MEDICAL REASONS (EG, CT STUDIES PERFORMED FOR RADIATION TREATMENT PLANNING OR IMAGE-GUIDED RADIATION TREATMENT DELIVERY)	Medrsn no dicom format doc
1987	G9342	SEARCH NOT CONDUCTED PRIOR TO AN IMAGING STUDY BEING PERFORMED FOR PRIOR PATIENT CT STUDIES COMPLETED AT NON-AFFILIATED EXTERNAL HEALTHCARE FACILITIES OR ENTITIES WITHIN THE PAST 12-MONTHS AND ARE AVAILABLE THROUGH A SECURE, AUTHORIZED, MEDIA-FREE, SHARED ARCHIVE, REASON NOT GIVEN	No srch for ct in 12mo norsn
1988	G9346	FOLLOW-UP RECOMMENDATIONS NOT DOCUMENTED ACCORDING TO RECOMMENDED GUIDELINES FOR INCIDENTALLY DETECTED PULMONARY NODULES DUE TO MEDICAL REASONS (E.G., PATIENTS WITH KNOWN MALIGNANT DISEASE, PATIENTS WITH UNEXPLAINED FEVER, CT STUDIES PERFORMED FOR RADIATION TREATMENT PLANNING OR IMAGE-GUIDED RADIATION TREATMENT DELIVERY)	No follow up pulm nod
1989	G9351	MORE THAN ONE CT SCAN OF THE PARANASAL SINUSES ORDERED OR RECEIVED WITHIN 90 DAYS AFTER DIAGNOSIS	Doc >1 sinus ct w 90d dx
1990	15261	Full thickness graft, free, including direct closure of donor site, nose, ears, eyelids, and/or lips; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)	SKIN FULL GRAFT ADD-ON
1991	15820	Blepharoplasty, lower eyelid;	REVISION OF LOWER EYELID
1992	15830	Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy	EXC SKIN ABD
1993	15832	Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh	EXCISE EXCESSIVE SKIN THIGH
1994	15933	Excision, sacral pressure ulcer, with primary suture; with ostectomy	REMOVE SACRUM PRESSURE SORE
1995	16020	Dressings and/or debridement of partial-thickness burns, initial or subsequent; small (less than 5% total body surface area)	DRESS/DEBRID P-THICK BURN S
1996	17340	Cryotherapy (CO2 slush, liquid N2) for acne	CRYOTHERAPY OF SKIN
1997	27303	Incision, deep, with opening of bone cortex, femur or knee (eg, osteomyelitis or bone abscess)	DRAINAGE OF BONE LESION
1998	27326	Neurectomy, popliteal (gastrocnemius)	NEURECTOMY POPLITEAL
1999	27329	Radical resection of tumor (eg, sarcoma), soft tissue of thigh or knee area; less than 5 cm	RESECT THIGH/KNEE TUM < 5 C
2000	27345	Excision of synovial cyst of popliteal space (eg, Baker's cyst)	REMOVAL OF KNEE CYST
2001	27356	Excision or curettage of bone cyst or benign tumor of femur; with allograft	REMOVE FEMUR LESION/GRAFT
2002	27369	Injection procedure for contrast knee arthrography or contrast enhanced CT/MRI knee arthrography	NJX CNTRST KNE ARTHG/CT/MRI
2003	27415	Osteochondral allograft, knee, open	OSTEOCHONDRAL KNEE ALLOGRAF
2004	27418	Anterior tibial tubercleplasty (eg, Maquet type procedure)	REPAIR DEGENERATED KNEECAP
2005	27447	Arthroplasty, knee, condyle and plateau; medial AND lateral compartments with or without patella resurfacing (total knee arthroplasty)	TOTAL KNEE ARTHROPLASTY
2006	27448	Osteotomy, femur, shaft or supracondylar; without fixation	INCISION OF THIGH
2007	27497	Decompression fasciotomy, thigh and/or knee, 1 compartment (flexor or extensor or adductor); with debridement of nonviable muscle and/or nerve	DECOMPRESSION OF THIGH/KNEE
2008	27498	Decompression fasciotomy, thigh and/or knee, multiple compartments;	DECOMPRESSION OF THIGH/KNEE
2009	27501	Closed treatment of supracondylar or transcondylar femoral fracture with or without intercondylar extension, without manipulation	TREATMENT OF THIGH FRACTURE
2010	27535	Open treatment of tibial fracture, proximal (plateau); unicondylar, includes internal fixation, when performed	TREAT KNEE FRACTURE
2011	45305	Proctosigmoidoscopy, rigid; with biopsy, single or multiple	PROCTOSIGMOIDOSCOPY W/BX
2012	45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique	COLONOSCOPY W/LESION REMOVA
2013	45550	Proctopexy (eg, for prolapse); with sigmoid resection, abdominal approach	REPAIR RECTUM/REMOVE SIGMOI
2014	27786	Closed treatment of distal fibular fracture (lateral malleolus); without manipulation	TREATMENT OF ANKLE FRACTURE
2015	27826	Open treatment of fracture of weight bearing articular surface/portion of distal tibia (eg, pilon or tibial plafond), with internal fixation, when performed; of fibula only	TREAT LOWER LEG FRACTURE
2016	00844	Anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; abdominoperineal resection	ANESTH PELVIS SURGERY
2017	28485	Open treatment of metatarsal fracture, includes internal fixation, when performed, each	TREAT METATARSAL FRACTURE
2018	28495	Closed treatment of fracture great toe, phalanx or phalanges; with manipulation	TREAT BIG TOE FRACTURE
2019	28525	Open treatment of fracture, phalanx or phalanges, other than great toe, includes internal fixation, when performed, each	TREAT TOE FRACTURE
2020	28660	Closed treatment of interphalangeal joint dislocation; without anesthesia	TREAT TOE DISLOCATION
2021	28755	Arthrodesis, great toe; interphalangeal joint	FUSION OF BIG TOE JOINT
2022	29581	Application of multi-layer compression system; leg (below knee), including ankle and foot	APPLY MULTLAY COMPRS LWR LE
2023	01714	Anesthesia for procedures on nerves, muscles, tendons, fascia, and bursae of upper arm and elbow; tenoplasty, elbow to shoulder	ANESTH UPPR ARM TENDON SURG
2024	01732	Anesthesia for diagnostic arthroscopic procedures of elbow joint	ANESTH DX ELBOW ARTHROSCOPY
2025	15842	Graft for facial nerve paralysis; free muscle flap by microsurgical technique	NERVE PALSY MICROSURG GRAFT
2026	15860	Intravenous injection of agent (eg, fluorescein) to test vascular flow in flap or graft	TEST FOR BLOOD FLOW IN GRAF
2027	15945	Excision, ischial pressure ulcer, with skin flap closure; with ostectomy	REMOVE HIP PRESSURE SORE
2028	17004	Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses), 15 or more lesions	DESTROY PREMAL LESIONS 15/>
2029	23120	Claviculectomy; partial	PARTIAL REMOVAL COLLAR BONE
2030	23195	Resection, humeral head	REMOVAL OF HEAD OF HUMERUS
2031	23334	Removal of prosthesis, includes debridement and synovectomy when performed; humeral or glenoid component	SHOULDER PROSTHESIS REMOVAL
2032	23335	Removal of prosthesis, includes debridement and synovectomy when performed; humeral and glenoid components (eg, total shoulder)	SHOULDER PROSTHESIS REMOVAL
2033	23350	Injection procedure for shoulder arthrography or enhanced CT/MRI shoulder arthrography	INJECTION FOR SHOULDER X-RA
2034	23406	Tenotomy, shoulder area; multiple tendons through same incision	INCISE TENDON(S) & MUSCLE(S
2035	23450	Capsulorrhaphy, anterior; Putti-Platt procedure or Magnuson type operation	REPAIR SHOULDER CAPSULE
2036	26210	Excision or curettage of bone cyst or benign tumor of proximal, middle, or distal phalanx of finger;	REMOVAL OF FINGER LESION
2037	26418	Repair, extensor tendon, finger, primary or secondary; without free graft, each tendon	REPAIR FINGER TENDON
2038	26455	Tenotomy, flexor, finger, open, each tendon	INCISION OF FINGER TENDON
2039	27570	Manipulation of knee joint under general anesthesia (includes application of traction or other fixation devices)	FIXATION OF KNEE JOINT
2040	27599	Unlisted procedure, femur or knee	LEG SURGERY PROCEDURE
2041	27607	Incision (eg, osteomyelitis or bone abscess), leg or ankle	TREAT LOWER LEG BONE LESION
2042	27638	Excision or curettage of bone cyst or benign tumor, tibia or fibula; with allograft	REMOVE/GRAFT LEG BONE LESIO
2043	27704	Removal of ankle implant	REMOVAL OF ANKLE IMPLANT
2044	29902	Arthroscopy, metacarpophalangeal joint, surgical; with reduction of displaced ulnar collateral ligament (eg, Stener lesion)	MCP JOINT ARTHROSCOPY SURG
2045	29914	Arthroscopy, hip, surgical; with femoroplasty (ie, treatment of cam lesion)	HIP ARTHRO W/FEMOROPLASTY
2046	29915	Arthroscopy, hip, surgical; with acetabuloplasty (ie, treatment of pincer lesion)	HIP ARTHRO ACETABULOPLASTY
2047	30000	Drainage abscess or hematoma, nasal, internal approach	DRAINAGE OF NOSE LESION
2048	30200	Injection into turbinate(s), therapeutic	INJECTION TREATMENT OF NOSE
2049	33010	Pericardiocentesis; initial
2050	33141	Transmyocardial laser revascularization, by thoracotomy; performed at the time of other open cardiac procedure(s) (List separately in addition to code for primary procedure)	HEART TMR W/OTHER PROCEDURE
2051	33207	Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); ventricular	INSERT HEART PM VENTRICULAR
2052	33215	Repositioning of previously implanted transvenous pacemaker or implantable defibrillator (right atrial or right ventricular) electrode	REPOSITION PACING-DEFIB LEA
2053	35221	Repair blood vessel, direct; intra-abdominal	REPAIR BLOOD VESSEL LESION
2054	35241	Repair blood vessel with vein graft; intrathoracic, with bypass	REPAIR BLOOD VESSEL LESION
2055	35311	Thromboendarterectomy, including patch graft, if performed; subclavian, innominate, by thoracic incision	RECHANNELING OF ARTERY
2056	35351	Thromboendarterectomy, including patch graft, if performed; iliac	RECHANNELING OF ARTERY
2057	00404	Anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; radical or modified radical procedures on breast	ANESTH SURGERY OF BREAST
2058	00520	Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified	ANESTH CHEST PROCEDURE
2059	00560	Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; without pump oxygenator	ANESTH HEART SURG W/O PUMP
2060	40804	Removal of embedded foreign body, vestibule of mouth; simple	REMOVAL FOREIGN BODY MOUTH
2061	40810	Excision of lesion of mucosa and submucosa, vestibule of mouth; without repair	EXCISION OF MOUTH LESION
2062	40831	Closure of laceration, vestibule of mouth; over 2.5 cm or complex	REPAIR MOUTH LACERATION
2063	19101	Biopsy of breast; open, incisional	BIOPSY OF BREAST OPEN
2064	19120	Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion (except 19300), open, male or female, 1 or more lesions	REMOVAL OF BREAST LESION
2065	19271	Excision of chest wall tumor involving ribs, with plastic reconstruction; without mediastinal lymphadenectomy
2066	19286	Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including ultrasound guidance (List separately in addition to code for primary procedure)	PERQ DEV BREAST ADD US IMAG
2067	19288	Placement of breast localization device(s) (eg clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; each additional lesion, including magnetic resonance guidance (List separately in addition to code for primary procedure)	PERQ DEV BREAST ADD MR GUID
2068	19306	Mastectomy, radical, including pectoral muscles, axillary and internal mammary lymph nodes (Urban type operation)	MAST RAD URBAN TYPE
2069	19342	Delayed insertion of breast prosthesis following mastopexy, mastectomy or in reconstruction	DELAYED BREAST PROSTHESIS
2070	20527	Injection, enzyme (eg, collagenase), palmar fascial cord (ie, Dupuytren's contracture)	INJ DUPUYTREN CORD W/ENZYME
2071	20604	Arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); with ultrasound guidance, with permanent recording and reporting	DRAIN/INJ JOINT/BURSA W/US
2072	20606	Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); with ultrasound guidance, with permanent recording and reporting	DRAIN/INJ JOINT/BURSA W/US
2073	20650	Insertion of wire or pin with application of skeletal traction, including removal (separate procedure)	INSERT AND REMOVE BONE PIN
2074	20661	Application of halo, including removal; cranial	APPLICATION OF HEAD BRACE
2075	20680	Removal of implant; deep (eg, buried wire, pin, screw, metal band, nail, rod or plate)	REMOVAL OF SUPPORT IMPLANT
2076	20692	Application of a multiplane (pins or wires in more than 1 plane), unilateral, external fixation system (eg, Ilizarov, Monticelli type)	APPLY BONE FIXATION DEVICE
2077	20694	Removal, under anesthesia, of external fixation system	REMOVE BONE FIXATION DEVICE
2078	20701	Removal of drug-delivery device(s), deep (eg, subfascial) (List separately in addition to code for primary procedure)	RMVL DEEP RX DELIVERY DEVIC
2079	20703	Removal of drug-delivery device(s), intramedullary (List separately in addition to code for primary procedure)	RMVL IMED RX DELIVERY DEVIC
2080	20934	Allograft, includes templating, cutting, placement and internal fixation, when performed; intercalary, complete (ie, cylindrical) (List separately in addition to code for primary procedure)	INTERCALARY ALGRFT COMPL
2081	20979	Low intensity ultrasound stimulation to aid bone healing, noninvasive (nonoperative)	US BONE STIMULATION
2082	86328	Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])
2083	86409	Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID19]); titer
2084	86769	Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])
2085	Q0243	Injection, casirivimab and imdevimab, 2400 mg
2086	C1890	NO IMPLANTABLE/INSERTABLE DEVICE USED WITH DEVICE-INTENSIVE PROCEDURES
2087	C9756	INTRAOPERATIVE NEAR-INFRARED FLUORESCENCE LYMPHATIC MAPPING OF LYMPH NODE(S) (SENTINEL OR TUMOR DRAINING) WITH ADMINISTRATION OF INDOCYANINE GREEN (ICG) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)
2088	D0419	THIS PROCEDURE IS FOR IDENTIFICATION OF LOW SALIVARY FLOW IN PATIENTS AT RISK FOR HYPOSALIVATION AND XEROSTOMIA, AS WELL AS EFFECTIVENESS OF PHARMACOLOGICAL AGENTS USED TO STIMULATE SALIVA PRODUCTION.
2089	D0605	ANTIBODY TESTING FOR A PUBLIC HEALTH RELATED PATHOGEN, INCLUDING CORONAVIRUS
2090	D0704	3-D PHOTOGRAPHIC IMAGE – IMAGE CAPTURE ONLY
2091	D0707	INTRAORAL – PERIAPICAL RADIOGRAPHIC IMAGE – IMAGE CAPTURE ONLY
2092	D0708	IMAGE AXIS MAY BE HORIZONTAL OR VERTICAL.
2093	D0709	A RADIOGRAPHIC SURVEY OF THE WHOLE MOUTH, USUALLY CONSISTING OF 14-22 IMAGES (PERIAPICAL AND POSTERIOR BITEWING AS INDICATED) INTENDED TO DISPLAY THE CROWNS AND ROOTS OF ALL TEETH, PERIAPICAL AREAS AND ALVEOLAR BONE.
2094	D1321	COUNSELING SERVICES MAY INCLUDE PATIENT EDUCATION ABOUT ADVERSE ORAL, BEHAVIORAL, AND SYSTEMIC EFFECTS ASSOCIATED WITH HIGH-RISK SUBSTANCE USE AND ADMINISTRATION ROUTES. THIS INCLUDES INGESTING, INJECTING, INHALING AND VAPING. SUBSTANCES USED IN A HIGH-RISK MANNER MAY INCLUDE BUT ARE NOT LIMITED TO ALCOHOL, OPIOIDS, NICOTINE, CANNABIS, METHAMPHETAMINE AND OTHER PHARMACEUTICALS OR CHEMICALS.
2095	D1516	SPACE MAINTAINER - FIXED - BILATERAL, MAXILLARY
2096	D1517	SPACE MAINTAINER - FIXED - BILATERAL, MANDIBULAR
2097	D1551	RE-CEMENT OR RE-BOND BILATERAL SPACE MAINTAINER - MAXILLARY
2098	D1552	RE-CEMENT OR RE-BOND BILATERAL SPACE MAINTAINER - MANDIBULAR
2099	D1556	REMOVAL OF FIXED UNILATERAL SPACE MAINTAINER - PER QUADRANT
2100	D1558	REMOVAL OF FIXED BILATERAL SPACE MAINTAINER - MANDIBULAR
2101	D2753	CROWN - PORCELAIN FUSED TO TITANIUM AND TITANIUM ALLOYS
2102	D2928	PREFABRICATED PORCELAIN/CERAMIC CROWN – PERMANENT TOOTH
2103	D3472	FOR SURGERY ON ROOT OF PREMOLAR TOOTH. DOES NOT INCLUDE PLACEMENT OF RESTORATION.
2104	D3473	FOR SURGERY ON ROOT OF MOLAR TOOTH. DOES NOT INCLUDE PLACEMENT OF RESTORATION.
2105	D5282	REMOVABLE UNILATERAL PARTIAL DENTURE – ONE PIECE CAST METAL (INCLUDING RETENTIVE/CLASPING MATERIALS, RESTS, AND TEETH), MAXILLARY
2106	D5283	REMOVABLE UNILATERAL PARTIAL DENTURE – ONE PIECE CAST METAL (INCLUDING RENTENTIVE/CLASPING MATERIAS, RESTS, AND TEETH), MANDIBULAR
2107	D5995	A CUSTOM FABRICATED, LABORATORY PROCESSED CARRIER FOR THE MAXILLARY ARCH THAT COVERS THE TEETH AND ALVEOLAR MUCOSA. USED AS A VEHICLE TO DELIVER PRESCRIBED MEDICAMENTS FOR SUSTAINED CONTACT WITH THE GINGIVA, ALVEOLAR MUCOSA, AND INTO THE PERIODONTAL SULCUS OR POCKET.
2108	D5996	A CUSTOM FABRICATED, LABORATORY PROCESSED CARRIER FOR THE MANDIBULAR ARCH THAT COVERS THE TEETH AND ALVEOLAR MUCOSA. USED AS A VEHICLE TO DELIVER PRESCRIBED MEDICAMENTS FOR SUSTAINED CONTACT WITH THE GINGIVA, ALVEOLAR MUCOSA, AND INTO THE PERIODONTAL SULCUS OR POCKET.
2109	D6098	A METAL-CERAMIC RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2110	D6099	A METAL-CERAMIC RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2111	D6120	A METAL-CERAMIC RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2112	D6121	A METAL RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2113	D6122	A METAL RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2114	D6123	A METAL RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN IMPLANT.
2115	D6195	A METAL-CERAMIC RETAINER FOR A FIXED PARTIAL DENTURE THAT GAINS RETENTION, SUPPORT, AND STABILITY FROM AN ABUTMENT ON AN IMPLANT.
2116	D6243	PONTIC - PORCELAIN FUSED TO TITANIUM AND TITANIUM ALLOYS
2117	D6784	RETAINER CROWN ¾ - TITANIUM AND TITANIUM ALLOYS
2118	D7922	THIS PROCEDURE CAN BE PERFORMED AT TIME AND/OR AFTER EXTRACTION TO AID IN HEMOSTASIS. THE SOCKET IS PACKED WITH A HEMOSTATIC AGENT TO AID IN HEMOSTASIS AND OR CLOT STABILIZATION.
2119	D8696	DOES NOT INCLUDE BRACKET AND STANDARD FIXED ORTHODONTIC APPLIANCES. IT DOES INCLUDE FUNCTIONAL APPLIANCES AND PALATAL EXPANDERS.
2120	D8698	RE-CEMENT OR RE-BOND FIXED RETAINER – MAXILLARY
2121	D8699	RE-CEMENT OR RE-BOND FIXED RETAINER – MANDIBULAR
2122	D8701	REPAIR OF FIXED RETAINER, INCLUDES REATTACHMENT – MAXILLARY
2123	D8703	REPLACEMENT OF LOST OR BROKEN RETAINER – MAXILLARY
2124	D8704	REPLACEMENT OF LOST OR BROKEN RETAINER – MANDIBULAR
2125	D9613	INFILTRATION OF A SUSTAINED RELEASE PHARMACOLOGIC AGENT FOR LONG ACTING SURGICAL SITE PAIN CONTROL. NOT FOR LOCAL ANESTHESIA PURPOSES.
2126	D9946	REMOVABLE DENTAL APPLIANCE DESIGNED TO MINIMIZE THE EFFECTS OF BRUXISM OR OTHER OCCLUSAL FACTORS. PROVIDES ONLY PARTIAL OCCLUSAL COVERAGE SUCH AS ANTERIOR DEPROGRAMMER. NOT TO BE REPORTED FOR ANY TYPE OF SLEEP APNEA, SNORING OR TMD APPLIANCES.
2127	D9990	CERTIFIED TRANSLATION OR SIGN-LANGUAGE SERVICES – PER VISIT
2128	D9997	SPECIAL TREATMENT CONSIDERATIONS FOR PATIENTS/INDIVIDUALS WITH PHYSICAL, MEDICAL, DEVELOPMENTAL OR COGNITIVE CONDITIONS RESULTING IN SUBSTANTIAL FUNCTIONAL LIMITATIONS, WHICH REQUIRE THAT MODIFICATIONS BE MADE TO DELIVERY OF TREATMENT TO PROVIDE COMPREHENSIVE ORAL HEALTH CARE SERVICES.
2129	85445	Heinz bodies; induced, acetyl phenylhydrazine	HEINZ BODIES INDUCED
2130	85611	Prothrombin time; substitution, plasma fractions, each	PROTHROMBIN TEST
2131	86147	Cardiolipin (phospholipid) antibody, each Ig class	CARDIOLIPIN ANTIBODY EA IG
2132	86157	Cold agglutinin; titer	COLD AGGLUTININ TITER
2133	86171	Complement fixation tests, each antigen	COMPLEMENT FIXATION EACH
2134	86277	Growth hormone, human (HGH), antibody	GROWTH HORMONE ANTIBODY
2135	86305	Human epididymis protein 4 (HE4)	HUMAN EPIDIDYMIS PROTEIN 4
2136	86320	Immunoelectrophoresis; serum	SERUM IMMUNOELECTROPHORESIS
2137	86654	Antibody; encephalitis, Western equine	ENCEPHALTIS WEST EQNE ANTBD
2138	Q4129	UNITE BIOMATRIX, PER SQUARE CENTIMETER	Unite biomatrix
2139	Q4131	EPIFIX OR EPICORD, PER SQUARE CENTIMETER	Epifix or epicord
2140	Q5103	INJECTION, INFLIXIMAB-DYYB, BIOSIMILAR, (INFLECTRA), 10 MG	Injection, inflectra
2141	Q9972	INJECTION, EPOETIN BETA, 1 MICROGRAM, (FOR ESRD ON DIALYSIS)	Epoetin Beta, ESRD Use
2142	Q9974	INJECTION, MORPHINE SULFATE, PRESERVATION-FREE FOR EPIDURAL OR INTRATHECAL USE, 10 MG	Morphine epidural/intratheca
2143	Q9992	INJECTION, BUPRENORPHINE EXTENDED-RELEASE (SUBLOCADE), GREATER THAN 100 MG	Buprenorphine xr over 100 mg
2144	S0093	INJECTION, MORPHINE SULFATE, 500 MG (LOADING DOSE FOR INFUSION PUMP)	Morphine 500 mg
2145	S0104	ZIDOVUDINE, ORAL, 100 MG	Zidovudine, oral, 100 mg
2146	S0109	METHADONE, ORAL, 5 MG	Methadone oral 5mg
2147	S0137	DIDANOSINE (DDI), 25 MG	Didanosine, 25 mg
2148	S0156	EXEMESTANE, 25 MG	Exemestane, 25 mg
2149	S0285	COLONOSCOPY CONSULTATION PERFORMED PRIOR TO A SCREENING COLONOSCOPY PROCEDURE	cnslt before screen colonoscopy
2150	S0508	TRIFOCAL VISION PRESCRIPTION LENS (SAFETY, ATHLETIC, OR SUNGLASS), PER LENS	Trifoc prscrp lens
2151	S0618	AUDIOMETRY FOR HEARING AID EVALUATION TO DETERMINE THE LEVEL AND DEGREE OF HEARING LOSS	Audiometry for hearing aid
2152	S1040	CRANIAL REMOLDING ORTHOSIS, PEDIATRIC, RIGID, WITH SOFT INTERFACE MATERIAL, CUSTOM FABRICATED, INCLUDES FITTING AND ADJUSTMENT(S)	Cranial remolding orthosis
2153	S2103	ADRENAL TISSUE TRANSPLANT TO BRAIN	Adrenal tissue transplant
2154	S2117	ARTHROEREISIS, SUBTALAR	Arthroereisis, subtalar
2155	S2140	CORD BLOOD HARVESTING FOR TRANSPLANTATION, ALLOGENEIC	Cord blood harvesting
2156	S2361	EACH ADDITIONAL CERVICAL VERTEBRAL BODY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)	Vertebroplast cerv addl
2157	S2411	FETOSCOPIC LASER THERAPY FOR TREATMENT OF TWIN-TO-TWIN TRANSFUSION SYNDROME	Fetoscop laser ther TTTS
2158	S3721	PROSTATE CANCER ANTIGEN 3 (PCA3) TESTING	Pca3 testing
2159	S3850	GENETIC TESTING FOR SICKLE CELL ANEMIA	Gene test sickle cell
2160	S3900	SURFACE ELECTROMYOGRAPHY (EMG)	Surface EMG
2161	S4991	NICOTINE PATCHES, NON-LEGEND	Nicotine patch nonlegend
2162	S5036	HOME INFUSION THERAPY, REPAIR OF INFUSION DEVICE (E.G. PUMP REPAIR)	HIT device repair
2163	S5161	EMERGENCY RESPONSE SYSTEM; SERVICE FEE, PER MONTH (EXCLUDES INSTALLATION AND TESTING)	Emer rspns sys serv permonth
2164	S8121	OXYGEN CONTENTS, LIQUID, 1 UNIT EQUALS 1 POUND	O2 contents liquid lb
2165	S8189	TRACHEOSTOMY SUPPLY, NOT OTHERWISE CLASSIFIED	Trach supply noc
2166	S8422	GRADIENT PRESSURE AID (SLEEVE), CUSTOM MADE, MEDIUM WEIGHT	Custom grad sleeve med
2167	S8429	GRADIENT PRESSURE EXTERIOR WRAP	Gradient pressure wrap
2168	S9024	PARANASAL SINUS ULTRASOUND	Paranasal sinus ultrasound
2169	S9055	PROCUREN OR OTHER GROWTH FACTOR PREPARATION TO PROMOTE WOUND HEALING	Procuren or other growth fac
2170	S9122	HOME HEALTH AIDE OR CERTIFIED NURSE ASSISTANT, PROVIDING CARE IN THE HOME; PER HOUR	Home health aide or certifie
2171	S9152	SPEECH THERAPY, RE-EVALUATION	Speech therapy, re-eval
2172	S9340	HOME THERAPY; ENTERAL NUTRITION; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (ENTERAL FORMULA AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT enteral per diem
2173	S9343	HOME THERAPY; ENTERAL NUTRITION VIA BOLUS; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (ENTERAL FORMULA AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT enteral bolus nurs
2174	S9357	HOME INFUSION THERAPY, ENZYME REPLACEMENT INTRAVENOUS THERAPY; (E.G. IMIGLUCERASE); ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT enzyme replace diem
2175	S9443	LACTATION CLASSES, NON-PHYSICIAN PROVIDER, PER SESSION	Lactation class
2176	S9472	CARDIAC REHABILITATION PROGRAM, NON-PHYSICIAN PROVIDER, PER DIEM	Cardiac rehabilitation progr
2177	S9482	FAMILY STABILIZATION SERVICES, PER 15 MINUTES	Family stabilization 15 min
2178	S9490	HOME INFUSION THERAPY, CORTICOSTEROID INFUSION; ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT corticosteroid/diem
2179	S9502	HOME INFUSION THERAPY, ANTIBIOTIC, ANTIVIRAL, OR ANTIFUNGAL THERAPY; ONCE EVERY 8 HOURS, ADMINISTRATIVE SERVICES, PROFESSIONAL PHARMACY SERVICES, CARE COORDINATION, AND ALL NECESSARY SUPPLIES AND EQUIPMENT (DRUGS AND NURSING VISITS CODED SEPARATELY), PER DIEM	HIT antibiotic q8h diem
2180	G9767	HOSPITALIZED PATIENTS WITH NEWLY DIAGNOSED CVA CONSIDERED FOR ENDOVASCULAR STROKE TREATMENT	Hosp new dx cva consid evst
2181	G9776	DOCUMENTATION OF MEDICAL REASON FOR NOT RECEIVING AT LEAST 2 PROPHYLACTIC PHARMACOLOGIC ANTI-EMETIC AGENTS OF DIFFERENT CLASSES PREOPERATIVELY AND/OR INTRAOPERATIVELY (E.G., INTOLERANCE OR OTHER MEDICAL REASON)	Doc med rsn no proph antiem
2182	00147	Anesthesia for procedures on eye; iridectomy	ANESTH IRIDECTOMY
2183	81192	NTRK2 (neurotrophic receptor tyrosine kinase 2) (eg, solid tumors) translocation analysis	NTRK2 (neurotrophic receptor tyrosine kinase 2) (eg, solid tumors) translocation analysis
2184	81193	NTRK3 (neurotrophic receptor tyrosine kinase 3) (eg, solid tumors) translocation analysis	NTRK3 (neurotrophic receptor tyrosine kinase 3) (eg, solid tumors) translocation analysis
2185	93243	External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; scanning analysis with report	External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; scanning analysis with report
2186	93248	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation
2187	44388	Colonoscopy through stoma; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)	COLONOSCOPY THRU STOMA SPX
2188	45114	Proctectomy, partial, with anastomosis; abdominal and transsacral approach	PARTIAL REMOVAL OF RECTUM
2189	45172	Excision of rectal tumor, transanal approach; including muscularis propria (ie, full thickness)	EXC RECT TUM TRANSANAL FULL
2190	26445	Tenolysis, extensor tendon, hand OR finger, each tendon	RELEASE HAND/FINGER TENDON
2191	26480	Transfer or transplant of tendon, carpometacarpal area or dorsum of hand; without free graft, each tendon	TRANSPLANT HAND TENDON
2192	26485	Transfer or transplant of tendon, palmar; without free tendon graft, each tendon	TRANSPLANT PALM TENDON
2193	26498	Transfer of tendon to restore intrinsic function; all 4 fingers	FINGER TENDON TRANSFER
2194	49425	Insertion of peritoneal-venous shunt	INSERT ABDOMEN-VENOUS DRAIN
2195	50135	Pyelotomy; complicated (eg, secondary operation, congenital kidney abnormality)	EXPLORATION OF KIDNEY
2196	61885	Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array	INSRT/REDO NEUROSTIM 1 ARRA
2197	62140	Cranioplasty for skull defect; up to 5 cm diameter	REPAIR OF SKULL DEFECT
2198	62160	Neuroendoscopy, intracranial, for placement or replacement of ventricular catheter and attachment to shunt system or external drainage (List separately in addition to code for primary procedure)	NEUROENDOSCOPY ADD-ON
2199	62225	Replacement or irrigation, ventricular catheter	REPLACE/IRRIGATE CATHETER
2200	62230	Replacement or revision of cerebrospinal fluid shunt, obstructed valve, or distal catheter in shunt system	REPLACE/REVISE BRAIN SHUNT
2201	64874	Suture of nerve; requiring extensive mobilization, or transposition of nerve (List separately in addition to code for nerve suture)	REPAIR & REVISE NERVE ADD-O
2202	64886	Nerve graft (includes obtaining graft), head or neck; more than 4 cm length	NERVE GRAFT HEAD/NECK >4 CM
2203	64907	Nerve pedicle transfer; second stage	NERVE PEDICLE TRANSFER
2204	65125	Modification of ocular implant with placement or replacement of pegs (eg, drilling receptacle for prosthesis appendage) (separate procedure)	REVISE OCULAR IMPLANT
2205	65135	Insertion of ocular implant secondary; after enucleation, muscles not attached to implant	INSERT OCULAR IMPLANT
2206	65285	Repair of laceration; cornea and/or sclera, perforating, with reposition or resection of uveal tissue	REPAIR OF EYE WOUND
2207	65426	Excision or transposition of pterygium; with graft	REMOVAL OF EYE LESION
2208	70491	Computed tomography, soft tissue neck; with contrast material(s)	CT SOFT TISSUE NECK W/DYE
2209	71100	Radiologic examination, ribs, unilateral; 2 views	X-RAY EXAM RIBS UNI 2 VIEWS
2210	72070	Radiologic examination, spine; thoracic, 2 views	X-RAY EXAM THORAC SPINE 2VW
2211	72191	Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing	CT ANGIOGRAPH PELV W/O&W/DY
2212	73040	Radiologic examination, shoulder, arthrography, radiological supervision and interpretation	CONTRAST X-RAY OF SHOULDER
2213	73219	Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; with contrast material(s)	MRI UPPER EXTREMITY W/DYE
2214	77333	Treatment devices, design and construction; intermediate (multiple blocks, stents, bite blocks, special bolus)	RADIATION TREATMENT AID(S)
2215	77412	Radiation treatment delivery, >=1 MeV; complex	RADIATION TREATMENT DELIVER
2216	77610	Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators	HYPERTHERMIA TREATMENT
2217	00797	Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; gastric restrictive procedure for morbid obesity	ANESTH SURGERY FOR OBESITY
2218	E0787	External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing	CGS DOSE ADJ INSULIN INF PMP
2219	00813	Anesthesia for combined upper and lower gastrointestinal endoscopic procedures, endoscope introduced both proximal to and distal to the duodenum	ANES UPR LWR GI NDSC PX
2220	00820	Anesthesia for procedures on lower posterior abdominal wall	ANESTH ABDOMINAL WALL SURG
2221	00922	Anesthesia for procedures on male genitalia (including open urethral procedures); seminal vesicles	ANESTH SPERM DUCT SURGERY
2222	10008	Fine needle aspiration biopsy, including fluoroscopic guidance; each additional lesion (List separately in addition to code for primary procedure)	FNA BX W/FLUOR GDN EA ADDL
2223	27392	Tenotomy, open, hamstring, knee to hip; multiple tendons, bilateral	INCISION OF THIGH TENDONS
2224	27400	Transfer, tendon or muscle, hamstrings to femur (eg, Egger's type procedure)	REVISE THIGH MUSCLES/TENDON
2225	27488	Removal of prosthesis, including total knee prosthesis, methylmethacrylate with or without insertion of spacer, knee	REMOVAL OF KNEE PROSTHESIS
2226	27516	Closed treatment of distal femoral epiphyseal separation; without manipulation	TREAT THIGH FX GROWTH PLATE
2227	27532	Closed treatment of tibial fracture, proximal (plateau); with or without manipulation, with skeletal traction	TREAT KNEE FRACTURE
2228	27594	Amputation, thigh, through femur, any level; secondary closure or scar revision	AMPUTATION FOLLOW-UP SURGER
2229	27604	Incision and drainage, leg or ankle; infected bursa	DRAIN LOWER LEG BURSA
2230	81536	Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; each additional single drug or drug combination (List separately in addition to code for primary procedure)	ONCOLOGY GYNECOLOGIC
2231	82163	Angiotensin II	ASSAY OF ANGIOTENSIN II
2232	82247	Bilirubin; total	BILIRUBIN TOTAL
2233	84620	Xylose absorption test, blood and/or urine	XYLOSE TOLERANCE TEST
2234	85041	Blood count; red blood cell (RBC), automated	AUTOMATED RBC COUNT
2235	85097	Bone marrow, smear interpretation	BONE MARROW INTERPRETATION
2236	85302	Clotting inhibitors or anticoagulants; protein C, antigen	CLOT INHIBIT PROT C ANTIGEN
2237	85305	Clotting inhibitors or anticoagulants; protein S, total	CLOT INHIBIT PROT S TOTAL
2238	85380	Fibrin degradation products, D-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitative	FIBRIN DEGRADJ D-DIMER
2239	85730	Thromboplastin time, partial (PTT); plasma or whole blood	THROMBOPLASTIN TIME PARTIAL
2240	86060	Antistreptolysin 0; titer	ANTISTREPTOLYSIN O TITER
2241	87341	Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen (HBsAg) neutralization	HEPATITIS B SURFACE AG IA
2242	87391	Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; HIV-2	HIV-2 AG IA
2243	90386	Rho(D) immune globulin (RhIgIV), human, for intravenous use	RH IG IV
2244	90389	Tetanus immune globulin (TIg), human, for intramuscular use	TETANUS IG IM
2245	M1157	Patient received bone marrow transplant any time during the measurement period	Patient received bone marrow transplant any time during the measurement period
2246	G8599	ASPIRIN OR ANOTHER ANTIPLATELET THERAPY NOT USED, REASON NOT GIVEN	No asa/antiplat ther use rng
2247	G0507	CARE MANAGEMENT SERVICES FOR BEHAVIORAL HEALTH CONDITIONS, AT LEAST 20 MINUTES OF CLINICAL STAFF TIME, DIRECTED BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, PER CALENDAR MONTH, WITH THE FOLLOWING REQUIRED ELEMENTS: INITIAL ASSESSMENT OR FOLLOW-UP MONITORING, INCLUDING THE USE OF APPLICABLE VALIDATED RATING SCALES; BEHAVIORAL HEALTH CARE PLANNING IN RELATION TO BEHAVIORAL/PSYCHIATRIC HEALTH PROBLEMS, INCLUDING REVISION FOR PATIENTS WHO ARE NOT PROGRESSING OR WHOSE STATUS CHANGES; FACILITATING AND COORDINATING TREATMENT SUCH AS PSYCHOTHERAPY, PHARMACOTHERAPY, COUNSELING AND/OR PSYCHIATRIC CONSULTATION; AND CONTINUITY OF CARE WITH A DESIGNATED MEMBER OF THE CARE TEAM	Care manage serv minimum 20
2248	81221	CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variants	CFTR GENE KNOWN FAM VARIANT
2249	81238	F9 (coagulation factor IX) (eg, hemophilia B), full gene sequence	F9 FULL GENE SEQUENCE
2250	81244	FMR1 (fragile X mental retardation 1) (eg, fragile X mental retardation) gene analysis; characterization of alleles (eg, expanded size and promoter methylation status)	FMR1 GENE CHARAC ALLELES
2251	81252	GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequence	GJB2 GENE FULL SEQUENCE
2252	81285	FXN (frataxin) (eg, Friedreich ataxia) gene analysis; characterization of alleles (eg, expanded size)	FXN GENE CHARAC ALLELES
2253	81290	MCOLN1 (mucolipin 1) (eg, Mucolipidosis, type IV) gene analysis, common variants (eg, IVS3-2A>G, del6.4kb)	MCOLN1 GENE
2254	63030	Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc; 1 interspace, lumbar	LOW BACK DISK SURGERY
2255	63048	Laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; each additional segment, cervical, thoracic, or lumbar (List separately in addition to code for primary procedure)	REMOVE SPINAL LAMINA ADD-ON
2256	81443	Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)	GENETIC TSTG SEVERE INH CON
2257	81448	Hereditary peripheral neuropathies (eg, Charcot-Marie-Tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1)	HRDTRY PERPH NEURPHY PANEL
2258	81450	Targeted genomic sequence analysis panel, hematolymphoid neoplasm or disorder, DNA analysis, and RNA analysis when performed, 5-50 genes (eg, BRAF, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS, KIT, MLL, NRAS, NPM1, NOTCH1), interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed	TARGETED GENOMIC SEQ ANALYS
2259	81493	Coronary artery disease, mRNA, gene expression profiling by real-time RT-PCR of 23 genes, utilizing whole peripheral blood, algorithm reported as a risk score	COR ARTERY DISEASE MRNA
2260	81520	Oncology (breast), mRNA gene expression profiling by hybrid capture of 58 genes (50 content and 8 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score	ONC BREAST MRNA 58 GENES
2261	83950	Oncoprotein; HER-2/neu	ONCOPROTEIN HER-2/NEU
2262	84305	Somatomedin	ASSAY OF SOMATOMEDIN
2263	84379	Sugars (mono-, di-, and oligosaccharides); multiple quantitative, each specimen	SUGARS MULTIPLE QUANT
2264	0380T	Computer-aided animation and analysis of time series retinal images for the monitoring of disease progression, unilateral or bilateral, with interpretation and report
2265	0575T	Under Cardiac Procedures with Evaluation on Valves and ICD System	Under Cardiac Procedures with Evaluation on Valves and ICD System
2266	3035F	Oxygen saturation less than or equal to 88% or a PaO2 less than or equal to 55 mm Hg (COPD)	O2 SATURATION<=88%/PAO<=55
2267	3301F	Cancer stage documented in medical record as metastatic and reviewed (ONC)	CANCER STAGE DOCD METAST
2268	4005F	Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed (OP) (IBD)	PHARM THX FOR OP RXD
2269	4054F	Hemodialysis via catheter (ESRD)	HEMODIALYSIS VIA CATHETER
2270	4481F	Patient receiving ACE inhibitor/ARB therapy and beta-blocker therapy for less than 3 months or patient not receiving ACE inhibitor/ARB therapy and beta-blocker therapy (HF)	PT RCVNG ACE/ARB BLKER <3MO
2271	0535F	Dyspnea management plan of care, documented (Pall Cr)	DYSPNEA MNGMNT PLAN DOCD
2272	0550F	Cytopathology report on routine nongynecologic specimen finalized within two working days of accession date (PATH)	CYTOPATH REPORT NONGYN SPCM
2273	1015F	Chronic obstructive pulmonary disease (COPD) symptoms assessed (Includes assessment of at least 1 of the following: dyspnea, cough/sputum, wheezing), or respiratory symptom assessment tool completed (COPD)	COPD SYMPTOMS ASSESS
2274	1019F	Dyspnea assessed, present (COPD)	ASSESS DYSPNEA PRESENT
2275	1031F	Smoking status and exposure to second hand smoke in the home assessed (Asthma)	SMOKING & 2ND HAND ASSESSED
2276	5100F	Potential risk for fracture communicated to the referring physician or other qualified health care professional within 24 hours of completion of the imaging study (NUC_MED)	RSK FX REF W/N 24 HRS XRAY
2277	3096F	Central dual-energy X-ray absorptiometry (DXA) ordered (OP)(IBD)	CENTRAL DEXA ORDERED
2278	0001F	Heart failure assessed (includes assessment of all the following components) (CAD): Blood pressure measured (2000F) Level of activity assessed (1003F) Clinical symptoms of volume overload (excess) assessed (1004F) Weight, recorded (2001F) Clinical signs of volume overload (excess) assessed (2002F)	HEART FAILURE COMPOSITE
2279	3510F	Documentation that tuberculosis (TB) screening test performed and results interpreted (HIV) (IBD)	DOC TB SCRNG-RSLTS INTERPD
2280	0507F	Peritoneal dialysis plan of care documented (ESRD)	PERITON DIALYSIS PLAN DOCD
2281	0521F	Plan of care to address pain documented (COA) (ONC)	PLAN OF CARE 4 PAIN DOCD
2282	0526F	Subsequent visit for episode (BkP)	SUBS VISIT FOR EPISODE
2283	7025F	Patient information entered into a reminder system with a target due date for the next mammogram (RAD)	PT INFOSYS ALARM 4 NXT MAMM
2284	3278F	Serum levels of calcium, phosphorus, intact Parathyroid Hormone (PTH) and lipid profile ordered (CKD)	SERUM LVLS CA/IPTH/LPD ORD
2285	3471F	Rheumatoid arthritis (RA) disease activity, moderate (RA)	RA DISEASE ACTIVITY MOD
2286	3514F	Hepatitis C screening documented as performed (HIV)	HEP C SCRNG DOCD AS DONE
2287	1000F	Tobacco use assessed (CAD, CAP, COPD, PV) (DM)	TOBACCO USE ASSESSED
2288	1180F	All specified thromboembolic risk factors assessed (AFIB)	THROMBOEMB RISK ASSESSED
2289	1461F	No qualifying cardiac event/diagnosis in previous 12 months (CAD)	NO QUAL CARD DIAG PRIOR12MO
2290	1116F	Auricular or periauricular pain assessed (AOE)	AURIC/PERI PAIN ASSESSED
2291	2014F	Mental status assessed (CAP) (EM)	MENTAL STATUS ASSESS
2292	2016F	Asthma risk assessed (Asthma)	ASTHMA RISK ASSESSED
2293	2050F	Wound characteristics including size and nature of wound base tissue and amount of drainage prior to debridement documented (CWC)	WOUND CHAR SIZE ETC DOCD
2294	84479	Thyroid hormone (T3 or T4) uptake or thyroid hormone binding ratio (THBR)	ASSAY OF THYROID (T3 OR T4)
2295	84480	Triiodothyronine T3; total (TT-3)	ASSAY TRIIODOTHYRONINE (T3)
2296	84681	C-peptide	ASSAY OF C-PEPTIDE
2297	85049	Blood count; platelet, automated	AUTOMATED PLATELET COUNT
2298	85270	Clotting; factor XI (PTA)	CLOT FACTOR XI PTA
2299	85335	Factor inhibitor test	FACTOR INHIBITOR TEST
2300	85348	Coagulation time; other methods	COAGULATION TIME OTR METHOD
2301	85384	Fibrinogen; activity	FIBRINOGEN ACTIVITY
2302	85420	Fibrinolytic factors and inhibitors; plasminogen, except antigenic assay	FIBRINOLYTIC PLASMINOGEN
2303	85675	Thrombin time; titer	THROMBIN TIME TITER
2304	64580	Incision for implantation of neurostimulator electrode array; neuromuscular	IMPLANT NEUROELECTRODES
2305	64681	Destruction by neurolytic agent, with or without radiologic monitoring; superior hypogastric plexus	INJECTION TREATMENT OF NERV
2306	87541	Infectious agent detection by nucleic acid (DNA or RNA); Legionella pneumophila, amplified probe technique	LEGION PNEUMO DNA AMP PROB
2307	87640	Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique	STAPH A DNA AMP PROBE
2308	87902	Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus	GENOTYPE DNA/RNA HEP C
2309	87904	Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; each additional drug tested (List separately in addition to code for primary procedure)	PHENOTYPE DNA HIV W/CLT ADD
2310	88142	Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; manual screening under physician supervision	CYTOPATH C/V THIN LAYER
2311	88162	Cytopathology, smears, any other source; extended study involving over 5 slides and/or multiple stains	CYTOPATH SMEAR OTHER SOURCE
2312	88172	Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site	CYTP DX EVAL FNA 1ST EA SIT
2313	86038	Antinuclear antibodies (ANA);	ANTINUCLEAR ANTIBODIES
2314	86356	Mononuclear cell antigen, quantitative (eg, flow cytometry), not otherwise specified, each antigen	MONONUCLEAR CELL ANTIGEN
2315	86653	Antibody; encephalitis, St. Louis	ENCEPHALTIS ST LOUIS ANTBOD
2316	86788	Antibody; West Nile virus, IgM	WEST NILE VIRUS AB IGM
2317	86808	Serum screening for cytotoxic percent reactive antibody (PRA); quick method	CYTOTOXIC ANTIBODY SCREENIN
2318	86850	Antibody screen, RBC, each serum technique	RBC ANTIBODY SCREEN
2319	86923	Compatibility test each unit; electronic	COMPATIBILITY TEST ELECTRIC
2320	50580	Renal endoscopy through nephrotomy or pyelotomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service; with removal of foreign body or calculus	KIDNEY ENDOSCOPY & TREATMEN
2321	50820	Ureteroileal conduit (ileal bladder), including intestine anastomosis (Bricker operation)	CONSTRUCT BOWEL BLADDER
2322	50951	Ureteral endoscopy through established ureterostomy, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service;	ENDOSCOPY OF URETER
2323	51520	Cystotomy; for simple excision of vesical neck (separate procedure)	REMOVAL OF BLADDER LESION
2324	51597	Pelvic exenteration, complete, for vesical, prostatic or urethral malignancy, with removal of bladder and ureteral transplantations, with or without hysterectomy and/or abdominoperineal resection of rectum and colon and colostomy, or any combination thereof	REMOVAL OF PELVIC STRUCTURE
2325	47785	Anastomosis, Roux-en-Y, of intrahepatic biliary ducts and gastrointestinal tract	FUSE BILE DUCTS AND BOWEL
2326	48100	Biopsy of pancreas, open (eg, fine needle aspiration, needle core biopsy, wedge biopsy)	BIOPSY OF PANCREAS OPEN
2327	48145	Pancreatectomy, distal subtotal, with or without splenectomy; with pancreaticojejunostomy	PARTIAL REMOVAL OF PANCREAS
2328	48160	Pancreatectomy, total or subtotal, with autologous transplantation of pancreas or pancreatic islet cells	PANCREAS REMOVAL/TRANSPLANT
2329	48552	Backbench reconstruction of cadaver donor pancreas allograft prior to transplantation, venous anastomosis, each	PREP DONOR PANCREAS/VENOUS
2330	48551	Backbench standard preparation of cadaver donor pancreas allograft prior to transplantation, including dissection of allograft from surrounding soft tissues, splenectomy, duodenotomy, ligation of bile duct, ligation of mesenteric vessels, and Y-graft arterial anastomoses from iliac artery to superior mesenteric artery and to splenic artery	PREP DONOR PANCREAS
2331	49205	Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor greater than 10.0 cm diameter	EXC ABD TUM OVER 10 CM
2332	49320	Laparoscopy, abdomen, peritoneum, and omentum, diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)	DIAG LAPARO SEPARATE PROC
2333	49321	Laparoscopy, surgical; with biopsy (single or multiple)	LAPAROSCOPY BIOPSY
2334	61210	Burr hole(s); for implanting ventricular catheter, reservoir, EEG electrode(s), pressure recording device, or other cerebral monitoring device (separate procedure)	PIERCE SKULL IMPLANT DEVICE
2335	61315	Craniectomy or craniotomy for evacuation of hematoma, infratentorial; intracerebellar	OPEN SKULL FOR DRAINAGE
2336	61321	Craniectomy or craniotomy, drainage of intracranial abscess; infratentorial	OPEN SKULL FOR DRAINAGE
2337	61516	Craniectomy, trephination, bone flap craniotomy; for excision or fenestration of cyst, supratentorial	REMOVAL OF BRAIN LESION
2338	61522	Craniectomy, infratentorial or posterior fossa; for excision of brain abscess	REMOVAL OF BRAIN ABSCESS
2339	61563	Excision, intra and extracranial, benign tumor of cranial bone (eg, fibrous dysplasia); without optic nerve decompression	EXCISION OF SKULL TUMOR
2340	61584	Orbitocranial approach to anterior cranial fossa, extradural, including supraorbital ridge osteotomy and elevation of frontal and/or temporal lobe(s); without orbital exenteration	ORBITOCRANIAL APPROACH/SKUL
2341	61635	Transcatheter placement of intravascular stent(s), intracranial (eg, atherosclerotic stenosis), including balloon angioplasty, if performed	INTRACRAN ANGIOPLSTY W/STEN
2342	61751	Stereotactic biopsy, aspiration, or excision, including burr hole(s), for intracranial lesion; with computed tomography and/or magnetic resonance guidance	BRAIN BIOPSY W/CT/MR GUIDE
2343	61770	Stereotactic localization, including burr hole(s), with insertion of catheter(s) or probe(s) for placement of radiation source	INCISE SKULL FOR TREATMENT
2344	88304	Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologic fracture Bursa/synovial cyst Carpal tunnel tissue Cartilage, shavings Cholesteatoma Colon, colostomy stoma Conjunctiva - biopsy/pterygium Cornea Diverticulum - esophagus/small intestine Dupuytren's contracture tissue Femoral head, other than fracture Fissure/fistula Foreskin, other than newborn Gallbladder Ganglion cyst Hematoma Hemorrhoids Hydatid of Morgagni Intervertebral disc Joint, loose body Meniscus Mucocele, salivary Neuroma - Morton's/traumatic Pilonidal cyst/sinus Polyps, inflammatory - nasal/sinusoidal Skin - cyst/tag/debridement Soft tissue, debridement Soft tissue, lipoma Spermatocele Tendon/tendon sheath Testicular appendage Thrombus or embolus Tonsil and/or adenoids Varicocele Vas deferens, other than sterilization Vein, varicosity	TISSUE EXAM BY PATHOLOGIST
2345	21256	Reconstruction of orbit with osteotomies (extracranial) and with bone grafts (includes obtaining autografts) (eg, micro-ophthalmia)	RECONSTRUCTION OF ORBIT
2346	88321	Consultation and report on referred slides prepared elsewhere	MICROSLIDE CONSULTATION
2347	62268	Percutaneous aspiration, spinal cord cyst or syrinx	DRAIN SPINAL CORD CYST
2348	62322	Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance	NJX INTERLAMINAR LMBR/SAC
2349	62327	Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)	NJX INTERLAMINAR LMBR/SAC
2350	62350	Implantation, revision or repositioning of tunneled intrathecal or epidural catheter, for long-term medication administration via an external pump or implantable reservoir/infusion pump; without laminectomy	IMPLANT SPINAL CANAL CATH
2351	94619	Exercise test for bronchospasm, including pre- and post-spirometry and pulse oximetry; without electrocardiographic recording(s)	Exercise test for bronchospasm, including pre- and post-spirometry and pulse oximetry; without electrocardiographic recording(s)
2352	93246	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)
2353	93247	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report	External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report
2354	G2179	Clinician documented that patient had medical reason for not performing lower extremity neurological exam	Med doc rsn no low ex
2355	G2181	Bmi not documented due to medical reason or patient refusal of height or weight measurement	Bmi not doc medrsn ptref
2356	G2183	Documentation patient unable to communicate and informant not available	Doc pt unable comm
2357	G2184	Patient does not have a caregiver	No caregiver
2358	G2185	Documentation caregiver is trained and certified in dementia care	Caregiver dem trained
2359	G2189	Patients with clinical indications for imaging of the head: abnormal neurologic exam	Img hd abnml neuro exam
2360	G2191	Patients with clinical indications for imaging of the head: positional headaches	Ind img hd pos hd ache
2361	G2192	Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age	>55 yrs temp hd ache
2362	G2196	Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method	Screen unhlthy etoh use
2363	G2197	Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user	Screen hlthy etoh use
2364	C9772	Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed	Revasc lithotrip tibi/perone
2365	C9773	Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed	Revasc lithotr-stent tib/per
2366	G2209	Patient refused to participate	Refused to participate
2367	G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	Complex e/m visit add on
2368	G2213	Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)	Initiat med assist tx in er
2369	G2214	Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional	Init/sub psych care m 1st 30
2370	G2251	Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5?10 minutes of clinical discussion	Brief chkin, 5-10, non-e/m
2371	G2252	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion	Brief chkin by md/qhp, 11-20
2372	J7212	Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram	Factor viia recomb sevenfact
2373	J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	Daratumumab, hyaluronidase
2374	00215	Anesthesia for intracranial procedures; cranioplasty or elevation of depressed skull fracture, extradural (simple or compound)	ANESTH SKULL REPAIR/FRACT
2375	22514	Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; lumbar	PERQ VERTEBRAL AUGMENTATION
2376	23020	Capsular contracture release (eg, Sever type procedure)	RELEASE SHOULDER JOINT
2377	23105	Arthrotomy; glenohumeral joint, with synovectomy, with or without biopsy	REMOVE SHOULDER JOINT LININ
2378	23107	Arthrotomy, glenohumeral joint, with joint exploration, with or without removal of loose or foreign body	EXPLORE TREAT SHOULDER JOIN
2379	23155	Excision or curettage of bone cyst or benign tumor of proximal humerus; with autograft (includes obtaining graft)	REMOVAL OF HUMERUS LESION
2380	26135	Synovectomy, metacarpophalangeal joint including intrinsic release and extensor hood reconstruction, each digit	REVISE FINGER JOINT EACH
2381	26180	Excision of tendon, finger, flexor or extensor, each tendon	REMOVAL OF FINGER TENDON
2382	26415	Excision of extensor tendon, with implantation of synthetic rod for delayed tendon graft, hand or finger, each rod	EXCISION HAND/FINGER TENDON
2383	26420	Repair, extensor tendon, finger, primary or secondary; with free graft (includes obtaining graft) each tendon	REPAIR/GRAFT FINGER TENDON
2384	29846	Arthroscopy, wrist, surgical; excision and/or repair of triangular fibrocartilage and/or joint debridement	WRIST ARTHROSCOPY/SURGERY
2385	29873	Arthroscopy, knee, surgical; with lateral release	KNEE ARTHROSCOPY/SURGERY
2386	29893	Endoscopic plantar fasciotomy	SCOPE PLANTAR FASCIOTOMY
2387	29898	Arthroscopy, ankle (tibiotalar and fibulotalar joints), surgical; debridement, extensive	ANKLE ARTHROSCOPY/SURGERY
2388	29916	Arthroscopy, hip, surgical; with labral repair	HIP ARTHRO W/LABRAL REPAIR
2389	30110	Excision, nasal polyp(s), simple	REMOVAL OF NOSE POLYP(S)
2390	30115	Excision, nasal polyp(s), extensive	REMOVAL OF NOSE POLYP(S)
2391	00120	Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified	ANESTH EAR SURGERY
2392	01963	Anesthesia for cesarean hysterectomy without any labor analgesia/anesthesia care	ANESTH CS HYSTERECTOMY
2393	00731	Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified	ANES UPR GI NDSC PX NOS
2394	00756	Anesthesia for hernia repairs in upper abdomen; transabdominal repair of diaphragmatic hernia	ANESTH REPAIR OF HERNIA
2395	00830	Anesthesia for hernia repairs in lower abdomen; not otherwise specified	ANESTH REPAIR OF HERNIA
2396	10036	Placement of soft tissue localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous, including imaging guidance; each additional lesion (List separately in addition to code for primary procedure)	PERQ DEV SOFT TISS ADD IMAG
2397	10040	Acne surgery (eg, marsupialization, opening or removal of multiple milia, comedones, cysts, pustules)	ACNE SURGERY
2398	10060	Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); simple or single	DRAINAGE OF SKIN ABSCESS
2399	15829	Rhytidectomy; superficial musculoaponeurotic system (SMAS) flap	REMOVAL OF SKIN WRINKLES
2400	15838	Excision, excessive skin and subcutaneous tissue (includes lipectomy); submental fat pad	EXCISE EXCESS SKIN FAT PAD
2401	15839	Excision, excessive skin and subcutaneous tissue (includes lipectomy); other area	EXCISE EXCESS SKIN & TISSUE
2402	43825	Gastrojejunostomy; with vagotomy, any type	FUSION OF STOMACH AND BOWEL
2403	43842	Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty	V-BAND GASTROPLASTY
2404	44227	Laparoscopy, surgical, closure of enterostomy, large or small intestine, with resection and anastomosis	LAP CLOSE ENTEROSTOMY
2405	44310	Ileostomy or jejunostomy, non-tube	ILEOSTOMY/JEJUNOSTOMY
2406	23500	Closed treatment of clavicular fracture; without manipulation	TREAT CLAVICLE FRACTURE
2407	23570	Closed treatment of scapular fracture; without manipulation	TREAT SHOULDER BLADE FX
2408	23802	Arthrodesis, glenohumeral joint; with autogenous graft (includes obtaining graft)	FUSION OF SHOULDER JOINT
2409	24065	Biopsy, soft tissue of upper arm or elbow area; superficial	BIOPSY ARM/ELBOW SOFT TISSU
2410	24077	Radical resection of tumor (eg, sarcoma), soft tissue of upper arm or elbow area; less than 5 cm	RESECT ARM/ELBOW TUM < 5 CM
2411	G9470	PATIENTS NOT RECEIVING CORTICOSTEROIDS GREATER THAN OR EQUAL TO 10 MG/DAY OF PREDNISONE EQUIVALENTS FOR 60 OR GREATER CONSECUTIVE DAYS OR A SINGLE PRESCRIPTION EQUATING TO 600MG PREDNISONE OR GREATER FOR ALL FILLS	No rec cortico>60d 1rx 600mg
2412	G9481	Remote in-home visit for the evaluation and management of a new patient for use only in the Medicare-approved Comprehensive Care for Joint Replacement model, which requires these 3 key components: A problem focused history; A problem focused examination; and Straightforward medical decision making, furnished in real time using interactive audio and video technology. Counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology.	Remote E/M new pt 10mins
2413	31201	Ethmoidectomy; intranasal, total	REMOVAL OF ETHMOID SINUS
2414	31231	Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)	NASAL ENDOSCOPY DX
2415	B4187	Omegaven, 10 grams lipids	OMEGAVEN, 10 GRAMS LIPIDS
2416	G9603	PATIENT SURVEY SCORE IMPROVED FROM BASELINE FOLLOWING TREATMENT	Pt surv improv bsline tx
2417	G9657	TRANSFER OF CARE DURING AN ANESTHETIC OR TO THE INTENSIVE CARE UNIT	Toc dur aneth to icu
2418	G9658	A TRANSFER OF CARE PROTOCOL OR HANDOFF TOOL/CHECKLIST THAT INCLUDES THE REQUIRED KEY HANDOFF ELEMENTS IS NOT USED	Toc tool incl elem not used
2419	G9787	PATIENT ALIVE AS OF THE LAST DAY OF THE MEASUREMENT YEAR	Pt alive
2420	G9832	AJCC STAGE AT BREAST CANCER DIAGNOSIS = I (IA OR IB) AND T-STAGE AT BREAST CANCER DIAGNOSIS DOES NOT EQUAL = T1, T1A, T1B	Brt ca dx i, no t1/t1a/t1b
2421	H1005	PRENATAL CARE, AT-RISK ENHANCED SERVICE PACKAGE (INCLUDES H1001-H1004)	Prenatalcare enhanced srv pk
2422	H2020	THERAPEUTIC BEHAVIORAL SERVICES, PER DIEM	Ther behav svc, per diem
2423	G9922	Safety concerns screen provided and if positive then documented mitigation recommendations	Sfty cncrns scrn nd mit recs
2424	G9954	Patient exhibits 2 or more risk factors for post-operative vomiting	Pt >2 rsk fac post-op vomit
2425	G9961	Systemic antimicrobials prescribed	Systemic antimicro presc
2426	00700	Anesthesia for procedures on upper anterior abdominal wall; not otherwise specified	ANESTH ABDOMINAL WALL SURG
2427	00730	Anesthesia for procedures on upper posterior abdominal wall	ANESTH ABDOMINAL WALL SURG
2428	H0036	COMMUNITY PSYCHIATRIC SUPPORTIVE TREATMENT, FACE-TO-FACE, PER 15 MINUTES	Comm psy face-face per 15min
2429	00870	Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; cystolithotomy	ANESTH BLADDER STONE SURG
2430	J9316	Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg	Pertuzu, trastuzu, 10 mg
2431	G9982	Remote in-home visit for the evaluation and management of a new patient for use only in a Medicare-approved Bundled Payments for Care Improvement Advanced (BPCI Advanced) model episode of care, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity, furnished in real time using interactive audio and video technology. Counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology.	Remote E/M new pt 60mins
2432	G9985	Remote in-home visit for the evaluation and management of an established patient for use only in a Medicare-approved Bundled Payments for Care Improvement Advanced (BPCI Advanced) model episode of care, which requires at least 2 of the following 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. Counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology.	Remote E/M est. pt 25mins
2433	H0027	ALCOHOL AND/OR DRUG PREVENTION ENVIRONMENTAL SERVICE (BROAD RANGE OF EXTERNAL ACTIVITIES GEARED TOWARD MODIFYING SYSTEMS IN ORDER TO MAINSTREAM PREVENTION THROUGH POLICY AND LAW)	Alcohol and/or drug preventi
2434	H0034	MEDICATION TRAINING AND SUPPORT, PER 15 MINUTES	Med trng & support per 15min
2435	J0178	INJECTION, AFLIBERCEPT, 1 MG	Aflibercept injection
2436	J0190	INJECTION, BIPERIDEN LACTATE, PER 5 MG	Inj biperiden lactate/5 mg
2437	J0200	INJECTION, ALATROFLOXACIN MESYLATE, 100 MG	Alatrofloxacin mesylate
2438	J0490	INJECTION, BELIMUMAB, 10 MG	Belimumab injection
2439	J0561	INJECTION, PENICILLIN G BENZATHINE, 100,000 UNITS	Penicillin g benzathine inj
2440	J0594	INJECTION, BUSULFAN, 1 MG	Busulfan injection
2441	J0598	INJECTION, C-1 ESTERASE INHIBITOR (HUMAN), CINRYZE, 10 UNITS	C-1 esterase, cinryze
2442	J0717	INJECTION, CERTOLIZUMAB PEGOL, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)	Certolizumab pegol inj 1mg
2443	J0770	INJECTION, COLISTIMETHATE SODIUM, UP TO 150 MG	Colistimethate sodium inj
2444	J0878	INJECTION, DAPTOMYCIN, 1 MG	Daptomycin injection
2445	J1096	Dexamethasone, lacrimal ophthalmic insert, 0.1 mg	DEXAMETHA OPTH INSERT 0.1 M
2446	J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	PHENYLEP KETOROLAC OPTH SOL
2447	J1110	INJECTION, DIHYDROERGOTAMINE MESYLATE, PER 1 MG	Inj dihydroergotamine mesylt
2448	J1250	INJECTION, DOBUTAMINE HYDROCHLORIDE, PER 250 MG	Inj dobutamine HCL/250 mg
2449	J1439	INJECTION, FERRIC CARBOXYMALTOSE, 1MG	Inj ferric carboxymaltos 1mg
2450	J1447	INJECTION, TBO-FILGRASTIM, 1 MICROGRAM	Inj tbo filgrastim 1 microg
2451	J1580	INJECTION, GARAMYCIN, GENTAMICIN, UP TO 80 MG	Garamycin gentamicin inj
2452	J1642	INJECTION, HEPARIN SODIUM, (HEPARIN LOCK FLUSH), PER 10 UNITS	Inj heparin sodium per 10 u
2453	J1815	INJECTION, INSULIN, PER 5 UNITS	Insulin injection
2454	J2248	INJECTION, MICAFUNGIN SODIUM, 1 MG	Micafungin sodium injection
2455	J2300	INJECTION, NALBUPHINE HYDROCHLORIDE, PER 10 MG	Inj nalbuphine hydrochloride
2456	J2326	Injection, nusinersen, 0.1 mg	Inj, nusinersen, 0.1mg
2457	J2680	INJECTION, FLUPHENAZINE DECANOATE, UP TO 25 MG	Fluphenazine decanoate 25 MG
2458	J2995	INJECTION, STREPTOKINASE, PER 250,000 IU	Inj streptokinase /250000 IU
2459	J3111	Injection, romosozumab-aqqg, 1 mg	INJ. ROMOSOZUMAB-AQQG 1 MG
2460	J3145	INJECTION, TESTOSTERONE UNDECANOATE, 1 MG	Testosterone undecanoate 1mg
2461	J3485	INJECTION, ZIDOVUDINE, 10 MG	Zidovudine
2462	J3530	NASAL VACCINE INHALATION	Nasal vaccine inhalation
2463	J7170	Injection, emicizumab-kxwh, 0.5 mg	Inj., emicizumab-kxwh 0.5 mg
2464	J7185	INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) (XYNTHA), PER I.U.	Xyntha inj
2465	J7188	INJECTION, VON WILLEBRAND FACTOR COMPLEX, HUMAN, IU	Inj Vonwillebrand factor iu
2466	J7190	FACTOR VIII (ANTIHEMOPHILIC FACTOR, HUMAN) PER I.U.	Factor viii
2467	J0591	Injection, deoxycholic acid, 1 mg	INJ DEOXYCHOLIC ACID, 1 MG
2468	J7626	BUDESONIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, UP TO 0.5 MG	Budesonide non-comp unit
2469	J8520	CAPECITABINE, ORAL, 150 MG	Capecitabine, oral, 150 mg
2470	J8540	DEXAMETHASONE, ORAL, 0.25 MG	Oral dexamethasone
2471	J8560	ETOPOSIDE; ORAL, 50 MG	Etoposide oral 50 MG
2472	J8650	NABILONE, ORAL, 1 MG	Nabilone oral
2473	J9027	INJECTION, CLOFARABINE, 1 MG	Clofarabine injection
2474	J9155	INJECTION, DEGARELIX, 1 MG	Degarelix injection
2475	J9171	INJECTION, DOCETAXEL, 1 MG	Docetaxel injection
2476	J9229	Injection, inotuzumab ozogamicin, 0.1 mg	Inj inotuzumab ozogam 0.1 mg
2477	J9267	INJECTION, PACLITAXEL, 1 MG	Paclitaxel injection
2478	J9351	INJECTION, TOPOTECAN, 0.1 MG	Topotecan injection
2479	K0037	High mount flip-up footrest, each	Hi mount flip-up footrest ea
2480	K0604	REPLACEMENT BATTERY FOR EXTERNAL INFUSION PUMP OWNED BY PATIENT, LITHIUM, 3.6 VOLT, EACH	Repl batt lithium 3.6 v
2481	15620	Delay of flap or sectioning of flap (division and inset); at forehead, cheeks, chin, neck, axillae, genitalia, hands, or feet	DELAY FLAP F/C/C/N/AX/G/H/F
2482	15946	Excision, ischial pressure ulcer, with ostectomy, in preparation for muscle or myocutaneous flap or skin graft closure	REMOVE HIP PRESSURE SORE
2483	00142	Anesthesia for procedures on eye; lens surgery	ANESTH LENS SURGERY
2484	00174	Anesthesia for intraoral procedures, including biopsy; excision of retropharyngeal tumor	ANESTH PHARYNGEAL SURGERY
2485	00212	Anesthesia for intracranial procedures; subdural taps	ANESTH SKULL DRAINAGE
2486	35286	Repair blood vessel with graft other than vein; lower extremity	REPAIR BLOOD VESSEL LESION
2487	35303	Thromboendarterectomy, including patch graft, if performed; popliteal artery	RECHANNELING OF ARTERY
2488	63101	Vertebral corpectomy (vertebral body resection), partial or complete, lateral extracavitary approach with decompression of spinal cord and/or nerve root(s) (eg, for tumor or retropulsed bone fragments); thoracic, single segment	REMOVE VERT BODY DCMPRN THR
2489	63197	Laminectomy with cordotomy, with section of both spinothalamic tracts, 1 stage; thoracic	INCISE SPINE&CORD 2 TRX THR
2490	63277	Laminectomy for biopsy/excision of intraspinal neoplasm; extradural, lumbar	BX/EXC XDRL SPINE LESN LMBR
2491	63301	Vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; extradural, thoracic by transthoracic approach	REMOVE VERT XDRL BODY THRC
2492	63304	Vertebral corpectomy (vertebral body resection), partial or complete, for excision of intraspinal lesion, single segment; intradural, cervical	REMOVE VERT IDRL BODY CRVCL
2493	63685	Insertion or replacement of spinal neurostimulator pulse generator or receiver, direct or inductive coupling	INSRT/REDO SPINE N GENERATO
2494	64595	Revision or removal of peripheral or gastric neurostimulator pulse generator or receiver	REVISE/RMV PN/GASTR STIMUL
2495	64612	Chemodenervation of muscle(s); muscle(s) innervated by facial nerve, unilateral (eg, for blepharospasm, hemifacial spasm)	DESTROY NERVE FACE MUSCLE
2496	64625	Radiofrequency ablation, nerves innervating the sacroiliac joint, with image guidance (ie, fluoroscopy or computed tomography)	RF ABLTJ NRV NRVTG SI JT
2497	64636	Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure)	DESTROY L/S FACET JNT ADDL
2498	14041	Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10.1 sq cm to 30.0 sq cm	TIS TRNFR F/C/C/M/N/A/G/H/F
2499	15040	Harvest of skin for tissue cultured skin autograft, 100 sq cm or less	HARVEST CULTURED SKIN GRAFT
2500	64640	Destruction by neurolytic agent; other peripheral nerve or branch	INJECTION TREATMENT OF NERV

The file is too large to be shown. View Raw

2.6 MiB Raw Blame History

2.6 MiB

Raw Blame History